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Haematopoietic stem cells (HSCs) have been described as potential therapeutic agents for the repair 
of several inflammatory injuries including inflammatory bowel diseases (IBDs).  However, their 
efficacy within clinics has been poor.  This has been partially attributed to poor recruitment to sites 
of injury.  Thus identifying the mechanisms by which HSCs are recruited to inflamed bowel, and 
developing strategies to enhance this recruitment, may increase their clinical efficacy.  Critical 
adhesive mechanisms and several pre-treatment strategies to enhance adhesion to chronically (DSS 
induced colitis) and acutely (IR) injured murine colon were investigated in vitro and in vivo.  It was 
found that recruitment to IR injured colon was mediated by CD49d, whereas recruitment to colitic 
colon was mediated by both CD18 and CD49d.  In vitro investigation revealed that both hydrogen 
peroxide (H2O2) and platelet derived pre-treatments, such as coating HSCs with platelet 
microparticles (PMPs), could enhance adhesion to colon endothelial cells, immobilised endothelial 
counterligands ICAM-1 and VCAM-1 and frozen tissue sections.  Furthermore, pre-treatment of HSCs 
with PMPs significantly enhanced their adhesion to chronically injured colon in vivo.  These increases 
in adhesion were likely to be attributed to the altered distribution of integrins on the HSC surface as 
determined confocally.  Furthermore, electron micrscopy showed that pre-treatment also resulted in 
overt HSC morphological changes reminiscent of activated macrophages.  Overall, these 
investigations describe a two-component recruitment mechanism for pre-treated cells in which 
enhanced recruitment is dependent on both activation of stem cells and also vascular endothelium.  
These studies provide novel evidence that pre-treatment of HSCs can result in their increased 
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1.1 Inflammatory Disorders of the Colon 
1.1.1 Inflammatory Bowel Disease  
Inflammatory bowel diseases (IBD) are a group of conditions that cause inflammation, particularly of 
the large bowel or colon.  The most common forms of autoimmune chronic IBD are Crohn’s disease 
and ulcerative colitis (UC); however, the aetiology of these life-long diseases still remains unknown.  
IBD is associated with significant morbidity and mortality as both Crohn’s and colitis can develop into 
gastrointestinal and colon cancers respectively.  Within the UK, the incidence of Crohn’s and colitis is 
approximately 1 in 200 people and is predicted to rise (Arnot et al., 2012).  In the USA, more than 1 
million new cases of IBD are identified annually (Singh et al., 2010).  Associated with rising worldwide 
incidence is the increase in the costs of treatment, with half the costs linked to relapsing patients 
(Arnot et al., 2012).   
 
Crohn’s affects all layers of the entire gastrointestinal tract (GIT) whereas UC primarily affects the 
lining or mucosa of the colon (Singh et al., 2010).  Common symptoms associated with these 
conditions include diarrhoea, rectal bleeding, urgency and abdominal cramps.  The GIT mucosa is 
lined by a simple epithelial layer which experiences continuous cell loss due to high rates of 
mechanical attrition, with cells constantly shed into the gut lumen.  However, both the mucosal villi 
of the small intestine and the mucosal crypts of the colon constantly receive new cells and thus have 
a high turnover rate.  This is a highly regulated process involving local stem cells located in the base 
of the mucosal crypts, referred to as ‘intestinal stem cells’ (van Leeuwen et al., 2009).  These stem 
cells provide daughter cells which migrate upwards into the intestinal villi or colonic crypts and 
differentiate either into absorptive (epithelial) or secretory (goblet, Paneth, enteroendocrine) cells.  
However, following serious tissue injury such as Crohn’s disease, UC, ischaemic damage, traumatic 
injury or necrotising enterocolitis, the auto-regenerative capacity of these local stem cells becomes 
insufficient to allow complete tissue repair, which therefore leads to long term problems.   
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1.1.2  Pathology of Colon Colitis Injury 
The pathology of colitis, which primarily affects the large bowel or colon, involves oedema, 
inflammation, ulceration, loss of goblet and crypt cells and decreased mucus production (Koboziev et 
al., 2010).  The many different alterations to the normal intestinal function may be triggered by 
environmental or genetic susceptibilities, although the exact aetiology of the disease still remains 
unknown (Cromer et al., 2011).  It has also been suggested that, in patients with colitis, the apparent 
lack of a mucous layer overlying the lining of the colon epithelial cells over-exposes them to large 
amounts of lumenal bacteria, either host or pathogenic (Cario and Podolsky, 2000). This has been 
shown to increase the risk of colitis in humans and in mice (Morohoshi et al., 2006, Asquith et al., 
2010, Maloy and Powrie, 2011).  Receptors on colon epithelial cells, namely toll-like receptors, 
become activated by lumenal bacteria, which trigger the release of inflammatory cytokines and 
chemokines.  The lack of a protective mucous barrier means bacteria also translocate or gain access 
between epithelial cells where they can activate resident immune cells in the colon, further 
promoting cyto/chemokine release from these cells as well (Cario and Podolsky, 2000).  Hence the 
innate and adaptive immune system is activated leading to significant neutrophil and lymphocyte 
infiltration into the mucosa (Ortega-Cava et al., 2003, Pallone et al., 2003, Singh et al., 2003, Sands 
and Kaplan, 2007).    
 
Cyto/chemokines are well known to activate cell adhesion molecules (CAMs), including integrins and 
selectins, on leukocytes and also CAMs on endothelial cells (intercellular adhesion molecule-1 (ICAM-
1); vascular cell adhesion molecules (VCAM-1); mucosal addressin cell adhesion molecule-1 
(MAdCAM-1)).  Interestingly, increased expression of CAMs is associated with increased colitis injury 
severity and has been demonstrated to occur across several experimental models of UC and in 
human IBDs (Kawachi et al., 2000, Bardin et al., 2006, Cromer et al., 2011).  Soriano et al. (2000) 
further demonstrated that although blockade of both endothelial VCAM-1 and MAdCAM-1 reduced 
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leukocyte adhesion, only blockade of VCAM-1 attenuated the colitis injury.  However, this is not 
consistent throughout the literature, where several laboratories have identified roles for ICAM-1 in 
experimental colitis progression as well as VCAM-1 and MAdCAM-1 (Wong et al., 1995, Hamamoto et 
al., 1999, Farkas et al., 2006, Panes et al., 2007).  This variation is likely due to differences between 
the experimental models used, the severity of the injury or the time point at which inflammation was 
investigated. 
 
1.1.3  Inflammatory Cells Involved in Colitis Injury 
The cellular component of the colitic inflammation is characterised by enhanced leukocyte 
infiltration into colonic tissue, which is predominantly mononuclear although polymorphonuclear 
cells are also present in the early stages of the disease (Shimoyama et al., 2001, Koboziev et al., 
2010).  This cellular component is considered to be a key component in the pathogenesis of colitis.  
The increased adhesive properties of the injured colon microvasculature triggers substantial 
recruitment of neutrophils which subsequently leads to tissue degradation and an increase in pro-
inflammatory mediators in the surrounding tissue.  This subsequently triggers the activation of T cells 
within the inflamed tissue further exacerbating the immune response (Cromer et al., 2011).   
 
Furthermore, within colitic injured tissue there is often a dysfunction within the antigen presenting 
components of the tissue leading to poor immune regulation and a resulting heightened immune 
response (Varol et al., 2009).  However, it has also been reported that in colitis tissue, there is not 
only an increase in activated immune responses but other immunological changes.    It has also been 
identified that in the rat dextran sodium sulfate (DSS)-induced colitis model there was a significant 
alteration in the immune profile of gut associated lymphoid tissue (GALT), whereby there was an 
increase in cytotoxic T cell populations with a decrease in helper T cell populations (Lenoir et al., 
2011).   
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In addition to leukocytes, there are over two decades of observations that platelet activity and 
thrombosis are directly involved in the pathogenesis of colitis, both in experimental animal models 
and in humans, and is a considerable cause of morbidity (Collins et al., 1994, Collins and Rampton, 
1997, Stadnicki, 2012, Tabibian and Streiff, 2012).  This is likely to occur in parallel to the increase in 
coagulation cascade components observed early in IBD (Anthoni et al., 2007, Vowinkel et al., 2007a) 
as well as an increased thrombogenic phenotype on vascular endothelial cells, as exhibited by an 
increased platelet-endothelial cell adhesion molecule-1 (PECAM-1) and P-selectin expression (Mori et 
al., 2005a, Fagerstam and Whiss, 2006). Furthermore, it is interesting to note that people suffering 
with IBDs have an increased likelihood to having genetic pro-thrombotic disease, whereas those with 
coagulation disorders rarely develop IBDs (Cromer et al., 2011). However, it is still unknown as to 
whether platelet activation and coagulation is an initiating event in IBDs or occurs as a consequence 
of the chronic inflammation (Cromer et al., 2011).  
 
Interestingly, the platelet activation and subsequent adhesion in the microcirculation also results in 
production of leukocyte-platelet aggregates, which have been suggested to be a potential trigger for 
a systemic inflammatory response (Irving et al., 2004, Anthoni et al., 2007).  Leukocyte recruitment in 
colitis, as well as an increase in endothelial and immune cell CAMs, has also been shown to be 
dependent on platelets, which are capable of releasing a host of pro-inflammatory mediators into 
the injury microenvironment (Mannaioni et al., 1997, Mori et al., 2005a, Vowinkel et al., 2007a, 
Vowinkel et al., 2007b).   
 
Another consequence of the enhanced platelet activity observed in IBDs is the subsequent increase 
in the platelet microparticle (PMP) numbers in the blood.  Indeed, it has been identified that in 
patients with IBD there is an increase in circulating PMPs (Andoh et al., 2006, Palkovits et al., 2012) 
and, interestingly, the increased number has been positively correlated with disease activity (Andoh 
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et al., 2006).  Collectively, these studies highlight the important role platelets play in the 
pathogenesis of chronic intestinal inflammation. 
 
Additional markers of colitis disease include significant increases in reactive oxygen species (ROS), 
originating from recruited leukocytes as well as the activated endothelium (Garside, 1999, Egger et 
al., 2000).  Interestingly, it has also been described that platelets isolated from UC patients trigger an 
increase in ROS production from neutrophils in vitro (Suzuki et al., 2001). Damiani et al. (2007) 
investigated the role of oxidative stress and free radical production in the commonly used 
experimental model of colitis, DSS-induced colitis, in rats.  Interestingly, they showed that DSS-
induced colitis triggered an increase in ATP-production, which they speculated was the tissue 
response to greater regenerative requirements, but this concomitantly led to increased ROS 
production.  Furthermore, administration of anti-oxidants and iron chelators, used to prevent 
production of ROS, substantially reduced colonic mucosal damage (Damiani et al., 2007). 
 
1.1.4 Ischaemia-Reperfusion Injury 
In addition to the above mentioned IBDs, ischaemia-reperfusion (IR) injury is also a common 
inflammatory condition that can affect the small intestine and colon.  Intestinal IR injury is associated 
with high morbidity and mortality in both surgical and trauma patients (Mallick et al., 2004).  IR injury 
occurs as a result of impairment or cessation of blood flow and subsequent restoration of flow to a 
tissue or organ.  This rapid and acute injury is a common occurrence following many surgical 
procedures, such as organ transplants where the blood supply is inevitably halted, as well as many 
clinical disorders such as stroke, myocardial infarct and diabetic foot ulcers (Collard and Gelman, 
2001).  The injury is not just in response to the absence of blood flow, as is described by the term 
ischaemia (from the Greek isch - restriction or thinning, haema - blood), but occurs primarily with the 
return of the blood supply or reperfusion.  Although this seems paradoxical in nature, as restoration 
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of blood flow to an organ is essential to prevent irreversible tissue injury, reperfusion is very highly 
damaging.  For example, Granger and colleagues demonstrated that in a model of intestinal IR, far 
greater mucosal damage was observed following 3 hours ischaemia and 1 hour reperfusion 
compared to the damage seen following ischaemia alone (Granger et al., 1986). 
 
However, the damage caused by ischaemia should not be overlooked.  With the absence of blood 
flow, there is the occurrence of hypoxia.  This imbalance in oxygen homeostasis leads to many 
cellular and structural changes.  This field has been extensively researched and there are several 
reviews describing the many outcomes of IR injury (Eltzschig and Collard, 2004, Rodrigues and 
Granger, 2010).  Some of the consequences include changes to vascular endothelium, including 
cytoskeletal rearrangement leading to cellular contraction and gap formation.  Dysregulation of 
energy metabolism leads to an increase in hypoxanthine production during reperfusion which results 
in increased ROS and free radical production (Li and Jackson, 2002, Rodrigues and Granger, 2010). 
More significantly, increases in CAM expression and the production and release of pro-inflammatory 
cytokines initiates a tissue damaging inflammatory response (Sprague and Khalil, 2009).  All of these 
manifestations contribute to increased leukocyte and platelet recruitment in IR injury, and so 
similarly to IBD, disturbances in the local microcirculation is a key feature of IR injury (Figure 1.1; 
Rodrigues and Granger, 2010).   
 
Following reperfusion of the previously ischaemic tissue, an exacerbation of the inflammation is 
observed - a greater increase in the production of ROS, free radicals and other inflammatory 
molecules (Collard et al., 1999, Li and Jackson, 2002), enhanced adhesion of leukocytes and platelets 
to endothelia (Vowinkel et al., 2007b, Linfert et al., 2009) and further dysfunction to the vascular 
endothelium including increased sloughing of endothelium and gap formation (Hernandez et al., 
1987, Gautam et al., 2001).  












Figure 1.1 Multiple Microcirculatory Effects of Ischaemia-Reperfusion Injury 
 
The IR injury microenvironment is a milieu containing blood cells and a vast repertoire of bioactive molecules.  Following 
colitis and IR stimulus, endothelial cells become activated triggering the recruitment and adhesion of leukocytes, both 
polymorphic nucleated and mononucleated cells, platelets and microparticles released from many cells, including platelet 
microparticles.  The loss of endothelia and the exposure of the basement membrane trigger the formation of platelet 
microthrombi.  This large body of activated platelets release platelet microparticles that subsequently interact with 
leukocytes and endothelia triggering further release.  However, intact platelets also play a role in neutrophil adhesion to 
endothelia and also in the formation of leukocyte-platelet aggregates.  Furthermore, activated neutrophils release many 
bioactive molecules such as reactive oxygen species (e.g. H2O2) and other compounds such as cytokines and chemokines.  
Similarly, activated endothelium also release a range of bioactive molecules including H2O2 and cytokines.  Adapted from a 
















IR injury of many organs can lead to severe clinical outcomes such as direct organ failure, multi-organ 
dysfunction syndrome (MODS) and systemic inflammatory response syndrome (SIRS) (Arumugam et 
al., 2004, Stallion et al., 2005).   However, the most susceptible organ to IR injury is the intestine 
(Granger et al., 1986, Yamamoto et al., 2001). Intestinal IR injury is associated with several 
pathologies where reduction in gut perfusion is followed by restoration of flow e.g. shock and 
vasculitis (Kong et al., 1998, Carden and Granger, 2000).  It most commonly results from a number of 
surgical procedures, including thoracoabdominal aorta aneurysm repair, cardiopulmonary bypass 
and small bowel transplantation (Banz et al., 2008, Lazaris et al., 2009, Sfyroeras et al., 2010). 
Furthermore, it has been identified that mortality associated with intestinal IR injury can be as high 
as 80% (Redaelli et al., 1998). 
  
The small intestinal mucosa undergoes extreme damage following the induction of experimental IR 
injury, which can be induced by occlusion of the superior mesenteric artery (SMA).  Even relatively 
short durations of ischaemia can elicit substantial localised tissue injury (Souza et al., 2005, Li et al., 
2009a, Kavanagh et al., 2010, Santen et al., 2010, Kavanagh et al., 2012).  The SMA is the major 
artery supplying blood to the intestines, from the duodenum (start of small intestine) to the 
transverse colon.  The descending colon, sigmoid colon and part of the rectum are also supplied by 
the inferior mesenteric artery, thus, occluding the SMA induces IR injury primarily within the 
ascending and transverse colon (anatomy of colon shown in Figure 1.2; taken from: 
http://www.cedars-sinai.edu).  Although it has been experimentally established that SMA occlusion 
has a lesser injurious effect on the colon compared to the small intestine (Leung et al., 1992), the 
colon nevertheless still undergoes significant structural and microvascular injury, as evidenced by 
increased leukocyte recruitment and greater local levels of ROS (Riaz et al., 2002b).   The colon is the 
most prevalent location for the clinical manifestation of intestinal ischaemia and occurs in patients 
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with IBD as well as other pathologies. Colonic IR injury is associated with hypermotility, abdominal 
pain, increased mucosal permeability, colonic ulceration and bacterial translocation (Parodi et al., 
1987).  
 
1.1.5 Microcirculatory Disturbances Associated with Ischaemia-Reperfusion Injury  
IR injury is reported to be a biphasic occurrence and in both phases the pathological changes are 
primarily mediated through alterations in the vascular endothelium (Rodrigues and Granger, 2010).  
The first phase of reperfusion injury, which occurs within 1-2 hours, causes vascular endothelium to 
rapidly up-regulate CAMs such as ICAM-1 and PECAM-1.  In the second stage, approximately 3-4 
hours post-ischaemia, vascular endothelia has been reported to up-regulate different CAMs such as 
VCAM-1 and MAdCAM-1 (Shigematsu et al., 2002).  The increased number of CAMs results in 
increased recruitment of leukocytes, further exacerbating injury responses (Figure 1.1).   
 
Vascular endothelia also increase levels of soluble inflammatory mediators such as tumour necrosis 
factor-α (TNFα) and interleukin-1 (IL-1) in most inflammatory responses (Santen et al., 2010).  The 
release of these mediators further contributes to leukocyte recruitment and activation (Figure 1.1), 
which in turn, further exacerbates the inflammation.  Furthermore, the increased production of 
hypoxanthine in endothelial cells following IR leads to the increased production of ROS (Collard and 
Gelman, 2001).  There are several reports demonstrating that the concentration of ROS produced 
can elicit two responses; direct oxidative damage to lipids and genetic material (Riaz et al., 2002b) 
and also activation of leukocytes via the phosphorylation of several regulatory pathways (Irani, 
2000).  Furthermore, ROS, in the presence of transition metals, often form highly oxidative and 
cytotoxic hydroxyl radicals (Damiani et al., 2007). 

















Figure 1.2 Cartoon schematic of the large intestine 
The large intestine is comprised of 5 components: the ascending, transverse, descending and sigmoid colon, followed by the 
rectum and terminating in the anus.  The SMA supplies blood to the small intestines and the proximal regions of the colon, 
namely the ascending and transverse colon.  The SMA itself lies beneath the small intestines (thus is not seen in this image) 
with the mesentery branching throughout the gut.  The other regions are supplied by the inferior mesenteric artery.  When 
the SMA is occluded experimentally it results in tissue ischaemia of the small intestine and the proximal regions of the 
colon, however, the damage is much more severe within the small intestines than the colon. Figure taken from: 
http://www.cedars-sinai.edu.  
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Interestingly, the biphasic response is also seen in the neutrophil recruitment pattern, with an initial 
recruitment shortly after injury, and a second recruitment seen during the latter phase (Victorino et 
al., 2009).  The increased levels of adherent neutrophils lead to further endothelial dysfunction 
(Victorino et al., 2009).  However, neutrophils and other inflammatory leukocytes within the injured 
environment also produce and release inflammatory mediators into the injury milieu (Figure 1.1).  
Similar to the endothelium releasate, the neutrophils release ROS such as hydrogen peroxide (Lu et 
al., 2012), cytokines (Sprague and Khalil, 2009) and other inflammatory mediators (Linfert et al., 
2009), which in turn, activates endothelium and increases recruitment of inflammatory leukocytes 
(Heidemann et al., 2007). 
 
The recruitment of leukocytes is often mirrored by that of platelets (Nakano et al., 2008, Rodrigues 
and Granger, 2010).  Platelet activation occurs in many pathological conditions, including IR injury 
(Yin et al., 2008, Esch et al., 2010), rheumatoid arthritis (Boilard et al., 2010) and colitis injury as 
described earlier (Andoh et al., 2005, Andoh et al., 2006).   The recruitment of platelets exacerbates 
gut IR injury either through interactions with the intact endothelium or through interactions with 
sub-endothelial matrix proteins such as collagen that become exposed after endothelial denudation.  
This latter event is associated with aggregation of platelets and microthrombus formation which 
often leads to microvessel occlusion and poor blood flow within the reperfused gut (Holyer, 2011).  
Indeed, the Kalia group has previously shown that inhibiting thrombus formation can attenuate 
intestinal IR injury and improve perfusion (Holyer, 2011).  Furthermore, platelet activation also 
triggers the release of many bioactive molecules including alpha-granules, cytokines and platelet 
microparticles (PMPs), which will be discussed later (Thiagarajan and Tait, 1991, Brown and 
McIntyre, 2011). 
 
Chapter 1: General Introduction 
13 
 
1.2 Current Therapies for Inflammatory Bowel Disorders 
 
Current therapies, including anti-inflammatory and immunosuppressive drugs, tend to suppress the 
symptoms of IBD rather than be curative (Schmidt et al., 2010, Coburn et al., 2012).   They remain 
inadequate primarily due to multiple side-effects, including severe toxicity, with no long-term 
efficacy observed.   Current clinical practice involves using the safest drugs with the least side-effects 
first, which include the aminosalicyclates and antibodies that target leukocyte sub-populations 
(Lichtenstein et al., 2009).  If these fail to be beneficial, corticosteroids and finally anti-tumour 
necrosis factor- (anti-TNFα) treatments are used, but the latter display the greatest side effects 
(Garcia-Bosch et al., 2010). Although these therapies are effective at inducing and maintaining 
remission, the occurrence of side effects, varying effectiveness within clinical populations and the 
loss of effectiveness over time limit their long-term use (Lichtenstein et al., 2009, Singh et al., 2010).  
For example, corticosteroids may trigger mucosal healing in Crohn’s but cannot maintain it 
(Lichtenstein et al., 2009, Armuzzi et al., 2012, Dave and Loftus, 2012).  A review of clinical trials, 
used to establish guidelines in the management of Crohn’s disease, highlighted that many existing 
treatments, including mesalamine, sulfasalazine and metranidazole, failed to reproducibly provide 
clinical efficacy (Lichtenstein et al., 2009).  
 
Most IBDs are composed of two pathologies – intestinal tissue damage and immunological 
dysfunction.  Thus far, no drugs used alone or in combination are capable of actively targeting both 
problems; hence explaining their poor effectiveness and high remission rates (Singh et al., 2010).   
Thus, alternative therapeutic strategies are urgently needed for patients who do not respond to or 
are intolerant of currently available treatments. One of the major considerations for treating a whole 
host of inflammatory and immunological disorders, including IBD, is the use of cellular therapy, 
particularly exogenously administered stem cells (Garcia-Bosch et al., 2010, Singh et al., 2010). 
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1.3 Stem Cells for Treatment of Inflammatory Bowel Disease 
1.3.1 Bone Marrow-Derived Stem Cells 
For a cell to be termed a stem cell it has to be capable of two properties: self-renewal and potency.  
Self-renewal refers to a cells ability to divide, but with one of the daughter cells retaining the original 
phenotype of the mother cell.  This is essential for maintaining the stem cell population.  Potency 
describes the process in which a cell can differentiate to a more specialised cell type that is distinct 
from the mother cell.  There are a number of stem cells within the adult body which are required for 
the constant renewal of several tissues.  
 
For example, bone marrow (BM)-residing haematopoietic stem cells (HSCs) constantly replenish the 
cellular constituents of the blood.  Similarly, as described earlier, intestinal stem cells constantly 
renew the mucosal lining of the GIT.  However, an increasing number of studies have demonstrated 
that some populations of endogenous stem cells, particularly those derived from the BM, can also 
repair or regenerate injured tissue following a number of ischaemic or degenerative diseases (Komori 
et al., 2005, Oyama et al., 2005, Khalil et al., 2007, Chen et al., 2008, Lanzoni et al., 2008, Bussolati et 
al., 2009, Okumura et al., 2009, Schlechta et al., 2010).  It is not clear which stem cells may be most 
useful for regenerative purposes.  Although embryonic stem cells (ESCs) would provide a more plastic 
and thus more flexible therapeutic option, their use is ethically questionable.  Furthermore, there is a 
significant concern of teratoma formation with the use of ESCs (Ratajczak et al., 2012).  The use of 
adult stem cells is more desirable due to ethical considerations, demonstrable clinical and 
experimental success and relative ease of availability.  
 
Several stem and progenitor cell populations exist with the adult BM, including HSCs, mesenchymal 
stem cells (MSCs) and endothelial progenitor cells (EPCs).  Accumulating evidence in the past decade 
or so has demonstrated that, in addition to having their own specialised role, all three of these BM-
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derived stem/progenitor cell populations have the ability to contribute to the repair and 
regeneration of damaged or degenerative tissue.  For example, EPCs have been reported to circulate 
within the peripheral blood and contribute to vasculogenesis and maintenance of the vasculature 
(Leone et al., 2009).  There are also multiple reports indicating that both HSCs and MSCs can confer 
benefit to a variety to digestive disorders in clinical and experimental studies (Leone et al., 2009, 
Okumura et al., 2009, Wei et al., 2009). 
 
1.3.2 Haematopoietic Stem and Progenitor Cells 
HSCs are essential for homeostasis as their primary role is to constantly replenish the cellular 
components of the blood (Figure 1.3).  HSCs were first identified by Till and McCulloch (1961) and 
were termed “colony forming units (CFUs)”.  These cells were defined by the ability to give rise to 
haematopoietic nodules in the spleen post-BM transplantation in irradiated animals (Till and 
McCulloch, 1961, Till et al., 1964).  HSCs are typically identified through their surface marker 
phenotype with the most common identity being c-kit+ Sca-1+ Lin-; termed KSL cells (Wognum et al., 
2003).  CD34 is also commonly used as a marker for human HSC populations (Civin et al., 1984), but it 
is not a murine HSC marker as ~90% of murine HSCs do not express CD34 (Osawa et al., 1996). 
However, HSCs have also been shown to play an active role in immune regulation (King and Goodell, 
2011) and have also been shown to be capable of extramedullary repair. 
 
1.3.3 Haematopoietic Stem Cells for Inflammatory Bowel Disease  
HSCs have been considered a potential source of stem cells for the purpose of regenerative medicine 
(Herzog et al., 2003, Garcia-Bosch et al., 2010, Kavanagh and Kalia, 2011) and have been shown to be 
beneficial in several injury states such as colitis, myocardial infarction and renal dysfunction (Lanzoni 
et al., 2008, Bussolati et al., 2009, Schlechta et al., 2010).  The beneficial effects of HSCs for IBD was 
Chapter 1: General Introduction 
16 
 
initially observed following early case reports of remission in patients undergoing HSC 
Transplantation (HSCT) for the treatment of haematological malignancies (Oyama et al., 2005, 
Lanzoni et al., 2008, Glocker et al., 2009, Garcia-Bosch et al., 2010).   
 
Since these initial observations, a number of HSCT clinical trials for IBD have been conducted in which 
autologous HSCs are mobilised, collected from the patient’s peripheral blood and then re-infused 
following myeloablation (Oyama et al., 2005, Burt et al., 2010).  An ongoing clinical trial called ASTIC 
(Autologous Stem Cell Transplant for Crohn’s Disease), headed by Professor Chris Hawkey at the 
University of Nottingham, has been investigating the use of autologous HSCT for Crohn’s disease as 
an alternative therapy to conventional options with results expected in 2013.  Early analyses report a 
significant reduction in clinical injury index and improved tissue repair in a high number of patients, 
with several requiring no further drug therapy (Hawkey, 2012).  However, they have also revealed 
that there was a high level of risk with infection occurring frequently.  This highlights that HSCT, 
rather than systemic infusion, may only be a viable option for a limited number of patients (Garcia-
Bosch et al., 2010, Hawkey, 2012).  There has also been considerable investigation carried out by the 
Burt laboratory.  They have also undertaken HSC therapy clinical trials, and similarly to ASTIC report a 
significant improvement in Crohn’s disease and indeed even induce remission (Oyama et al., 2005, 
Burt et al., 2010). 
 
However, none of these HSCT trials have identified a cure for IBD as recurrence rates remain high.  
HSCT is essentially a form of immune suppressive therapy in which drugs are firstly used to ablate or 
suppress the immune system to remove disease causing immune cells, with HSCs infused to 
regenerate a new, antigen-naive immune system. However, recent experimental data has 
demonstrated that exogenous HSCs can themselves confer therapeutic effects even in the absence of 
myeloablative or immunosuppressive drugs.   













Figure 1.3 Haematopoietic stem cells constantly replenish blood  
The haematopoietic or blood system is constantly replenished from HSC populations within the bone marrow.  This is 
achieved through two major differentiation pathways - myeloid or lymphoid routes.  The routes are entered via HSC 
differentiation into either the common myeloid progenitor, giving rise to red blood cells and the cells of the innate 
immunity, or the common lymphoid progenitor, providing the cells of the adaptive immune system.  
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1.4  Mechanisms by which Haematopoietic Stem Cells are Beneficial 
1.4.1  Direct Repair of Injured Tissues by Haematopoietic Stem Cells 
Although it is not fully established how HSCs confer benefit in injured tissues, several potential 
mechanisms have been described.  One mechanism is the differentiation of the HSC into the required 
host cell.   Okamoto and colleagues identified BM-derived HSCs within the GIT of patients undergoing 
HSCT for the treatment of differing leukaemic and myeloid disorders.  They reported that significant 
numbers of HSCs within the gut had differentiated into epithelial cells (Okamoto et al., 2002).  A 
further role for stem cell differentiation was demonstrated in studies in which HSCs were 
transplanted into IBD patients also suffering from malignant cancers.  Donor HSC-derived epithelial 
cells were found within the inflamed bowels of these patients, which was associated with a 
concomitant reduction in their injury scores (Ishikawa et al., 2004, Khalil et al., 2007).   
 
A number of experimental studies have also suggested HSC differentiation as a putative mechanism 
by which HSCs mediate tissue repair.   Indeed, BM-derived cells are recruited to inflamed regions of 
the colitic mouse colon and contribute to tissue repair by differentiation into vascular smooth muscle 
cells, endothelial cells, pericytes, or epithelial cells (Brittan et al., 2005).  Furthermore, Komori and 
colleagues showed that GFP-expressing BM cells occupied 37.6% and 4.25% of the rat colonic 
epithelium at 28 and 56 days respectively after TNBS-induced colitis (Komori et al., 2005).  The 
authors suggested that the BM-derived cells induced regeneration through differentiation into colon 
cells, but they did not distinguish which population of stem cells within the BM were involved.   
 
Interestingly, Wei and colleagues (2009) demonstrated that exogenously administered HSCs and 
MSCs could equally populate the colonic mucosa of following TNBS-induced colitis.  Furthermore, 
both cell types were able to improve the gross morphology of the colon with administration of both 
stem cell types together only improving the morphology slightly more than that of HSC or MSC alone.  
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Although the reparative mechanisms were not investigated, it was again postulated to be mediated 
through integration of stem cells into the epithelial layer (Wei et al., 2009). 
 
Another potential mechanism by which HSCs have been reported to aid in repair is through stem cell-
host cell fusion.  This mechanism involves formation of heterokaryons consisting of the donor stem 
cell and the host target cell.  This phenomenon had been put forward to provide an alternative 
mechanism to explain the plasticity seen following stem cell repair.  It has been reported that in vitro 
cultured stem cells can fuse with differentiated cell types to form tetraploid cells that exhibit cell 
markers typical of the differentiated cells, whilst maintaining pluripotency markers (Terada et al., 
2002, Ying et al., 2002). It has been demonstrated culturing embryonic SCs with B cells and 
fibroblasts can result in fusion and subsequent reprogramming of the target cells to a pluripotent 
state (Tsubouchi and Fisher, 2013, Tsubouchi et al., 2013). 
 
However, the mechanism of stem-donor cellular fusion has not been fully elucidated, primarily 
because it has not been demonstrated to occur in vivo with adult stem cells. For example, Okamoto 
et al. extensively studied the GIT following HSC treatment and whilst observing engrafted donor 
HSCs, they failed to observe any heterokaryons formed by cellular fusion (Okamoto et al., 2002).  
 
Many of these early studies demonstrating differentiation and fusion have not since been 
reproduced.  It is also difficult to conceptualise how altering the phenotype of a very small number of 
cells within a damaged organ would be capable of exerting such an effect as to enable organ repair, 
as, due to the limited recruitment of stem cells seen even shortly after infusion, there would simply 
be too few cells to have a significant effect.    
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Furthermore, many, but not all, of the observations of stem cell fusion can be explained via 
horizontal transfer of molecules between cells.  As is described below, microparticle production of 
cells often results in the transfer of genetic, soluble and membranous material, which can explain the 
presence of cytosolic dyes, donor cell phenotype change through surface markers as well as a change 
in expression profile (Ratajczak et al., 2012). Indeed, horizontal transfer of surface, mRNA and miRNA 
molecules has been observed to occur in vitro with a detectable frequency (Janowska-Wieczorek et 
al., 2001, Mause et al., 2005, Meziani et al., 2008, Burnier et al., 2009, Tang et al., 2010).    
 
Overall, the general consensus is that HSCs, and indeed other stem cells such as MSCs, are unlikely to 
confer therapeutic benefit in vivo via cellular fusion or trans-differentiation, however, these 
mechanisms cannot be ruled out wholly. 
 
1.4.2 Paracrine Effects of Haematopoietic Stem Cells 
For inflammatory intestinal disorders, particularly Crohn’s disease, UC and IR injury, immune 
modulation is a key component of their treatment (Lichtenstein et al., 2009, Schmidt et al., 2010, 
Coburn et al., 2012).  More recent evidence suggests that stem cells confer benefit in these disorders 
through a paracrine effect whereby they release anti-inflammatory or immunomodulatory factors.  
Stem cells can produce and release an array of cytokines and trophic mediators that can act upon 
blood and tissue cells (Caplan and Dennis, 2006).   
 
This release of immunomodulators can then allow for the dampening or limiting of pro-inflammatory 
cell recruitment and promote recruitment of resolution stage leukocytes (Chen et al., 2008).  
Furthermore, it has been reported that this manner of signalling by stem cells not only effects the 
cells of the bloodstream and immune system, but may induce the proliferation of endothelial cells to 
repair damaged vasculature (Aguilar et al., 2009).  
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It is well documented that MSCs are immunomodulatory (Caplan and Dennis, 2006).  They have been 
shown to impair T-cell priming in vivo by limiting interaction of T-cells with dendritic cells (Chiesa et 
al., 2011), and have also been shown to be capable of modulating leukocyte behaviour in vivo 
(Caplan and Dennis, 2006).  Although an anti-inflammatory and immunomodulatory effect has been 
well described for MSCs, there is little evidence that HSCs also have similar capabilities.  This is not 
likely due to the inability of HSC to immunomodulate, but most likely due to a paucity of 
investigation within this area.  For example, recent data from the Kalia laboratory has demonstrated 
that within 4 hours of systemic HSC infusion into a mouse undergoing intestinal IR injury, leukocyte 
infiltration is significantly reduced (Kavanagh et al., 2013).  
 
Emerging evidence suggests stem cells may also undertake a paracrine repair mechanism through 
the release of bioactive lipid vesicles.  Indeed stem cells are capable of, and often do, produce 
microparticles (Ratajczak et al., 2012).  It has been shown that microparticles harvested from stem 
cell cultures exhibit the same level of repair as the stem cells themselves (Quesenberry et al., 2010, 
Gatti et al., 2011).  Although their role and the mechanism in which stem cell microparticles confer 
beneficial effects in repair have not been definitively explained, there is evidence that MPs are able 
to shuttle a variety of membrane molecules, such as S1P and C1P (both of which limit apoptosis 
whilst stimulating angiogenesis; Ratajczak et al., 2012), mRNA molecules, including those that 
transcribe for  pluripotency markers,  tissue specific markers and chemokine transcripts, all of which 
have been demonstrated to enhance liver and kidney repair (reviewed in Ratajczak et al,. 2012).   
 
The observations that HSC can directly mediate tissue repair as well as have indirect paracrine effects 
suggests stem cells may confer benefit via a two-pronged approach; through immune modulation 
and through direct repair of tissue by donor derived HSCs, thus making them an attractive 
therapeutic option for treatment of IBD. 
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1.5  Stem Cell Homing  
As previously mentioned, existing therapies for inflammatory disorders of the bowel are not 
adequate.  Studies suggest adult BM-derived stem cells, including HSCs, may be a useful therapy for 
treating inflammatory and ischaemic digestive disorders. Clinical studies have been primarily HSCT 
investigations in which HSCs are delivered following immunoablation.  However, experimental 
studies suggest that simply injecting HSCs either directly into the injured tissue or systemically can 
confer benefit.  Despite evidence that HSCs improve intestinal problems, success is either minor or 
transitory in both clinical and experimental studies.  The rarity of HSCs and MSCs (<0.01% & 0.001% 
of BM respectively) has partly contributed to their limited clinical utility and success due to their 
limited availability (Karp and Leng Teo, 2009).   
 
It has also been suggested that the poor efficacy of cellular therapy may be a result of limited 
recruitment of injected stem cells to the target area (Kinnaird et al., 2004).  Indeed Khalil and 
colleagues conducted an experimental study in which HSCs were injected into mice with colitis injury 
(Khalil et al., 2007).  However, they noted limited efficacy, which they and others have postulated is 
due to limited stem cell numbers found within the tissue following infusion (Jackson et al., 2001, 
Strauer and Kornowski, 2003, Kinnaird et al., 2004).  Therefore, when delivered by the preferred 
systemic route, poor homing and a subsequent low efficiency of tissue engraftment occurs, 
processes essential for stem cells to mediate repair  (Karp and Leng Teo, 2009, Schulz et al., 2009).  
Furthermore, the large size of cultured stem cells, particularly MSCs, has meant that post-infusion, 
many cells are lost to the circulation as they become entrapped within organs such as the lungs.  This 
limits the number of circulating stem cells that are available for recruitment to injured sites (Fischer 
et al., 2009). 
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It is therefore likely that increasing the number of exogenously administered stem cells that become 
adherent within the injured colon microcirculation may improve their efficacy for IBD patients 
(Kinnaird et al., 2004, Kavanagh and Kalia, 2011).  Thus, identifying methods to enhance the stem cell 
recruitment following systemic infusion would provide an alternative, safer and more economically 
viable option to HSC transplantation.    
 
Developing methodologies that improve stem cell trafficking/homing and recruitment into injured 
tissues is a high priority for cellular therapies and could potentially confer more efficient, rapid and 
longer lasting tissue recovery. Indeed, transfecting plasmid DNA encoding for stromal derived factor-
1 (SDF-1), a potent stem cell chemoattractant, into ischaemic muscle enhances endothelial 
progenitor cell recruitment (Hiasa et al., 2004).  However, delivery of vectors to allow for targeted 
chemokine expression has been challenging, particularly in the clinical setting. Thus, non-invasive 
techniques that do not require introduction of genetic material are appealing. To enhance stem cell 
adhesion and derive a targeted therapy regime for IBD, the adhesive mechanisms governing stem cell 
recruitment to the injured colon need to firstly be elucidated.  However, there are currently no 
studies that have determined these events in the diseased colon. 
 
1.5.1 Kinetics of Haematopoietic Stem Cell Recruitment  
Limited data has identified the adhesive mechanisms utilised by HSCs to home to injured sites.  There 
are multiple reports that HSC can be captured from flow and that stable adhesion is integrin 
mediated (Frenette et al., 1998, Kavanagh and Kalia, 2011, White et al., 2013).  Furthermore, HSCs 
have been shown to share a similar adhesion molecule phenotype to that of leukocytes (Kobayashi et 
al., 1994, Turner et al., 1995), suggesting that their recruitment is likely to follow a similar pathway.   
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The leukocyte adhesion cascade was first described by Cohnheim well over a century ago (Cohnheim, 
1877) and has since been substantially developed.  The current paradigm was first proposed in 1991 
and involves the capture, rolling, firm adhesion and transmigration of leukocytes (Butcher, 1991).  
The capture stage is involved in the slowing of leukocytes from the vascular flow to enable the initial 
transient interactions between the leukocyte and the vascular endothelium. The initial interactions 
are predominantly mediated via selectins and cadherins that are expressed on leukocytes, platelets, 
endothelia and other cell types such as dendritic cells (Ley, 1996, Vowinkel et al., 2007b).  These 
reversible interactions enable rolling of the leukocytes along the vessel wall so that stable adhesion 
can subsequently occur.  With the many different proteins involved in rolling it enables organ and 
site-specific interaction through a vast number of combinatorial interactions (Figure 1.4; Ley, 1996).     
 
There have been few observations of HSC rolling within tissue microvasculature.  Reports from the 
Kalia laboratory have found that HSC rolling could only be observed within muscle vasculature and 
not intestinal microvasculature (Kavanagh et al., 2013).  Furthermore, unpublished results from the 
Kalia laboratory have found that HSCs only exhibit stable adhesion in tissues that have low blood 
shear rates such as the hepatic microcirculation, and do not roll.  Again this is similar to leukocyte 
behaviour, where it has been reported that leukocyte rolling is not a prerequisite for stable adhesion 
in the injured liver sinusoidal capillaries (Kubes et al., 2002).  
 
Activation of the tethered cell is crucial for the cell to achieve firm adhesion.  This is modulated by 
factors released from the local endothelium and, more importantly, the duration the cell remains in 
contact with the local endothelium (Jung et al., 1998).  The firm adhesion is mediated by CAMs 
expressed on the circulating cell and its counter-receptor on the endothelial cells, such as the 
integrin-ligand interaction VLA-4 with VCAM-1 (Figure 1.4).  This stage of recruitment is essential for 
many cells.  For example, T cells lacking the integrin L2 (LFA-1) exhibit poor activation and T cell 
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priming (Kasirer-Friede et al., 2007), as well as poor homing to target tissues.  Also, T cells lacking the 
integrin α4β7 display impaired homing to gut associated lymphoid tissue (Lefrancois et al., 1999, 
Johansson-Lindbom et al., 2003).  It has similarly been hypothesised by several groups, that integrin 
mediated adhesion is also a necessary pre-requisite for stem cell recruitment (Kumar and 
Ponnazhagan, 2007, Sordi, 2009, Kavanagh and Kalia, 2011). 
 
1.5.2 Site Specific Mechanisms Govern HSC Recruitment to Injured Tissue 
Although much is known regarding leukocyte recruitment, including mechanisms, site specific 
behaviour and consequences of the adhesion interactions, little data has been generated with 
regards to stem cells. Early intravital microscopy and histological studies initially described the 
mechanisms governing HSC recruitment to BM microcirculation.  
 
Similar to that seen with leukocytes, within the BM microcirculation HSCs have been observed to roll 
prior to firm adhesion (Frenette et al., 1998).  HSC rolling has also been identified within cremaster 
muscle post-capillary venules (Kavanagh et al., 2013). In the BM, firm adhesion was primarily selectin 
mediated with a major role identified for the cell surface glycoprotein CD44 (Frenette et al., 1998, 
Avigdor et al., 2004). Interestingly, the VLA-4 / VCAM-1 pathway only appeared to play a role in HSC 
adhesion when P- and E- selectin adhesion was antibody blocked (Frenette et al., 1998).  It was also 
found during these studies that interfering with the adhesion interactions, on either stem cell or 
endothelium, was sufficient to inhibit recruitment to these organs (Frenette et al., 1998, Avigdor et 
al., 2004) highlighting the key role CAMs play in stem cell recruitment.  Following the stable adhesion 
of leukocytes and the subsequent activation of adhesion, leukocytes will often transmigrate (Figure 
1.4), however, there is limited information regarding the transmigration of HSC.  Observations from  
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within the Kalia laboratory have yet to see any evidence of HSC transmigration within 4 hours of 
recruitment (pers. comms.), but long term studies have seen HSC engraftment within tissue away 
from the vasculature (Khalil et al., 2007, Tanaka et al., 2008, Wei et al., 2009). 
 
Later studies focussed on the adhesive mechanisms mediating HSCs recruitment to injured non-
medullary tissues, with major contributions to the field coming from the Kalia laboratory.  Stem cell 
recruitment to peripheral tissues, such as the injured murine liver, heart and intestines, is primarily 
integrin mediated (Jackson et al., 2001, Kumar and Ponnazhagan, 2007, Karp and Leng Teo, 2009, 
Schulz et al., 2009, Kavanagh and Kalia, 2011). Indeed, the integrin VLA-4 (CD49d/CD29, α4β1) and its 
interaction with endothelial VCAM-1 has shown to be involved in HSC recruitment to the injured 
mouse liver capillaries or sinusoids (Kavanagh et al., 2010), a similarity shared with leukocyte 
recruitment to the same organ (Alon et al., 1995).   
 
The concept of site specific mechanisms governing HSC recruitment gains more importance when we 
note that recruitment to injured murine kidney utilises integrins but also other CAMs such as the 
glycosaminoglycan (GAG) CD44. Indeed, antibody blockade of CD49d or CD44 results in near total 
amelioration of HSC recruitment to the kidney (White et al., 2013).  Interestingly, CD44 has also been 
demonstrated to be critical in mediating MSC homing to injured murine liver (Aldridge et al., 2012). 
Recruitment to the injured small intestine is independent of CD49d, but dependent on the CD18-
ICAM pathway (Kavanagh et al., 2013), whereas, adhesion within the cremaster muscle is dependent 
on both CD18 and CD49d, but with a greater reliance on CD49d (Kavanagh et al., 2013).   
 
Overall, these studies have highlighted that HSC surface adhesion molecules play a critical role in the 
homing of injected stem cells to not only the BM but also to sites of injury.  Therefore, investigation 
into the adhesive mechanisms utilised by stem cells may allow for the development of strategies to  









Figure 1.4 Cell Adhesion Cascade 
The cell adhesion cascade has been investigated using a range of cell types (predominantly leukocytes) and different injury 
and stimuli.  However, in most physiological settings the principles are the same, but using a variety of differing adhesion 
molecules and indeed combinations of molecules. The cartoon above demonstrates the initial capture and rolling of 
leukocytes, predominantly involving selectins.  Rolling allows the cell to be slowed and is often a pre-requisite for firm 
adhesion.  It also allows for cells to become activated by increasing the exposure to membrane bound molecules such as 
cytokines.  Firm adhesion requires integrins and their counter-ligands.  However, there are tissue specific, injury and 
temporal differences in the integrin combinations used.  For example, depicted is the temporal difference in intestinal 
endothelial CAM expression.  During the early phase of reperfusion, ICAM1 is the major endothelial CAM evident.  
However, following several hours of reperfusion, intestinal endothelia increase their surface expression of VCAM1 and 
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increase their recruitment and potentially increase their clinical efficacy (Kinnaird et al., 2004, 
Lanzoni et al., 2008, Kavanagh and Kalia, 2011).  It is well established from studies on leukocytes that 
integrin behaviour, and therefore adhesion, can be modulated via several mechanisms.  
 
1.5.3 Integrin Mediated Circulating Cell Adhesion   
Integrins are a protein family of molecules important in cell-cell and cell-extracellular matrix 
adhesion.  24 integrin heterodimers have been identified, which are made up of 18α and 8β subunits 
forming heterodimer complexes of non-covalently bound α and β subunits (Springer and Dustin, 
2012). Both subunits consist of large extracellular N-terminus domains, a single span transmembrane 
domain and C-terminus cytoplasmic domains (Springer and Dustin, 2012).  The ligand binding domain 
of integrins is formed of a binding pocket composed of the extracellular domains of the α and β 
subunits.  Some integrins bind ligand primarily with the αI domain, however, some integrins that lack 
this domain bind primarily with the βI domain (Springer and Dustin, 2012).  It is the specificity of 
these regions for their ligand that provides integrins with their high level of specificity (Springer and 
Dustin, 2012), but may also go some way to explaining why there is a level of cross-reactivity 
between some integrin heterodimers – such as that seen between α4β1 (VLA-4) and α4β7 for VCAM-
1.   
 
The integrin’s primary role is to allow for stable adhesion of cells to substrate, however, some 
integrins have been shown to be used for cell rolling (Alon et al., 1995).  Interestingly, integrins have 
also been shown to play a key role in cell signalling – both outside-in signalling and inside-out 
signalling, and furthermore, variations in the transmembrane domains of integrin heterodimers alter 
the ability to conduct the signalling (Kim and Kim, 2013). 
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External stimuli result in multiple, highly complex mechanisms of cellular activation, with 
simultaneous activation of multiple signalling mechanisms that result in an increase in cellular 
adhesion (Yu et al., 2010). In relation to integrin binding, however, the number of mechanisms a cell 
can use to increase adhesion are limited.  The mechanisms fall into three categories: a change in the 
level of integrin expression level, a change in integrin conformation and /or a change in integrin 
arrangement on the cell surface (Figure 1.4).  
 
1.5.3.1 Integrin Expression Changes 
The change in expression level is often achieved following cell stimulation (Grabovsky et al., 2000, 
Chigaev et al., 2003).  For example treating neutrophils with chemokines such as interleukin-8 (IL-8) 
triggers an up-regulation of the integrin Mac-1 (CD11b) (Conklyn et al., 1996).  Similarly, 
macrophages can upregulate surface expression of Mac-1 following activation (Takada et al., 1987).  
However, integrin mediated cell adhesion can be modulated without affecting surface expression of 
integrins (Yauch et al., 1997, Hart and Greaves, 2010) (Figure 1.5). 
 
1.5.3.2 Integrin Conformation Changes 
Several models of integrin activation via conformational change have been proposed, however, the 
most widely accepted model is that of an ‘extension and opening’ model which is often referred to as 
an ‘activated’ state (Reviewed in Springer and Dustin, 2012). It consists of two components: 
extension of the integrin legs and opening of the integrin head piece (Figure 1.4) (Takagi et al., 2002, 
Wang and Luo, 2010). These conformational changes have been proposed to occur following several 
occurrences, with ligand binding (Springer and Dustin, 2012), metal ion binding and cytoskeletal 
torsion (Takagi and Springer, 2002) being common triggers.   
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Conformational changes have been identified using multiple methods including electron microscopy 
(Takagi et al., 2002) and X-ray crystallography (Zhu et al., 2008). Furthermore, conformation changes 
have been assayed through the use of conformation specific antibodies in human.  These antibodies 
have been used to identify extension status of an integrin (Yang et al., 2004) as well as the affinity 
status of an integrin (Gupta et al., 2007). However, to the author’s knowledge, conformation specific 
antibodies have yet to be raised against murine integrins. 
 
Integrin conformation changes and affinity changes have previously been considered synonymous, 
but it has been demonstrated that adhesion activating changes consist of three stages – bent closed, 
extended closed and extended open with each step having differing affinity states.  It is most 
commonly described that the crucial step increasing integrin affinity, which describes how tightly a 
single monomeric ligand binds to a single heterodimer integrin, is the head piece opening whereby 
the open conformation increases affinity by 103-4 fold (Springer and Dustin, 2012).   
 
However, whether both extension and head piece opening are required to occur for a high affinity 
state to be achieved is still contentious, with evidence for the bent conformation with a high affinity 
state of an integrin in existence (Adair et al., 2005), although there is far more overwhelming and 
substantial evidence against this (Reviewed in: Wang and Luo, 2010, Springer and Dustin, 2012).  
Further highlighting this contention, whilst supporting the latter argument, are data reported by 
Chen et al. (2010) that describe that Fab binding could trigger an extended open and an extended 
closed conformation with a concomitant increase in cellular adhesion, but, a second Fab that induced 
only the extended closed conformation did not result in increased cellular adhesion. Hence, there is 
the requirement for both extended and open conformation for an increase in affinity, and that the 
intermediate stage (extended closed) has no effect on integrin affinity (Chen et al., 2010).  
  









Figure 1.5 Changes in Integrin Activation. 
Upon stimulation, cell adhesion can be modulated in a number of manners.  These include integrin conformational changes 
(affinity modulation), increased lateral motility of integrins on a cell surface (avidity modulation), clustering of integrins 
(avidity modulation) or an increased surface expression of integrins (avidity modulation). It is unlikely that each of these 
occurs independently in a physiological setting, but it is a combination of some or all of these effects that contribute to 
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Conversely, Yu et al. (2010) review data that suggests that the high affinity state is not solely 
dependant on extended and open conformation, as Shi et al. (2007) describe a high-affinity state 
integrin in a bent conformation (Shi et al., 2007).  However, Springer & Dustin (2008) have 
highlighted that many previous studies have poorly assayed for affinity due to the use of multimeric 
and not monomeric ligand binding.  This then is not solely a measure of affinity as avidity is 
introduced into the system, due to the possibility of multiple integrins involved in the binding process 
(Springer and Dustin, 2012). 
 
1.5.3.3 Integrin Clustering and Avidity Changes 
Avidity modulation is defined as an increase in adhesiveness independent of integrin conformational 
changes (Yu et al., 2010).  Avidity changes may be due to integrins ‘clustering’ on the surface of the 
cell, increased rates of movement upon the cell surface or a combination of them both (Figure 1.5).  
However, conformational independent changes in adhesion are less understood than conformational 
regulated changes in adhesion.   
 
On leukocytes, cellular activation triggers integrin clustering (Wu et al., 2012), but it has been shown 
that the clustering is not a result of directed movement, but via diffusion following release from 
cytoskeleton (Sigal et al., 2000, Kucik, 2002, Yu et al., 2010).  This is supported through observations 
that cytochalasin D, a potent actin polymerisation inhibitor, treatment has no effect on integrin 
clustering (Hart and Greaves, 2010).  Furthermore, when integrin α tails are mutated, such that 
integrins can no longer effectively dissociate from the actin cytoskeleton (due to increased β tail 
interactions with the cytoskeleton), integrin clustering is inhibited (Yauch et al., 1997).  
 
Regardless of the mechanism, clustering may prove essential physiologically as it provides a rapid 
and effective increase in adhesion, independent of affinity in 2 ways: first it may allow for movement 
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of integrins to regions of high ligand density, and secondly, may allow for minute adjustment in 
orientation, increasing the likelihood for binding interactions to occur (van Kooyk et al., 1999, Kucik, 
2002).  Furthermore, when integrin clustering is inhibited reduced adhesion is seen as well as a 
decrease in stable adhesion under shear stresses (Yauch et al., 1997).  Conversely, when integrin 
clustering is triggered, in the absence of further cell stimulation, increased adhesion is seen (Yauch et 
al., 1997), even if integrin conformation changes are prevented (Yu et al., 2010).  Finally, an 
interesting observation seen recently is that clustering of integrins, artificially via the clustering of 
ligands upon a surface, resulted in enhanced mesenchymal stem cell differentiation into bone (Petrie 
et al., 2010), highlighting a role for integrin clustering for cellular signalling, as well as maintaining 
adhesion.  Collectively, these results demonstrate that clustering of integrins upon a cell surface is a 
critical event in cell adhesion. 
 
Much of the structural understanding on integrin behaviour has been examined through the use of 
leukocyte sourced materials and integrins.  However, this work still has direct applicability with 
regards to stem cell integrin behaviour.  Most recently, Vanderslice and colleagues examined the use 
of a small molecule agonist against VLA-4 that resulted in enhanced HSC binding to VCAM-1 
(Vanderslice et al., 2013).  The novel small molecule agonist they had developed was initially a VLA-4 
antagonist developed for targeting leukocyte VLA-4, and indeed, any cell expressing VLA-4, however, 
it was still capable of binding HSC VLA-4 (Vanderslice et al., 2013).   
 
Similarly, results from the Kalia laboratory have demonstrated that stromal cell derived factor-1 
(SDF-1α) pre-treatment of HSCs is capable of inducing the clustering of LFA-1 on the cell surface 
(Kavanagh et al., 2013).  This is also seen when primary T cells are stimulated with SDF-1α (Wu et al., 
2012).  These observations highlight that integrin behaviour, and research of said behaviour, are 
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directly applicable across fields. However, these observations should be confirmed within HSC to 
ensure a complete understanding of integrin mediated adhesion and cellular activation of stem cells. 
 
1.6  Enhancing Stem Cell Recruitment to Sites of Injury 
 
Although it has been demonstrated that exogenous HSC transfer might be an effective regenerative 
or anti-inflammatory regimen for the treatment of colonic injury, their efficacy remains poor.  One 
possible explanation for the limited effectiveness is a result of poor recruitment efficiency once these 
potentially therapeutic cells are injected systemically.  For stem cells to confer benefit more 
efficiently, they must first be recruited more readily and in greater numbers to sites of injury.    
 
Current attempts to increase stem cell recruitment efficiency involve techniques such as genetic 
manipulation or modification of the stem cells (Kumar and Ponnazhagan, 2007).  However, this in 
itself could pose a potential risk when used, as it is currently unclear whether these changes to the 
stem cell may cause potential problems in the long term in vivo.  For example, genetically modified 
stem cells may create problems due to the potential misguided insertion of genetic material can lead 
to oncogene activation and genome instability.  Aberrant genomes and gene expression profiles can 
then lead to uncontrolled proliferation and have the potential to form carcinomas.   Instead, 
identifying a lower risk strategy of improving stem cell recruitment by pre-treatment may provide a 
safer therapeutic option. 
 
 
1.6.1 Pre-treatment Strategies to Improve Stem Cell Homing  
Pre-treatment of cells is considered a possible therapeutic tool to increase the efficacy of cell based 
treatments via increased cellular recruitment to the injured organ. This idea was developed by the 
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observation that stem cell recruitment to many different organs is increased following injury.  This 
suggests local, soluble inflammatory factors activate trafficking stem cells causing them to adhere in 
a similar manner to that described for leukocytes.  From this it could be postulated that pre-exposing 
stem cells to a mimetic inflammatory environment containing factors known to be released in injured 
tissue may modulate their activity, either through transcript- and preoteome alterations, changing 
surface molecule expression, or changing the affinity of adhesion molecules for their counter-ligand 
may increase cellular recruitment and thus enhance efficacy.   
 
The concept of pre-treating cells to alter behaviour is not novel; indeed many methods exist in cell 
culture biology.  For example the use of thrombopoietin (TPO) to cause HSCs to differentiate into 
megakaryocytes (Dumon et al., 2006), changing the constitution of culture media to induce MSC into 
bone, cartilage and fat (Morikawa et al., 2009, Soleimani and Nadri, 2009) and pre-treating 
leukocytes with hydrogen peroxide (H2O2) to increase their rolling on endothelium (Johnston et al., 
1996) are all examples of cell pre-treatments.  However, investigating their use as a stem cell 
targeting regime has not yet been fully investigated. 
 
Studies within the Kalia laboratory have identified that the chemokine SDF1α (CXCL12), a known 
potent chemoattractant, is capable of enhancing HSC adhesion to murine injured small intestine 
(Kavanagh et al., 2013), injured kidney (White et al., 2013) and can increase HSC rolling in post-
capillary venules of the cremaster muscle (Kavanagh et al., 2013); tissue beds in which IR injury 
results in an increase in stem cell adhesion. Similarly, other groups have demonstrated that exposure 
of stem cells to SDF1α results in an increase in stem cell homing to injured liver and BM (Kollet et al., 
2003, Avigdor et al., 2004).   
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1.6.1.1 Hydrogen Peroxide (H2O2) 
Although the aetiology of IBD is unknown, central to diseases such as UC and Crohn’s is the presence 
of both acute and chronic inflammation during times of active disease.  Therefore, these pathologies 
are associated with significant increases in the generation of ROS such as hydrogen peroxide (Harris 
et al., 1992), generated during the respiratory burst of infiltrating neutrophils (Cook-Mills and 
McCary, 2010) and from endothelia (Matoba et al., 2000).  It is also known that H2O2 can modulate 
the adhesive behaviour of inflammatory leukocytes, as increased rolling and adhesion of pre-treated 
leukocytes is observed (Fraticelli et al., 1996).  ROS are starting to be considered as signalling 
molecules in their own right (Gough and Cotter, 2011).  This idea has developed due to the 
observation of hyperphosphorylation of signalling components within signalling cascades such as the 
NFκB pathway and their role as second messengers within these signalling pathways (Anderson et al., 
1994, Staal et al., 1994, Baeuerle et al., 1996). Furthermore, Kavanagh et al. (2012) have 
demonstrated that pre-treatment of HSC with H2O2 leads to a substantially increased recruitment of 
HSC within the injured murine gut (Kavanagh et al., 2012).  It was found that the increased adhesion 
was due to an increase in integrin mediated adhesion.  Indeed, there are multiple reports that 
integrin affinity and behaviour are redox regulated that result in enhanced cellular adhesion (Liu et 
al., 2008, de Rezende et al., 2012, Lim and Hotchin, 2012) (Figure 1.6).   
 
Overall these observations suggest that H2O2 pre-treatment may be a promising method of 
enhancing cellular therapy by enhancing stem cell recruitment to target tissues.   
 
1.6.1.2 Platelet Microparticles (PMPs) 
In addition to the presence of ROS, numbers of platelet microparticles (PMPs) in the blood have also 
been found to increase as a result of inflammatory injury.  Following IBD, circulating numbers of 
PMPs in both clinical and experimental studies is significantly increased (Andoh et al., 2005, Andoh et 
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al., 2006, Palkovits et al., 2012).  Interestingly, an increased PMP number has also been positively 
correlated with disease activity (Andoh et al., 2006) suggesting they may be used as biomarkers in 
IBD as well as other pathologies.  PMPs are reportedly increased in several additional acute 
pathologies such as IR injury (Burnier et al., 2009) and myocardial infarction (Gawaz et al., 1996).  
Their role in injury and inflammation is not completely clear, however, several models have been 
proposed. 
 
PMPs are submicrometer vesicles that are released or shed from the platelet surface following 
platelet activation into the circulation (Perez-Pujol et al., 2007, Morel et al., 2008, Boilard et al., 
2010).  Although initially considered as cell debris, a central role in haemostasis has been identified 
for PMPs (Merten et al., 1999, Forlow et al., 2000, Mause et al., 2005).  They are now thought to play 
a significant role in mediating circulating cell adhesion and inflammation.  This may be through direct 
cell interaction (coating or loading) of leukocytes (Mause et al., 2005), through paracrine effects via 
the release of soluble mediators (Iwamoto et al., 1996) or by acting as a bridge between blood cells 
and endothelium/extracellular matrix (Forlow et al., 2000).  Indeed, Jy and colleagues presented 
seminal data that PMPs can ‘coat’ neutrophils and induce their activation, as measured by increased 
integrin CD11b (M) expression and phagocytic activity (Jy et al., 1995).  PMPs can also promote 
platelet interaction with subendothelial matrix proteins exposed after vessel injury (Merten et al., 
1999).  These submicrometer particles have also been used to enhance EPC recruitment (Mause et 
al., 2010), HSC recruitment to BM (Janowska-Wieczorek et al., 2001) and are also capable of 
mediating molecule transfer between cells (Tang et al., 2010, Risitano et al., 2012).   
 
However, their potential for enhancing HSC recruitment to injured extramedullary tissues has not 
been fully examined, particularly with regards to initial capture of HSC from flow in vivo.  It is highly 
likely that they are involved in modulating cellular recruitment considering their extensive existence  





Figure 1.6 Mechanisms by which Cellular Pre-treatment may Improve Adhesion 
Stem cell therapies are likely limited by poor recruitment of stem cells to target sites.  Pre-treatment of HSCs may be a 
simple yet effective way to enhance their adhesion.  Pre-treatment with H2O2 (left side) may have several effects; it may 
affect integrins directly or have effects on the cytosol and its constituents, resulting in enhanced adhesion.  Pre-treatment 
with platelet microparticles (right side) may have similar effects on cell adhesion.  It may trigger integrin modulation, but it 
may also result in new adhesion molecules present on the cell membrane, either through adhesion of the molecules to the 
cell, thereby acting as a bridge, or through merging of membranes and depositing surface markers onto the cell.  However, 
it may also have an effect on gene expression and proteome management through the delivery of its cytosolic contents.  
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within the blood of patients with inflammatory disorders.  They may therefore play a role in 
increasing HSC adhesion to injured tissues, either through activation of HSCs to a state more able to 
be recruited (i.e. activation), or through increased expression of integrins (either through stimulation 
or potentially through expression of the bound microparticles; Figure 1.6).  As previously stated, 
there is evidence to suggest that CD34+ stem cells can be coated with PMPs and that this was 
therapeutically beneficial as covered cells engrafted the BM of lethally irradiated mice significantly 
faster that those that had not been covered (Janowska-Wieczorek et al., 2001).  This suggests PMPs 
have the potential to play an important role in the homing of HSCs to sites of injury also which may 
have clinical implications for the optimisation of cellular therapies.   
 
However, it is poorly understood how these molecules are loaded, and how they are having a 
beneficial effect on cellular recruitment.  It has been identified that PMPs can deliver cell surface 
molecules such as phosphatidylserine (PS), glycoprotein (GP) Ib, GPIIb/IIIa, P-selectin, CXCR4 and 
other molecules (Barry et al., 1998, Mause et al., 2005, Mause et al., 2010), but the transfer of 
integrins VLA-4 and LFA-1 is highly unlikely due to a lack of expression of these on the platelet 
surface.  However, the transfer of other molecules, such as CXCR4 and SDF-1α from the platelets, 
may allow for the modulation of integrin behaviour (Figure 1.6).   
 
In summary, soluble inflammatory molecules such as ROS, as well as inflammatory cells such as 
platelets, are found in abundance at sites of inflammatory colonic injury.  These molecules or cells 
may activate the HSCs to adhere as they traffick through the colon. As continued observations from 
the Kalia laboratory highlight a critical role for integrins in HSC adhesion, it was speculated that the 
bioactive molecules present will enhance integrin mediated adhesion.   




Overall, inflammatory gut injuries such as Crohn’s and colitis are difficult to treat, with treatment 
regimens rapidly losing effectiveness (Lichtenstein et al., 2009, Singh et al., 2010).  Similarly, acute 
intestinal injuries such as IR injury are also faced with difficulties during treatment.  Ultimately, both 
acute and chronic bowel injuries are faced with inefficient and ineffaceable therapies and result in 
high morbidity rates.  Thus a need for new, effective options are required.  Cellular therapy, 
particularly HSC-based therapy, could provide this needed alternative.  It has been demonstrated 
experimentally and clinically that HSCs are able to directly repair tissue as well as combat the 
excessive immune responses triggered by these inflammatory injuries.  Currently, however, HSC 
therapies are faced with limited clinical efficacy.  This is thought to be attributed partly to limited 
recruitment of stem cells to the target, injured tissue.  It is this need to identify strategies in which 
stem cell recruitment may be increased that this research is based around.   
 
If stem cells do hold promise in the context of regenerative medicine or for the repair of colon injury, 
what is clear is that strategies to enhance HSC retention within sites of injury are of utmost 
importance. Elucidating the molecular adhesive mechanisms governing HSC homing to injured 
colonic microvessels may have significant clinical consequences as it may allow us to optimise their 
effective intestinal delivery and improve their therapeutic efficacy. Identifying methods of enhancing 
HSC engraftment rates in vivo, and whether a systemic delivery of HSCs can efficiently deliver cells to 
intestinal tissues have had limited investigation, with no studies conducted in the colon.   
 
1.8 Aims and Hypotheses 
The aims of this thesis were firstly to identify whether HSC adhesion to murine colon 
microvasculature in vivo could be enhanced following two different injuries, namely IR injury and 
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colitic injury.  Furthermore, this project aimed to identify the molecular mechanisms involved in the 
adhesion of HSC to injured tissue.  Following investigations conducted in the Kalia laboratory, it was 
postulated that pre-exposure of HSCs to a mimetic inflammatory environment may enhance their 
adhesion within the microcirculation of the murine colon crypts in vivo.  Therefore, it was 
investigated whether an injury conditioned media (ICM) containing soluble factors released from 
injured colon, H2O2 or PMPs could be used to enhance HSC adhesion.  Furthermore, the mechanisms 
behind any potential increased adhesion were also investigated. 
   
1.8.1 Specific Aims and Hypotheses 
 
1. Does injury increase HSC adhesion to murine colon microvasculature in vivo, and is this 
pattern seen in both IR and colitic injured tissue? 
 It was hypothesised that, similar to that seen in other tissues, an acute and chronic 
injury will increase the number of adherent HSCs within colon microvasculature, with 
possibly greater adhesion observed if the injury is more severe. 
 
2. What are the molecular mechanisms involved in HSC adhesion to the injured colon 
microvasculature? 
 It was hypothesised that the integrin CD18 (β2) will play a role in adhesion to IR colon, 
but not CD49d (α4), as a similar role for CD18 was seen in IR injured small intestine.   
 Adhesion to colitic colon will be mediated by both CD18 (β2) and CD49d (α4).  This was 
hypothesised as the longer duration of the inflammation in colitic tissue may up-
regulate endothelial counterligands such as VCAM-1 as well as ICAM-1. 
 
3. Can pre-treating HSCs significantly enhance their adhesion within the injured colon in vivo? 
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 Pre-treatment with either chemical (H2O2) and/or biological (platelet derived pre-
treatments) pre-treatments will significantly enhance HSC adhesion within both IR and 
colitis injured colons in vivo. 










Chapter 2   
 








2.1 Tissue Culture 
 
2.1.1 CHO K3 Culture 
CHO (Chinese hamster ovary) K3 cells, a kind gift from Professor Leif Carlsson (University of Umeå, 
Sweden), rapidly grow in culture and were used to generate a stem cell factor (SCF) conditioned 
media. CHO K3 cells generate SCF as a result of a stable transfection.  SCF is an essential component 
of media used for HSC culture and expansion.  CHO K3 cells were cultured in Dulbecco’s modified 
Eagles medium (DMEM; Invitrogen, UK) supplemented with 10% FBS (Invitrogen, UK), 50U/ml 
streptomycin (Invitrogen, UK), 50U/ml penicillin (Invitrogen, UK) and 2mM L-glutamine (PAA 
Laboratories, UK). CHO K3 cells were grown to confluency in gelatin coated flasks and then split 1 in 4 
and grown at 37°C, 5% CO2. To generate SCF conditioned media, CHO K3 were grown to confluency 
and left for 48 hours without replacing media.  From this point the media was changed to Stem Pro 
34 Serum Free Media (SFM) 34 with 0.5% FBS.  Cells were kept in this media for 24 hours, then 
replaced with fresh Stem Pro SFM 34 with 0.5% FBS for a further 48 hours.  After this time the media 
was harvested and filtered through a 0.22µm syringe driven filter unit.  The generated SCF media was 
stored at -20°C in aliquots until required. 
 
2.1.2 Haematopoietic Stem Cell Line Culture  
Throughout this body of work the HSC cell line HPC7 has been used for all experiments.  The HPC7 
cell line was also a gift from Professor Leif Carlsson (University of Umeå, Sweden). Investigating in 
vivo HSC homing intravitally has been hampered by the limited numbers of primary HSCs obtainable 
from individual mice.  Therefore, we utilized an immortalised HSC line, HPC7, generated by 
transfecting embryonic SCs with the murine LIM-homeobox gene LH2 (Pinto do O et al., 1998).  
Haematopoietic progenitor cell lines immortalized in this manner display characteristics of primary 




HSCs including surface expression of common murine HSC markers (c-kit+, CD34-, Lin-; Pinto do O et 
al., 1998) and similar behaviour at a molecular level (Wilson et al., 2009).  Interestingly HPC cell lines 
derived in this manner are able to reconstitute haematopoiesis when injected into lethally irradiated 
mice (Pinto do O et al., 2002).  HPC7 cells also express adhesion molecules present on primary HSCs 
and we have previously used them to model hepatic, renal and intestinal HSC recruitment (Kavanagh 
et al., 2010, Kavanagh et al., 2012, White et al., 2013). 
 
HPC7s  were cultured in Stem Pro SFM 34 (Invitrogen, UK) supplemented with 50U/ml streptomycin, 
50U/ml penicillin, 2mM L-glutamine and SCF obtained from conditioned media harvested from CHO 
K3 (see section 2.1.1) cells at a concentration of 1 in 10.  However, the use of CHO-K3 conditioned 
medium to generate SCF for HPC7 growth was not always reliable.  To counter this, HPC7 media was 
supplemented with 100ng/ml rmSCF (recombinant murine stem cell factor; Invitrogen, UK).  This 
altered method of HPC7 culture was the protocol used for the majority of the work in this thesis. 
 
2.1.3 Labelling HPC7 with Fluorescent Dyes 
2.1.3.1 5’6-Carboxyfluorescien Diacetate Succinimidyl Ester (CFDA-SE) 
HPC7 were fluorescently labelled using the fluorescein label 5’6-carboxyfluorescein diacetate 
succinimidyl ester (CFDA-SE; Invitrogen, UK) to enable their tracking in vivo and their identification in 
vitro.  CFDA-SE is the cell permeable precursor to the cell impermeable, fluorescent molecule 5’6-
carboxyfluorescein succinimidyl ester (CFSE).  This change in molecule is achieved by intracellular 
esterases, enzymes responsible for both the change in fluorescence and retention within the cell.  
CFSE labelled cells fluoresce under blue light (488nm) and emit green light at a wavelength of 510nm, 
similar to the properties of fluorescein isothiocyanate (FITC). To label HPC7, 3-6x106 HPC7 were 
isolated from culture and washed with PBS.  Cells were then resuspended in 4ml PBS containing 5μM 




CFDA-SE and incubated at 37oC for 20 minutes.  The staining reaction was stopped by adding 4ml 
cold Stem Pro.  Cells were washed 3 times in warm media, counted by trypan blue exclusion and 
suspended in complete media at a final density of 2x106 cells/ml until use.  HPC7 were used within 4 
hours of staining. 
 
2.1.3.2 Cell Tracker Orange 
For visualising HPC7 whilst imaging platelet microparticle loading onto the cell surface confocally, it 
was necessary to label the HPC7 with a different dye, to allow for dual colour fluorescence 
microscopy.  In this instance the commercially available cell labelling kit CellTracker Orange 
(Invitrogen, UK) was used. The cell tracker dyes are highly cell permeable until intracellular 
processing renders them cell impermeable.  CTO has a peak excitation wavelength of approximately 
550nm with a peak emission at approximately 580nm.  As this dye is sufficiently separate from FITC 
(and Alexa488) it was selected as the cellular counter-stain in the dual colour microscopy analysis.  
HPC7 were labelled with CTO as per manufacturer’s instructions.  HPC7 were washed by 
centrifugation with warm PBS and then resuspended in 5μM CTO solution in serum free media.  Cells 
were incubated at 37oC for 45 minutes in the dark.  The reaction was stopped by adding 4 ml cold 
media.  Cells were then washed 3 times by centrifugation and counted by trypan blue exclusion.  
HPC7 were then suspended in complete media at a final density of 2x106 cells/ml until use.  HPC7 
were used within 4 hours of staining. 
 
2.1.4 Murine Cardiac Endothelial Cell (MCEC-1) Culture 
For some in vitro adhesion assays, a murine cardiac endothelial cell line (MCEC-1) was used.  These 
cells were used due to the difficulty and time consuming purification techniques and the high 
numbers of contaminating cells obtained when culturing primary murine endothelial cells long-term 




(Marelli-Berg et al., 2000; Peek et al., 2000).  MCEC-1 cells were isolated from H-2kb-tsA58 mice, 
which express a thermoliable strain (tsA58) of the SV40 large T antigen (tsA58 Tag) to allow the 
production of conditionally immortalised cell line (Lidington et al., 2002) and were a gift from 
Professor Leif Carlsson.  The endothelial cells are characterised by a phenotypic cobblestone 
appearance and their ability to form tubes on artificial extra-cellular matrix described by Lidington 
and colleagues.  MCEC-1 are ICAM-1 and VCAM-1 positive, but with negligible selectin expression 
(Lidington et al., 2002).   
 
MCEC-1 were grown to confluence on 1% gelatin coated tissue culture flasks and maintained in 
complete media (DMEM supplemented with 10% FBS, 50U/ml penicillin, 50U/ml streptomycin, 2mM 
L-Glutamine and 10ng/ml mEGF (murine endothelial growth factor, Peprotech, UK)).  At confluence, 
cells were dissociated from tissue flasks with 0.25% Trypsin-EDTA (Invitrogen, UK), washed in MCEC-1 
media and split 1 in 3.  When used experimentally, MCEC-1 were cultured in 24 well tissue culture 
flasks.  When confluent, wells were washed thoroughly with PBS then some wells were incubated 
with 100U/ml TNFα (Peprotech, UK) for 4 hours at 37oC.  Wells were again washed thoroughly prior 
to the addition of the HPC7 cells being assayed.  
 
2.1.5 Colon Endothelial Cell Line Culture 
Similarly, for some in vitro adhesion assays, the colon endothelial cell (CEC) line was used due to the 
difficulty and time consuming purification techniques of primary colonic endothelial cells.  These 
endothelial cells also offered an attractive and more relevant model than the MCEC-1 cells.  CEC cells 
were a kind gift from Professor Steven Alexander (Louisiana State University, USA), and were isolated 
from H-2kb-tsA58 mice, which express a thermoliable strain (tsA58) of the SV40 large T antigen 
(tsA58 Tag) to allow the production of conditionally immortalised cell line (Ando et al., 2005).   
 




CEC were grown to confluence on 1% gelatin coated tissue culture flasks and maintained in growth 
media (D-Valine MEM (Promocell, UK), 10% FBS, 50U/ml penicillin, 50U/ml streptomycin, 2mM L-
Glutamine, 1/100 Non Essential Amino Acids (Sigma, UK), 1/100 Vitamin Mix (Gibco, UK) and 
10units/ml mIFNγ (murine interferon gamma (Peprotech, UK)) at 33oC, 5% CO2.  At confluence, cells 
were dissociated from tissue flasks with 0.25% Trypsin-EDTA, washed in growth media and split 1 in 
3.  When used for experiments, CEC were grown in 24 well tissue culture flasks at 37oC, in 
experiment media (450ml Dulbecco’s Modified Eagles Medium (4.5g/l glucose) (DMEM); Invitrogen, 
UK; 10% FBS, 50U/ml penicillin, 50U/ml streptomycin), until confluency and washed thoroughly prior 
to the addition of 100U/ml TNFα in media to some wells, with some wells left unstimulated.  The CEC 
were incubated for 4 hours at 37oC then washed thoroughly prior to the addition of HPC7 for 
experiments. 
 
2.2 Animal Experimental Procedures 
2.2.1 Animals 
Male C57BL/6 mice (Harlan, Oxon, UK) were used. Animals were anaesthetised with an intra-
peritoneal injection of ketamine [100mg/kg] and 2% xylazine [10mg/kg].  The trachea was intubated 
and the left carotid artery cannulated.  The carotid cannulation was to allow for the systemic 
administration of labelled stem cells and to allow the maintenance of anaesthesia with 
ketamine/xylazine.  Throughout all procedures, anaesthetised animals were kept warm with the use 
of a heating mat and lamp. All intravital procedures were conducted in accordance with the Animals 
(Scientific Procedures) Act of 1986 (Project Licence: 40/3336; 19b1; Dr Kalia) and had also received 
local University of Birmingham ethical approval.    For some experiments, DSS-induced colitis male 
C57BL/6 mice were used.  These were generated under a separate project licence overseen by Dr 
Bertus Eksteen (PPL: 40/3226, 19b2a1), until transfer (post-DSS treatment) to PPL 40/3336 for 




intravital experimentation.   For experiments in which platelet microparticles were generated from 
donor mice, the bleeding and isolation of platelets from whole blood procedures was performed 
under a licence overseen by Professor Steve Watson (PPL: 30/2721, 19b2). 
 
2.2.2 Intestinal Ischaemia-Reperfusion Injury Model 
To induce ischaemia-reperfusion (IR) injury in the small intestine, a midline laparotomy was 
performed, following which the superior mesenteric artery (SMA) was isolated and occluded using a 
non-traumatic artery clamp for 45 minutes.  The major portion of the blood supply to the colon is 
also provided by the SMA in rodents and clamping this vessel reduces microvascular perfusion in the 
colon by more than 85% (Leung et al., 1992, Riaz et al., 2002b, Santen et al., 2010).  Subsequent 
removal of the clamp initiated the reperfusion injury as blood flow was restored.  Control animals 
underwent sham surgery in which the midline laparotomy and the SMA was isolated but not 
clamped. 
 
2.2.3 DSS-Induced Colitis Injury Model 
Within the mouse there are several well documented models of colitis including oral administration 
of dextran sodium sulfate (Okayasu et al., 1990), using genetic knockout mice for IL-10 (Singh et al., 
2003) in addition to the many other models (Blumberg et al., 1999, Wirtz and Neurath, 2000).  All of 
these models display some of the symptoms experienced by patients with IBDs; however, there are 
some differences.   
 
For example, within the DSS model, mice exhibit a significant shortening of the colon, whereas the 
murine IL-10-/- model can display a lengthening of the colon (Kawachi et al., 2000).  Interestingly, 
several groups have identified differences in the chemokine expression of the different models, and 




in some cases within models but from different laboratories (Kawachi et al., 2000, Coburn et al., 
2012, Yan et al., 2012), further highlighting the complexity of these pathologies.  DSS is a sulfated 
polysaccaride that can exist at a range of molecular masses. The use of sulphated polysaccarides to 
induce inflammatory bowel disorders was first described in 1969 where carrageenan was used to 
induce an ulcerative colitis-like model in guinea pigs and rabbits (Marcus and Watt, 1969). In mice, 
however, Okayasu et al., (1990) first described the use of DSS to induce a colitis-like injury, with a 
chronic model of colitis that could be induced through cyclic administration of DSS.  The feeding of 
DSS in the drinking water of rodents ad libitum induces a colitis-like injury with bloody diarrhoea, 
ulcerations, histological damage, shortening of the colon and enhanced leukocyte infiltrations of 
both PMN and mononuclear components (Okayasu et al., 1990).  
 
It is thought that the colitis injury symptoms displayed following DSS administration are induced by 
disruption of the mucosal barrier, which likely triggers an inflammatory response via activation of the 
immune system through contact with luminal antigens, similar to that reported in human IBDs.  This 
has been determined by studies in which germ free and antibiotic treated animals were induced with 
colitis and that the inflammation occurred as a result of luminal antigens derived from the host, and 
not pathogens (Maloy and Powrie, 2011). Furthermore, it has been demonstrated that the DSS can 
rapidly degrade the colon mucus leading to an infiltration of bacterial species prior to any signs of 
inflammation (Johansson et al., 2010) and that DSS is toxic to certain intestinal epithelial cells 
including paneth cells and goblet cells (Maloy and Powrie, 2011).  It has also been suggested that the 
DSS associated inflammation may also be contributed to by macrophages that have engulfed DSS and 
subsequently contribute to the local inflammatory response (Okayasu et al., 1990).   
 
To establish a model of colitis in mice the drinking water was changed to 3% dextran sodium sulfate 
(DSS) water (MW 36–50kDa; MP Biomedicals, UK) and maintained for up to 6 days.  Onset of colitis 




was defined as the appearance of bloodied stools or 20% weight loss.  DSS treatment was typically 
for 5 days, but did not exceed 6 days. Although there appeared to be a large degree of variation, 
potentially raising concerns that animals were not injured, Mori et al. (2005) described that DSS 
supplemented drinking water typically caused endothelial dysfunction within 3 days of 
administration, and indeed the injury scoring measure used allowed for verification of injury (see 
Table 2.1).   Animals were maintained at the Biomedical Services Unit (University of Birmingham, UK) 
until use for intravital experiments. 
 
Although all colitis mice were treated using this protocol, by the nature of the DSS treatment there 
was a marginal degree of variability exhibited.  Indeed, it has been reported that although DSS does 
induce colitis in rodents, there is a considerable variation in the extent of colitic injury between mice 
strains, between sources and molecular weights of DSS, between institutions and even between 
testing groups  (Bamba et al., 2012).  So to ensure that all colitis mice were injured to the same 
degree, the extent of injury was scored based on the scoring system from Soriano et al. (2000) that 
relies on investigator interpretation for scoring inflammation, stool consistency, faecal blood 
presence and ulceration.  The results obtained using this scoring system are displayed in Table 2.1.  
As has been previously reported, following the DSS treatment regime, animals underwent significant 
weight loss, colonic inflammation and shortening of the colon with some associated bleeding from 
the anus and also contained within the colon (exhibited by presence of blood found within the stool).  
However, little to no ulceration was exhibited in the colon. 
 
2.2.4 Preparation of the Colon for Intravital Microscopy  
2.2.4.1 Method 1 
Limited studies have imaged the mouse colon intravitally and no studies have previously tracked the 
homing of stem cell to this organ.  Difficulties in imaging the colon lie with the fact that in the mouse 














Table 2.1 DSS-induced colitis injury scores 
This table displays the mean±SEM values from the scoring system based on Soriano et al. (2000). Scoring was done as follows: Colon Inflammation: 0 = No observable inflammation, 1 = 
some swelling and oedema, 2 = Swelling, oedema and some rubor evident, 3 = extensive swelling, oedema, rubor and evidence of bleeding in the tissue.  Blood in stool, determined 
using tissue paper touched to stool and the existence of red colour to the absorbed fluid: 0 = No observable blood in stool, 1 = some blood present, 2 = clear evidence of blood in stool, 
3 = clear evidence of blood in stool and blood present within the colon lumen. Stool consistency: 0 = normal stool, 1 = loose stool (not fully formed, but still structure evident), 3 = 
diarrhoea (no stool formation evident).  Anal bleeding: 0 = No evidence of blood around anus, 1 = dried blood around anus, 2 = extensive dried blood around anus and fresh blood 
observable.  Ulceration: 0 = No ulceration evident, 1 = <5 small, isolated ulcers, 2 = extensive ulceration.  Δ Body Weight/g (change in body weight in grams): total body weight change 
as determined on day 0 (start of treatment) subtracted by body weight on day 5 (end of treatment).  Colon length/mm: length of entire colon - colon excised from ceacum to anus and 
measured with a 30cm ruler. Values are mean values across all experiments. Sham N=6, Colitis N=53. 
Animal Colon Inflammation Blood in stool Stool Consistency Anal Bleeding Ulceration Δ Body Weight/g Colon Length/mm
Sham 0 0 0 0 0 0.88±0.12 65.3±2.4
Colitis 2.12±0.07 2.01±0.05 1.55±0.03 1.43±0.06 0.30±0.03 -2.06±0.17 52.5±0.7




the colon is incredibly short and it is therefore difficult to exteriorise a sufficient length.  Therefore, 
part of the research involved establishing a viable preparation for intravital imaging of the colon 
mucosa.  Following intubation of the trachea, carotid artery cannulation and midline laparotomy the 
abdominal viscera were moved out of the abdominal cavity to the left of the animal.  Using a surgical 
swab and taking care not to damage any organs or vasculature, the ceacum was located and gently 
pulled away from the animal taking care not to puncture the organ.  A longitudinal incision was made 
using a cautery to expose the mucosa of the ascending colon.   The colon was raised onto a specially 
designed board (comprising of a 1.5ml eppendorf tube lid that was removed from the eppendorf and 
fixed into place).  This allowed the colon to lie flat without the use of any other implements.  
However, this preparation proved to be unreliable as the colon persistently slipped from the 
eppendorf lid causing the field of view to be lost. 
 
2.2.4.2 Method 2 
Following intubation of the trachea, carotid artery cannulation and midline laparotomy the 
abdominal viscera were moved out of the abdominal cavity to the left of the animal.  Using a surgical 
swab and taking care not to damage any organs or vasculature, the ceacum was located and gently 
pulled away from the animal onto a sterile 9cm petri dish, taking care not to puncture the organ.  
Bent paper-clips were used to hold the ascending colon approximately 2cm from the ceacum (this 
was as much of the ascending colon that could be removed from the abdominal cavity without 
damaging it or any of the other abdominal viscera) and to hold it stationary on the petri dish.  A 
longitudinal incision was made using a cautery to expose the mucosa of the colon.  The colon was 
opened flat, mucosal side up, onto the petri dish and held in place using 2 further paper clips (Figure 
2.1).   The mucosa was gently wiped to remove any solid matter and then gently washed with saline.  
The colonic microcirculation was visualised using an upright widefield fluorescent microscope 
(motorised BX61WI) with a 10x, 1.4 numerical aperture (NA) air objective (Olympus, UK).  A field of 




view was randomly pre-selected for intravital observations.  Initially, this preparation proved to be 
unreliable as the signal to noise ratio was very poor.  In order to improve image quality, a glass 
coverslip was placed onto the mucosa and held in place.  Due to the excessive mucus produced by 
the colon, the coverslip had to be removed and the mucosa cleaned gently with a cotton swab every 
15 minutes, with care being taken to ensure the pre-selected field of view was not altered.  This 
method was utilised to generate all IVM data within this thesis.   
 
For the laser speckle microscopy, the colon was prepared in the same manner, but the coverslip was 
removed.  To asses blood flow flux values (which are directly proportional to blood flow) were 
determined within the focussed region of the colon (Figure 2.1).  
 
2.2.5 Tracking Stem Cells In Vivo in the Colon  
In IR injured mice, a single bolus dose of 2x106 CFSE labelled stem cells was injected via the carotid 
artery cannula at 1 hour reperfusion. The pre-selected field of view was imaged intravitally every 5 
minutes for one hour.  For tracking cells in the colitic colon, labelled cells were infused once the 
surgical preparation was completed and had been allowed to stabilise for 30 minutes.  Again, HPC7 
were systemically infused via the carotid artery.  Adherent cells were defined as cells that remained 
stationary ≥30s.  Freeflowing cells were defined as those moving freely through the field of view 
without remaining stationary for ≥30s.  Throughout these experiments, as well as other studies of 
low shear vasculature, HPC7 did not show any evidence of rolling, nor any sign of extravasation.  This 
can be determined as the vasculature of the colon, and indeed the gut, can be seen as “shadows” or 
a darker network within the field of view (at 10x).  HPC7 adherent in the manner described are 
considered recruited, as there is evidence to suggest that HPC7, when adherent, are capable of 
reducing the number of adherent leukocyte and platelets within the microvasculature (Unpublished 
results from the Kalia Laboratory).  To ensure the events in the pre-selected area for IR and colitis   










Figure 2.1 Preparation of the mouse colon for intravital imaging 
The mouse colon was moved onto a sterile petri dish and mucosa exposed via a longitudinal incision made using a cautery.  
The colon was then opened flat onto the dish surface and held in place using paper clips.  For IVM a glass coverslip was held 
in place on the mucosal surface (not seen in above image) whilst for laser speckle imaging the glass coverslip was removed. 
For laser speckle determination of blood flow, flux values were quantitated within the mask defining the in focus colon 
mucosa (white dotted line). 
  




mice were representative of events taking place in the whole colon, post experiment, the colon was 
excised and 5 additional fields of view were monitored.   
 
2.2.6 Quantification of HSC Recruitment to Remote sites - Ex Vivo Analysis 
Post intravital experiment, animals were culled and the lungs and ileum (terminal region of the small 
intestine) were also excised and imaged to determine stem cell recruitment. The tissues were  
removed, washed with saline to remove blood and laid flat onto a petri dish.  The dish was inverted 
to allow for imaging using an upright fluorescent microscope (motorised Olympus BX61WI) with a 
10x 1.4NA air objective. 
 
2.2.7 Isolation of Washed Mouse Platelets from Whole Blood  
Mice were CO2 narcosed following isofluorane anaesthesia.  Following midline laparotomy, blood 
was collected from the descending aorta into 10% acid citrate dextrose (ACD: 120mM sodium citrate, 
110mM glucose, 80mM citric acid).  The blood was diluted in 200µl of Tyrode’s-HEPES buffer 
(134mM NaCl, 0.34mM Na2HPO4, 2.9mM KCl, 12mM NaHCO3, 20mM HEPES, 5mM glucose, 1mM 
MgCl2, pH 7.3) and centrifuged at 2000rpm for 5 minutes in a microcentrifuge.  The platelet rich 
plasma (PRP) and the top 33% of erythrocytes were removed and further centrifuged at 200xg for 6 
minutes.  PRP was retained and, to obtain the maximum number of platelets, a further 200µl of 
Tyrode’s-HEPES buffer was added to the remaining erythrocytes, mixed and centrifuged again at 
200xg for 6 minutes.  The PRP was taken and added to the first isolation of PRP, taking care to ensure 
no erythrocytes were added to the isolated PRP solution.  To prevent aggregation 10µg/ml 
prostacyclin was added to the total PRP and centrifuged at 1000xg for 6 minutes.  The platelet pellet 
was resuspended in 200µl Tyrode’s-HEPES buffer and counted.  These platelets were later used to 
generate platelet microparticle as described in Section 2.3.7. 




2.3 In Vitro Experiments 
2.3.1 Gelatin Coating of Tissue Culture Flasks  
To aid endothelial cell adhesion to culture surface, the culture surface was coated with gelatin.  This 
was achieved by incubating tissue culture surface with sterile 1% gelatin Type IIb, from bovine skin 
(Sigma, UK) for 30 minutes, then aspirating prior to the addition of an endothelial cell suspension.  
Gelatinised plates, once aspirated and dry, could be stored for up to one week prior to use. 
 
2.3.2 APES Coating of Glass Coverslips for Endothelial Cell Adhesion Assays  
To permit adhesion of endothelial cells to 13mm diameter glass coverslips, the coverslips were 
treated with 3-aminopropyltriethoxysilane (APES) overnight, then treated with 5M nitric acid 
overnight, 10 washes in 50ml running water, 3 washes with 25ml acetone and 2 further washes with 
25ml of 4% APES in acetone.  The coverslips were then kept in the dark overnight, washed twice with 
acetone, followed by a final wash in distilled water.  The coverslips were then dried, separated and 
autoclaved prior to use in in vitro endothelial cells adhesion assays.  
 
2.3.3 Lysine Coating of Glass Coverslips for Confocal Microscopy 
Poly-lysine polymers are useful molecules to prepare surfaces for cell attachment as they enhance 
cell adhesion to glass.  13mm diameter glass coverslips were washed in 5M nitric acid overnight, 10 
washes in 50ml running water followed by incubation for at least one hour in 10% poly-L-lysine.  
Lysine solution was aspirated immediately prior to addition of cells for confocal microscopy 
experiments.  
  




2.3.4 Tissue Preparation and Sectioning for Stamper Woodruff Assay 
The Stamper-Woodruff (S-W) assay will be detailed in Section 2.5.1.  Briefly, it allows adhesion of 
cells to be monitored on frozen tissue sections in vitro.  Tissue samples were harvested from animals’ 
post-intravital experiment and snap frozen in liquid nitrogen within 5 minutes.  Organs isolated were 
the proximal jejunal region of the small intestine, distal ileal region of the small intestine and the 
ascending colon (2cm).  Samples were stored at -80°C until use.  Prior to sectioning, intestinal 
samples were mounted onto a cork board using O.C.T. mountant.  Tissue was transversally sectioned 
into 10µm sections using a cryostat (Bright Instruments, UK), and transferred onto glass microscope 
slides by heat transfer and fixed in acetone for 5 minutes before wrapping slides in foil and storing at 
-20°C until ready for use. 
 
2.3.5 Sectioning of Frozen Tissue for the Static Adhesion Assay – Modified Method  
As will be explained in detail in the results section of Chapter 3, the above tissue sectioning did not 
provide the best tissue for the static adhesion assay and was therefore modified.  Tissue samples 
were isolated from the proximal jejunum, distal ileum and the ascending colon from sham, IR and 
colitis injured animals after the intravital experiment.  The intestinal mucosal surface was exposed by 
cauterising along the anti-mesenteric border and the organ was pinned flat onto cork before being 
snap frozen in liquid nitrogen. To expose the mucosal microcirculation, small intestinal samples were 
cryostat sectioned to remove 60µm of the mucosal surface and from the colon 20µm of the mucosal 
surface was removed.  Samples were stored at -80°C until use.   
 
2.3.6 Sham and Injury Conditioned Media Production  
2cm of terminal jejunum, 2cm of terminal ileum or 2cm of the ascending colon were removed from 
sham, IR and colitis injured mice and placed into 3ml Stem Pro and incubated at 37°C for 24 hours.  




Tissue was then macerated, centrifuged at 300xg for 5 minutes and the filtered through a 0.22µm 
syringe driven filter unit to remove any remaining particulate matter.  The conditioned media was 
then aliquoted and stored at -20°C until ready for use. 
 
Traditionally, conditioned media’s have been considered to be derived from the supernatant taken 
from defined, cultured cell types.  The harvested supernatant then has been conditioned by the cells 
grown within that media.  However, within this thesis conditioned media refers to media in which 
tissue samples are incubated and macerated to ensure the contents microenvironment were also 
present – thus the media had been conditioned with a tissue environment.  Conditioned media from 
sham and injured mice was called sham conditioned media (SCM) and injury conditioned media 
(ICM) respectively.  Table 2.2 provides a full list of the CMs generated and the abbreviations used to 
describe the CMs in this thesis. 
 
2.3.7 Generation of Platelet Microparticle Pre-treatment Suspensions 
One of the responses of activated platelets to certain stimuli is the shedding of microparticles. In 
order to generate PMPs, mouse platelets were activated with thrombin.  In addition to its role in the 
coagulation pathway, thrombin also promotes platelet activation and aggregation following 
activation of protease-activated receptors (PAR-1) on the cell membrane (Janowska-Wieczorek et al., 
2001).   It has routinely been used to generate PMPs from mouse platelets (Janowska-Wieczorek et 
al., 2001, Mause et al., 2005). Washed platelets were centrifuged at 1000xg for 6 minutes and 
resuspended at 3 x 107/ml in Stem Pro SFM 34. To prevent aggregation 10µg/ml prostacyclin was 
added to the washed platelets prior to centrifugation and rested for 30 minutes prior to experiments.  
Platelets were activated with 2U/ml of thrombin for 30 minutes at room temperature and then 
centrifuged at 1000xg for 6 minutes.    The supernatant generated after centrifugation was aspirated 
and kept and the pellet discarded.  The supernatant was classed as a platelet microparticle enriched 




supernatant (PES; Figure 2.2).  It contained not only the PMPs, but also the soluble factors released 
by the activated platelets.  To generate purified platelet microparticles (PMP), the PES was 
microcentrifuged at 18,000xg for 20 minutes.  The supernatant was then removed and the pellet 
resuspended in an equal volume of Stem Pro as started with.  This PMP contained only the 
microparticles and not the releasate (the total constituents of material released by an activated cell, 
in this case platelets) from the activated platelets (Figure 2.2).  PES and PMP suspensions were used 
within 30 minutes of being generated and not stored prior to use. 
 
2.4 HPC7 Pre-treatment Protocols 
2.4.1 Pre-treatment with Tissue SCM/ICM  
HPC7 cells were suspended in conditioned media at a density of 2x106/ml with aliquots incubated at 
37°C, 5% CO2 for 30 minutes. The different conditioned medias used are outlined in Table 2.2. The 
cell-CM suspension was then centrifuged at 300xg for 5 minutes, then resuspended in un-
supplemented Stem Pro at the required volume immediately prior to use. 
 
2.4.2 Pre-treatment with H2O2 
 HPC7 were incubated in Stem Pro supplemented with H2O2 (1mM, 100µM or 10µM) at a density of 
2x106/ml at 37°C, 5% CO2 for 1 hour.  The cells were then centrifuged at 300xg for 5 minutes.  HPC7 
were then resuspended in un-supplemented Stem Pro at the required volume immediately prior to 
use in experiment. 
 
  




Name Organ Originated Injury Type 
Ileum SCM Ileum (terminal) Non-Injured 
Ileum IR ICM Ileum (terminal) SMA IR* 
Ileum Col ICM Ileum (terminal) DSS Colitis† 
Jejunum SCM Jejunum (terminal) Non-Injured 
Jejunum IR ICM Jejunum (terminal) SMA IR* 
Jejunum Col ICM Jejunum (terminal) DSS Colitis† 
Colon SCM Colon (ascending) Non-Injured 
Colon IR ICM Colon (ascending) SMA IR* 
Colon Col ICM Colon (ascending) DSS Colitis† 
 
*small mesenteric artery occlusion and release (45mins ischaemia, 120mins reperfusion) 
† 























Table 2.2 Intestinal Sham and Injury Conditioned Media 
 
This table lists the conditioned Medias used and the tissue of origin and injury type the conditioned media was sourced 
from.  Abbreviations: SCM – sham conditioned media, ICM – injury conditioned media, IR – ischemia-reperfusion, Col – DSS-
induced colitis.  




2.4.3 Pre-treatment of HPC-7 with Platelet Microparticle Enriched Supernatant (PES) 
and Purified Platelet Microparticles (PMP) 
HPC7 were suspended in either PES or purified PMP at a density of 4x106/ml at 37°C, 5% CO2 for 1 
hour.  The HPC7 were then centrifuged at 300xg for 5 minutes and resuspended in un-supplemented 
Stem Pro at the required volume immediately prior to use in experiment. 
 
2.4.4 Antibody Blockade of HPC7 Integrins 
To ascertain the roles of critical surface adhesion molecules potentially utilised by HPC7 to adhere 
within injured tissue, the integrin subunits CD18 (2 integrin subunit) and CD49d (-subunit of the 
41 integrin) were functionally blocked with monoclonal antibodies.  The Kalia laboratory have 
previously demonstrated an important role for CD18 in small intestinal and CD49d in hepatic stem 
cell homing (Kavanagh et al., 2010, Kavanagh et al., 2012).  2x106 cells were resuspended in 250μl of 
PBS supplemented with 0.1% BSA and 80μg/ml of either LEAF (low endotoxin, azide free) rat anti-
mouse CD18 (Clone: GAME-46; BD Pharmingen, UK) or rat anti-mouse CD49d (Clone: R1-2; 
Cambridge Bioscience, UK).  Control experiments used the isotype control Rat IgG (Clone: RTK2758; 
Cambridge Biosciences, UK).  Blockade treatments were performed on fluorescently labelled HPC7  
for 15 minutes immediately prior to use.  Kavanagh and colleagues previously demonstrated that this 
treatment regime was sufficient to achieve functional blockade of these integrins (Kavanagh, 2009). 
 
2.5 Static Adhesion Assays 
2.5.1 Stamper Woodruff Adhesion Assay 
The Stamper-Woodruff (SW) frozen tissue adhesion assay used here is a modified form of the assay 
described by Stamper and Woodruff (Stamper and Woodruff, 1976).  Frozen 10µm sections were   











Figure 2.2 Generation and isolation of platelet microparticle enriched supernatant (PES) and 
purified platelet microparticles (PMP) 
(A) Cartoon schematic of the procedure used to generate PES.  Washed platelets are stimulated with thrombin for 
30minutes and then remaining whole platelets are removed by centrifugation.  The supernatant is then kept and the 
platelet pellet is discarded.  To isolate PMP from PES the steps illustrated in (B) are performed.  PES is centrifuged at 
20000xg to pellet platelet microparticles in the solution.  The supernatant is discarded and the PMP resuspended in 
unsupplemented media at the same volume as started with.  In both A and B these steps are completed immediately prior 

































fixed onto a glass slide and used to quantitate stem cell adhesion in vitro.  Sections were taken from 
storage at -20°C and allowed to defrost at room temperature for 10 minutes.  Once removed from 
foil the sections were circled using a wax immunology pen (Immedge, Vector Laboratories, UK) and 
washed with 1X PBS.  100µl of a fluorescently labelled HPC7 suspension in base Stem Pro SFM 34 (at 
a density of 1x106 cells/ml) was added to each slide and incubated in a dark humidified tray for 20 
minutes.  Slides were then immediately fixed in 100% acetone for 5 minutes, washed with PBS, dried 
and coverslips mounted using Hydromount.  Slides were kept in the dark until ready for analysis.  
Slides were imaged on the upright Olympus microscope using a 10x 1.4 numerical aperture objective 
air lens, frames captured with Slidebook v.5 (Intelligent Imaging Solutions) which were then exported 
for off-line analysis.  Fluorescent cells were counted blind using in-house software.  This SW assay 
was later modified such that 5-10mm lengths of intestinal frozen sections were used to quantitate 
stem cell adhesion in vitro.    Details of this modification are fully described in the results section of 
Chapter 3. 
 
2.5.2 Static Endothelial Adhesion Assay using Endothelial Cells Grown on Glass 
Coverslips 
Gelatin coated coverslips with a monolayer of MCEC-1 or CEC maintained in a 24-well plate were 
used to determine stem cell adhesion in vitro.  Prior to use, some wells were washed with PBS and 
then 500µl Stem Pro supplemented with 100ng/ml TNFα was added to the endothelium and 
incubated for 4 hours at 37oC, 5% CO2.    This pre-treatment was done to stimulate endothelium in 
order to mimic an inflammatory injury.  Some wells remained untreated by incubation with un-
supplemented media as controls. 
 




50µl cell suspensions, with cells at a density of 2x106 cells/ml, were treated with sham or injury 
conditioned media (see section 2.4.1), washed with Stem Pro and re-suspended in 500µl Stem Pro 
then immediately added to the endothelium.  The cells and endothelium were incubated at 37°C, 5% 
CO2 for 20 minutes.  Each well was washed twice with PBS and the endothelium was kept in PBS for 
10 minutes.  The PBS was removed and the endothelium washed once more with PBS, followed by 
incubation with 2% glutaraldehyde (Sigma, UK) for 15 minutes at 37°C, 5%CO2.  Each well was then 
washed thoroughly 3 times with PBS.  Coverslips were mounted onto glass microscope slides using 
slide mountant.  Slides were stored in the dark until ready for imaging with an inverted Olympus 
microscope using a 10x 1.4 numerical aperture air objective lens and analysed using in-house cell 
counting software. 
 
2.5.3 Static Endothelial Adhesion Assay Using Endothelial Cells Grown on Well Base 
In order to simplify the adhesion assay, and thus increase throughput and accuracy, endothelial cells 
were grown on the base of tissue culture flasks (24 well plates) and imaged as above.  Cells were 
handled in the exact same manner, with the exception that were not grown on coverslips and 
mounted prior to imaging. 
 
2.5.4 Static Adhesion Assays using Immobilized VCAM-1 and ICAM-1 
The base of a flat bottomed 96-well plate was coated with 50µl of recombinant murine (rm)VCAM-1 
(R&D Systems, UK) or rmICAM-1 (R&D Systems, UK), which are the endothelial counter-ligands for 
the integrins containing CD49d and CD18 respectively, at a concentration of 10µg/ml for 1 hour at 
room temperature, or overnight at 4°C.  To provide a negative control, some wells were coated with 
1% bovine serum albumin in phosphate buffered solution (PBSA) under the same conditions.   
Protein solutions were then aspirated and wells washed three times with PBS.  Any non-coated 




plastic was subsequently blocked with heat denatured 1% PBSA for 1 hour at room temperature.  
Wells were washed 3 times with PBS and the pre-treated HPC-7s were added.  HPC7 Fc receptors 
were simultaneously blocked using low endotoxin axide free (LEAF) CD16/32 blocking antibody 
(Biolegend, UK) at a dilution of 1:50.  Some HPC7 were treated with function blocking monoclonal 
antibodies against CD18 (LEAF rat anti-mouse CD18 (GAME-46)) and CD49d (LEAF rat anti-mouse 
CD49d (R1-2)), as described in section 2.4.4, simultaneous to Fc blocking. Cells were incubated in the 
wells for 20 minutes at 37°C, then aspirated and washed gently 3 times with PBS.  Cells were then 
fixed by incubation 2% glutaraldehyde for 15minutes at 37°C.  At this stage, plates could be stored at 
4°C until ready for imaging.  To image, wells were aspirated and washed gently three times with PBS.  
100µl of PBS was subsequently added and cells imaged using an inverted microscope using a 10x, 1.4 
numerical aperture air objective. 
 
2.6 Flow Cytometry Protocols 
2.6.1 Flow Cytometry Investigation of Cell Surface Markers 
Stem cells were removed from media by centrifugation (300xg, 5 minutes) and washed in cold PBS.  
Cells were then resuspended in 300µl PBS supplemented with 5% FBS to block Fc receptors.  This was 
performed to reduce non-specific binding.  Following Fc block, cells were incubated with a primary 
fluorescent antibody at a dilution of 1:250 for 15 minutes in darkness.  Antibodies used were rat anti-
mouse FITC conjugated anti-CD49d (Clone: R1-2, Cambridge Bioscience, UK), rat anti-mouse FITC 
conjugated anti-CD18 (Clone: GAME-46, Santa Cruz Biotechnology, US), rat anti-mouse PE conjugated 
anti-CD44 (Clone: IM7, eBioscience, US).  Following antibody incubation, cells were washed three 
times with 300µl PBS supplemented with 5% FBS.  Following washes, cells were resuspended in 300µl 
PBS supplemented with 5% FBS and supplemented with 1µg/ml propidium iodide, a fluorescent 
nuclear counter-stain.  This was used to identify dead cells from a population as it is not permeable 




to viable cells.  Once stained, suspensions were loaded onto and analysed using a BD FACSCalibur 
flow cytometer.  
 
2.6.2 Flow Cytometry Protocol for PMP Coating Verification  
To confirm that HPC7s were actually coated with PMPs, flow cytometry was utilised to determine 
whether the expression of platelet surface markers were increased on the stem cell surface.  HPC7 
were pre-treated with PMP/PES as previously described and centrifuged at 300xg for 5 minutes. 
HPC7 were fixed in 300µl 1% neutral buffered formalin in FACS buffer (5% FBS in PBS) and incubated 
for 15 minutes at room temperature.  HPC7 were centrifuged at 300xg for 5 minutes and 
subsequently resuspended in 100µl FACS buffer with 2µl conjugate antibody.  Antibodies used were 
FITC-Rat anti-mouse IgG (poly4060; Biolegend, UK), FITC-Rat anti-mouse CD41 (platelet glycoprotein 
IIb of IIb/IIIa complex; MWReg30; BD Biosciences, UK) and FITC Rat anti-mouse GP42 (platelet GPIbα 
component of the GPIb-V-IX complex; Clone: Xia.B2, Emfret, Germany).  Antibodies were incubated 
for 20 minutes in the dark at room temperature.  HPC7 centrifuged at 300xg for 5 minutes and 
resuspended in 300µl FACS buffer.  Samples then run on BD FACS Caliber (BD Biosciences, UK).  Data 
were analysed offline using software detailed below. 
 
2.7 Cell Preparation for Microscopic Analysis 
2.7.1 Confocal Investigation of Integrin Clustering 
HPC7 were labelled with Cell Tracker Orange (CTO) prior to pre-treatment with either H2O2 or PMP 
pre-treatments as described above.  Following pre-treatment, HPC7s were fixed in 5% neutral 
buffered formalin/1% bovine serum albumin in PBS (PBSA) for 30 minutes at room temperature. 
Following fixation HPC7 were washed by centrifugation 3 times in 2% PBSA.  Following final wash, 
HPC7 were left in the PBSA for 30 minutes to reduce any un-specific binding.  HPC7 were washed and 




resuspended in cold blocking antibody rat anti-mouse CD18 (Clone: GAME-46) or rat anti-mouse 
CD49d (Clone: R1-2) at a 2:25 dilution in 2% PBSA and incubated on ice for 60 minutes.  HPC7 were 
washed 3 times then resuspended in cold Alexa Fluor 488 goat anti-rat IgG in 2% PBSA at 1:100 on ice 
for 30 minutes.  Following incubation HPC7 were washed 3 times, allowed to settle onto poly-L-lysine 
coated coverslips overnight and then mounted using Hydromount prior to imaging.  Slides were 
imaged using a DM IRE2 confocal microscope (Leica, UK), with a 63x oil immersion lens and images 
captured using Leica Control Software.  Off-line image analysis was conducted using ImageJ software 
(NIH, US).  
 
2.7.2 Confocal Investigation of PMP Coating 
The physical interaction of PMPs with HPC7 cells was further confirmed confocally by labelling the 
two cells with different colour dyes.  HPC7 were pre-treated with the PMP pre-treatments as 
described above.  Following pre-treatment, HPC7 were fixed in 5% neutral buffered formalin/1% 
bovine serum albumin in PBS (PBSA) for 30 minutes at room temperature. Following fixation HPC7 
were washed by centrifugation 3 times in 2% PBSA.  Following final wash, HPC7 were left in the PBSA 
for 30 minutes to reduce any un-specific binding.  HPC7 were washed and resuspended in cold 
blocking antibody Rat anti-mouse CD41 (MWReg30; BD Biosciences, UK) and Rat anti-mouse GPIbα 
(Clone: Xia.B2, Emfret, Germany) at a 1:50 dilution in 2% PBSA and incubated on ice for 60 minutes.  
HPC7 were washed 3 times then resuspended in cold Alexa Fluor 488 goat anti-rat IgG in 2% PBSA at 
1:100 on ice for 30 minutes.  Following incubation HPC7 were washed 3 times, allowed to settle onto 
poly-L-lysine coated coverslips overnight and then mounted using Hydromount prior to imaging.  
Slides were imaged using a DM IRE2 confocal microscope (Leica, UK), with a 63x oil immersion lens 
and images captured using Leica Control Software.  Offline analysis conducted using ImageJ (NIH, 
US).  
 




2.7.3 Scanning Electron Microscopy Analysis of HPC7 Surface Morphology 
Samples were kindly prepared for SEM examination by Paul Stanley and Theresa Morris (Centre for 
Electron Microscopy, University of Birmingham).  In brief, samples were fixed and suspended in 2.5% 
glutaraldehyde in phosphate buffer.  Samples were settled onto poly-L-lysine coated coverslips 
overnight then processed for SEM by dehydrating.  Samples were dehydrated through a graded 
ethanol series (2x15 minutes in 70% ethanol, 2x15 minutes 90% ethanol, 2x15 minutes 100% 
ethanol, 2x15 minutes Dried 100% ethanol).  Samples were then critical point dried and mounted 




For all static adhesion assays, cells were counted using in house cell counting software (written and 
developed by Dr D Kavanagh, University of Birmingham, UK) that allowed blind counting of adherent 
HPC7 per image.  All flow cytometry data were analysed offline using Summit v.4.2 (Dako 
Cytommation, USA).  All statistical analyses performed and graphs compiled using Prism 4 (GraphPad 
Software, USA). Image capture was completed using Slidebook v.5 (Intelligent Imaging Innovations, 
US) and Leica Control Software (Leica Microsystems, Germany).  Dual colour images and cluster 
analysis calculated using ImageJ (NIH, US) with the “Find Maxima…” PlugIn. 
 
2.9 Statistics 
The statistical tests applied to identify significance have all been detailed within the figure legends 
for each experiment.  In brief, however, two-way analysis of variance (ANOVA) was used to compare 
multiple treatments between several tissues.  One-way ANOVA was used to compare multiple groups 
with a tissue.  Dunnet’s post-hoc test was applied to identify significance within ANOVA groups when 




compared to a single group.  When this was not appropriate (as some groups were compared to one-
another) Bonferroni’s correction was used to identify significance.  Student’s t-test was used to 
compare two groups to one-another.  Results were considered significant if p<0.05. 









Chapter 3  
 
USING ICM TO ENHANCE HPC7 ADHESION 
  





The adhesive mechanisms governing HSC recruitment to the inflamed mouse gut, especially the 
colon, are poorly known.  Furthermore, it is not known whether intestinal HSC recruitment can be 
enhanced.  Work within the Kalia laboratory has previously identified that HSC adhesion within tissue 
microvasculature in vitro and in vivo is increased following injury.  Indeed, it has been shown that 
HPC7 are recruited more to the IR injured mouse liver (Kavanagh et al., 2010), IR injured ileum 
(Kavanagh et al., 2012, Kavanagh et al., 2013) and to the IR injured kidney (White et al., 2013) when 
compared to non-injured shams.  Whilst, the increased adhesion as a result of injury has been 
identified in several tissues, the Kalia group has also demonstrated that the recruitment to various 
tissues is site specific, relying on different adhesive mechanisms.  In the IR liver the adhesion is 
mediated by the VCAM-1-VLA-4 pathway (Kavanagh et al., 2010), whereas in the gut the recruitment 
is predominantly dependent on CD18 (Kavanagh et al., 2013). This chapter therefore firstly aimed to 
identify whether HPC7 adhesion was enhanced on different regions of the murine gut following an 
acute inflammatory IR injury and a more chronic colitis injury.  Adhesion to the frozen tissue sections 
of jejunum (proximal region of small intestine), ileum (distal region of small intestine) and colon was 
investigated in vitro.  Adhesion to the jejunum was also investigated, as the Kalia lab has previously 
demonstrated that IR injury induces the greatest injury to this region of the gut.  Since recruitment to 
the colon is the focus of this thesis, recruitment to the IR and colitis injured colon was also 
determined intravitally.  Furthermore, the role of CD18 and CD49d in mediating recruitment to the 
injured colon was determined both in vitro and in vivo. 
 
It is well established that a whole host of factors within the injured microenvironment are capable of 
activating circulating leukocytes and platelets and thus permitting their adhesion to the endothelium 
(Mori et al., 2005a, Vowinkel et al., 2007b, Sprague and Khalil, 2009, Santen et al., 2010, Cromer et 
al., 2011). It was therefore hypothesised that similar events would also activate trafficking stem cells.  




An injury conditioned media (ICM) was generated, potentially containing a whole host of pro-
inflammatory / pro-adhesive factors, and its effects were compared to a sham conditioned media 
(SCM) generated from healthy tissue.   ICM was generated from IR and colitis injured jejunum, ileum 
and colon and used to pre-treat HPC7s prior to quantitating their adhesion in vitro to frozen tissue 
sections and murine colon ECs.  To identify the mechanisms by which the ICM could be enhancing 
stem cell adhesion, the effects of pre-treatment on HPC7 (i) adhesion molecule expression and (ii) 
affinity for endothelial counterligands ICAM/VCAM-1 was also determined.  Luminex (Invitrogen, UK) 
was used to identify what was contained within the ICM. 
 
3.1 Methods 
3.1.1 Mice and injury models 
Experiments were conducted on healthy C57BL/6 wild-type mice or those that had undergone either 
IR injury (45 minutes ischaemia, 120 minutes reperfusion) or 5 days of 3% DSS induced colitis injury. 
 
3.1.2 Generation of an injury conditioned media production  
In brief, conditioned media was derived by incubation of healthy and injured jejunum, ileum and 
ascending colon tissue for 24 hours in media at 37oC.  Tissue was macerated, solid material removed 
by centrifugation followed by filtration through a 0.22μm filter.  HPC7 were incubated in SCM or ICM 
for 30 minutes at 37oC, washed by centrifugation and resuspended in base media immediately before 
conducting an experiment. 
 




3.1.3 Stamper Woodruff assay: method development 
Conventionally, static cell adhesion assays on frozen tissue sections in vitro, also called the Stamper 
Woodruff (SW) assay, use transverse sections of tissue.  However, initial attempts to section 
intestinal tissue transversely through the entire gut wall, with high reproducibility, proved extremely 
difficult due to the fragility of the tissue.  As a result, the methodology was adapted such that 
intestinal tissue was firstly cut open longitudinally to expose the lumenal mucosa and then snap 
frozen.  Tissue amounting to 60m for the small intestinal sections and 20μm for the colon sections 
was then cryostat sectioned from the lumenal surface to expose the mucosal vasculature (Figure 3.1) 
and mounted onto glass slides lumen face up.  Stem cells were incubated with these surfaces and the 
adhesion was then quantitated. 
 
3.1.4 Endothelial static adhesion Assay 
Murine colon or cardiac ECs, cultured in 24 well plates, were used to identify whether tissue specific 
differences in stem cell adhesion could be identified in vitro.  Some ECs were treated with TNFα for 4 
hours to activate them prior to monitoring adhesion of fluorescently labelled HPC7.  Wells were 
washed and fixed prior to imaging. 
 
3.1.5 Intravital microscopy  
Intravital microscopy was performed to determine HPC7 recruitment in the colon microcirculation.  
Mice were anaesthetised and prepared for surgery as described in Chapter 2.  The colon was 
exteriorised following a mid-line laparotomy and the mucosal surface of the ascending colon was 
exposed following an incision along the anti-mesenteric border. In mice undergoing IR injury, HPC7s 
were injected at 60 minutes post-reperfusion.  In mice that had been induced with colitis, the colon 
was prepared for imaging and allowed to rest for 30 minutes prior to infusion of stem cells. A 




randomly selected field of view was imaged every 5 minute for 60 minutes with adherent and free 
flowing cells were quantitated.  
 
3.2 Results 
3.2.1 Extensive intestinal tissue destruction following transverse sectioning results in 
poor reliability when used for the S-W assay 
When intestinal tissue was sectioned transversely, much of the tissue became severely fractured, 
resulting in smaller fragmented intestinal tissue sections.  When these sections were subsequently 
used for the S-W assay, the results were interpreted as the number of adherent HPC7 per 10000μm2 
to account for the extensive damage.  Although HPC7 adhesion was increased on IR injured jejunal 
sections, it did not reach significance (Figures 3.2 A, C, D). The number of adherent HPC7 to IR 
injured ileum was significantly (p<0.05) greater than adhesion to sham injured ileum (Figure 3.2 B, E, 
F).  Interestingly, previous studies from the Kalia group had demonstrated significantly increased 
HPC7 in both the IR injured mouse jejunum and ileum in vivo.  The destruction of the tissue whilst 
preparing for the SW assay, coupled with variable and inconsistent results compared with those 
observed in vivo, highlight the un-reliable nature of this assay to investigate HPC7 adhesion to injured 
tissue sections in vitro. 
 
3.2.2 HPC7 adhesion increased on IR and colitis injured tissue sections in vitro 
To reliably investigate HPC7 adhesion in vitro, a modified SW assay was performed in which adhesion 
to the exposed mucosal surface was assessed.  Using this modified sectioning method, we 
demonstrated that HPC7 adhesion was significantly increased to IR injured jejunum (p<0.001), ileum 
(p<0.01) and colon (p<0.01) when compared to sham controls (Figure 3.3 A, C, E).  Furthermore,  
  























Figure 3.1 Modified Stamper-Woodruff tissue sectioning and assay for use with intestinal 
tissues 
It proved difficult to cryostat section snap frozen mouse small intestine or colon in transverse.  The gut was therefore cut 
open (dotted line) (a) and a layer was removed by cryostat sectioning from the lumenal surface (b) to expose the 
microvasculature within the small intestinal villi or the colonic crypts.  (c) Adhesion of stem cells to this exposed surface was 
then quantitated with fluorescence microscopy.   
  




HPC7 adhesion was also significantly increased on colitic injured jejunum (p<0.01), ileum (p<0.05) 
and colon (p<0.01) tissue sections compared to sham controls (Figure 3.3 B, D, F).  Interestingly, the 
greatest adhesion was always observed on injured ileal and colon tissue and less on jejunum.  
 
3.2.3 HPC7 recruitment increased in colon following both IR and colitis injury in vivo 
HPC7 recruitment to IR and colitis injured colon mucosal microcirculation in vivo was investigated 
intravitally.  HPC7 adhesion was significantly increased following IR injury (p<0.01) and colitis injury 
(p<0.05) when compared to shams (Figures 3.4 A, B).  Adhesion was increased by approximately 
2.5/3-fold throughout the duration of the experiment in both IR and colitis injured colons.  The 
recruited HPC7 remained within the vasculature throughout the duration of the experiment.  Free 
flowing cell number was also significantly increased in IR injured colon when compared to shams 
(p<0.05; Figure 3.4 C).  However, this was not observed in colitis injured colon (Figure 3.4 D).  
Increased HPC7 adhesion could be the result of more HPC7s being delivered to the tissue due to 
reactive hyperaemia (increased blood flow), often observed as a consequence of tissue injury.  
However, blood flow was significantly reduced in both IR (p<0.01) and colitis (p<0.01) injured colon 
from the point of HPC7 infusion onwards compared with the sham controls (Figure 3.4 E, F; Figure 
3.5).  Therefore, the increased stem cell number within the injured tissues is not a result of reactive 
hyperaemia.  
 
3.2.4 HPC7 recruitment in the ileum increased following IR injury - IR and colitis injury 
have no effect on pulmonary recruitment 
To determine HPC7 recruitment to remote organs and to verify the colonic intravital observations, 
the colon, ileum and lungs were excised following intravital experimentation.  Ex vivo quantification 
of HPC7 recruitment was quantitated in 5 random fields.  As observed intravitally, HPC7 adhesion   






Figure 3.2 More HPC7 cells adhere to IR injured ileum than healthy ileum but similar results 
are not obtained on the jejunum.  These studies were conducted using our original methodology of 
cutting transverse intestinal sections.  
(A) There is no significant difference in adhesion of HPC7 adhesion between sham and IR injured. (B) HPC7 adhere 
significantly more to IR injured ileum than sham injured ileum. C, D, E and F are representative fluorescence micrographs of 
adherent HPC7 (brighter dots) to sham jejunum, IR injured jejunum, sham ileum and IR injured ileum respectively.  Dotted 
lines denote tissue boundaries as defined for analysis. Results are presented as mean number of adherent HPC7 per 
10000μm
2
 ± SEM.  Statistical analysis performed using one-way Student’s t-test, N≥4 for all groups. *p<0.05.  
  








Figure 3.3 HPC7 adhere significantly more to IR and colitis injured snap frozen intestinal tissue 
sections using the modified methodology of cutting intestinal sections.  
HPC7 adhere significantly more to longitudinally sectioned snap frozen IR injured jejunum (p<0.001; A) and colitis injured 
jejunum (p<0.01; B) tissue sections compared to vehicle controls.  Similarly, HPC7 adhere significantly more to IR (p<0.01; C) 
and colitis (p<0.05; D) injured ileum sections compared to vehicle controls.  Similarly, HPC7 adhere significantly more to 
colon tissue sections following IR (p<0.01; E) or colitis (p<0.01; F) injury compared to vehicle controls.  Results presented as 


























































































































































was significantly increased in both the IR injured colon (p<0.05) and the colitis colon (p<0.01; Figure 
3.6 A) when compared to sham controls.  Recruitment to the ileum was significantly (p<0.001) 
greater following IR injury compared with the sham control.  However, there was no significant 
difference between the number of adherent cells found in the colitis injured ileum and sham controls 
(Figure 3.6 B).  Following both IR and colitis injury, there was no significant difference in recruitment 
to the lungs (Figure 3.6 C). 
 
3.2.5 HPC7 recruitment in IR injured colon microcirculation dependent on CD18 in vivo  
Use of a function blocking antibody against CD18 (β2 integrin) resulted in a significant reduction in 
HPC7 adhesion in IR injured colon (Figure 3.7 A).  Conversely, blocking CD49d (α4 integrin) had no 
effect on HPC7 adhesion to IR injured colon (Figure 3.7 B).  Blocking either integrin had no effect on 
the number of free flowing HPC7 observed during the experiment compared with sham controls 
(Figure 3.7 C, D).  
 
3.2.6 HPC7 recruitment to colitis injured colon dependent on CD18 and CD49d in vivo 
Use of a function blocking antibody against CD18 resulted in a significant reduction in HPC7 adhesion 
in colitis injured colon (Figure 3.7 E).  Similarly, blocking CD49d also significantly reduced adhesion in 
the colitis colon (Figure 3.7 F).  It is noteworthy that unlike in IR injury, blocking either CD18 or CD49d 
only partially reduced HPC7 adhesion in the colitis injured colon compared to the basal level of 
adhesion exhibited in IR following CD18 blockade.  Furthermore, blocking CD18 or CD49d did not 
influence the number of free flowing HPC7 observed in the colitic colon (Figure 3.7 G, H). 
 








Figure 3.4 HPC7 adhere significantly more to IR and colitis injured tissue in vivo, without an 
increase in perfusion of the injured colon.   
HPC7 adhere significantly more to the IR injured (p<0.01; A) and colitis injured (p<0.05; B) colon microvasculature in vivo. 
(C) Following IR injury there is a modest, but significant (p<0.05), increase in the number of HPC7 freeflowing through the 
microvasculature compared to that seen in the sham.  However, there is no significant difference in the number of 
freeflowing HPC7 seen in either colitis or sham colon (D). (E) Mean flux values, directly proportional to blood flow, are 
lower following IR (p<0.01; E) and colitis (p<0.05; F) injury during the intravital monitoring period.  Results are presented as 
mean ± SEM.  Statistical analyses performed using one-way t-tests, analysing the area under the curves, N≥ 5 for all groups.  
*p<0.05, **p<0.01.  In (E) and (F) bar represents area of graph compared for analysis – “infusion period”. 
  
































































































































































Figure 3.5  IR and colitis injury was not associated with an increase in blood flow to the colon  
Mean flux values, directly proportional to blood flow, was lower following IR (p<0.01; B) and colitis (p<0.05; C) injury when 
compared to sham controls (A).  This suggests increased HPC-7 adhesion in the injured colon is not due to increased blood 
flow delivering more cells to the organ.  These images were obtained using laser speckle microscopy of the colon in vivo. 
(Moor Instruments Ltd).  Red indicates areas of high blood flow and blue areas of least blood flow.  Dotted lines define 
mask bounding in focus region in which flux values were obtained from. 
  












Figure 3.6 IR injury increases HPC-7 adhesion in ileum and colon, colitis injury increases 
adhesion in colon, and neither injury affects pulmonary adhesion when examined ex vivo 
(A) Both IR and colitis injury significantly enhance adhesion within the colon (p<0.05, p<0.01 respectively).  (B) Analysis of 
the ileum revealed that HPC7 adhesion within the ileum is significantly increased (p<0.001) following IR injury, but colitis 
injury does not enhance ileal recruitment.  (C) Ex vivo analysis of tissues following IR and colitis intravital experiments 
reflect that HPC7 adhesion within the lungs is unaffected.  Results presented as mean ± SEM.  Statistical analysis performed 
















































































3.2.7 Ex vivo tissue analysis confirms the observations seen in vivo - CD18 critical in IR 
injury and both CD18 and CD49d used in colitis injury 
As observed intra-vitally, blocking CD18 significantly (p<0.05) reduced adhesion within the IR injured 
colon, whereas blockade of CD49d had no effect (Figure 3.8 A).  Ex vivo analysis of the IR injured 
ileum also revealed that blocking CD18, but not CD49d, significantly (p<0.05) reduced adhesion 
(Figure 3.8 B).  Blocking CD18 or CD49d did not affect adhesion within the lungs isolated from an IR 
injured mice (Figure 3.8 C).   
 
As observed intravitally, blocking either CD18 (p<0.01) or CD49d (p<0.01) significantly reduced 
adhesion within the colitic colon (Figure 3.8 D).  Ex vivo analysis of the colitis injured ileum showed a 
trend for adhesion to decrease with blocking of either CD18 or CD49d but this did not reach 
statistical significance (Figure 3.8 E).  Again, blocking CD18 or CD49d did not affect adhesion within 
the lungs isolated from colitis injured mice (Figure 3.8 F).   
 
3.2.8 Pre-treatment of HPC7 with IR and colitis ICM increases their adhesion to colon 
endothelial cells in vitro 
To investigate whether HPC7 adhesion can be modulated, they were pre-treated with various 
conditioned medias.  The effects on adhesion to a murine colon derived endothelial monolayer was 
then determined.   Interestingly, TNF activation of colon ECs did not cause an increase in HPC7 
adhesion (Figure 3.9 A-D).  Furthermore, pre-treating HPC-7 with sham conditioned media (SCM) 
generated from healthy jejunum, ileum or colon did not increase adhesion compared with vehicle 
controls (Figure 3.9 A-D).  Jejunum IR injury conditioned media (IR ICM) significantly increased 
adhesion when compared to vehicle control (p<0.01) and the SCM control (p<0.05), whereas jejunum 
colitis injured conditioned media (Col ICM) had no significant effect on enhancing adhesion (Figure 
3.9 A).  Similarly, ileal IR ICM significantly enhanced adhesion compared to vehicle control  





Figure 3.7 HPC7 adhesion to the IR colon is dependent on CD18 and independent of CD49d, whereas 
HPC7 adhesion to the colitis colon utilises both CD18 and CD49d 
Blockade of CD18 significantly reduced adhesion in IR injured colon (A) whereas CD49d had no role (B).  In contrast, 
blocking CD18 (E) or CD49d (F) significantly reduced adhesion in the colitis colon but adhesion was not completely 
abolished.  Blocking integrins CD18 or CD49d did not affect numbers of free flowing HPC7 in IR injured (C-D) or colitis (G-H) 
colons.  Results presented as mean ± SEM. Solid line: IgG control, dotted line anti-integrin group.  Statistical analysis 
performed on area under the curve using Student’s t-test. N≥5 for all groups. *p<0.05, ***p<0.001. 
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Figure 3.8 Ex vivo analysis confirms the observations seen intravitally following antibody 
blockade – CD18 critical in IR injury and both CD18 and CE49d used in colitis injury  
Recruitment to IR injured colon (A) and ileum (B) was significantly reduced after blocking CD18, but not CD49d.  Blocking 
CD18 or CD49d had no effect on pulmonary recruitment following intestinal IR injury (C).  Recruitment to colitis injured 
colon (D) and ileum (E) was reduced after blocking either CD18 or CD49d, but this was only significant in the colon.  Again, 
blocking CD18 or CD49d had no effect on pulmonary recruitment following intestinal colitis injury (F).  Results presented as 
































































































































































(Figure 3.9 A), but ileum Col ICM did not (Figure 3.9 B). Again, colon IR ICM significantly (p<0.05) 
increased adhesion to colon ECs compared to vehicle control, but Col ICM had no effect (Figure 3.9 
C). To determine whether the adhesion enhancing effects of colon ICM were specific for colon ECs 
only, adhesion was also determined on cardiac ECs.  Again, TNF pre-treatment of cardiac ECs had 
no effect on adhesion (Figure 3.9 D).   
 
To investigate whether pre-treatment of HPC7 with the various conditioned medias affected their 
survival, cells were pre-treated, washed and re-suspended in normal growth media.  The number of 
viable cells 24 hours later was determined using trypan blue exclusion.  No significant differences in 
cell viability was observed between any of the groups (Figure 3.9 E). 
 
3.2.9 Pre-treatment of HPC7 with conditioned media increases their adhesion to frozen 
tissue sections in vitro   
3.2.9.1  Jejunum and jejunal conditioned media 
Following the quantitation of HPC7 adhesion to sham and IR injured jejunal tissue following pre-
treatment with vehicle, SCM and IR ICM, it was identified that the pre-treatment (p<0.01) and the 
injury state of the tissue (p<0.001) influenced HPC7 adhesion.  However, there was no significant 
interaction between these variables. SCM increased adhesion to both sham (p<0.001) and IR (p<0.05) 
tissue compared with vehicle controls (Figure 3.10 A).  Similarly, IR ICM pre-treatment significantly 
increased adhesion to both sham (p<0.001) and IR (p<0.001) jejunum sections (Figure 3.10 A).  
However, IR ICM treated cells adhered significantly more (p<0.05) to IR injured tissue than to sham 
tissue (Figure 3.10 A).   
 




Again, adhesion of HPC7 to sham and colitic injured jejunum tissue was significantly affected as a 
result of cellular pre-treatment (p<0.001) and the injury status of the tissue (p<0.01).  Col ICM 
significantly enhanced adhesion to colitic tissue compared to sham jejunal tissue (p<0.001; Figure 
3.10 B).  Furthermore Col ICM enhanced adhesion to colitic tissue more than the vehicle control 
(p<0.05) and SCM (p<0.01), whereas SCM did not increase adhesion on colitis tissue (Figure 3.10 B). 
 
3.2.9.2 Ileum and ileal conditioned media 
Similarly, HPC7 adhesion to sham and IR injured ileum following pre-treatment with vehicle, SCM and 
IR ICM also displayed that both the pre-treatment (p<0.001) and the injury state of the tissue 
(p<0.001) significantly affected HPC7 adhesion.  Again, there was no interaction between the two 
groups.  Unlike jejunal tissue, pre-treatment with ileal SCM had no effect on adhesion to either sham 
or IR injured tissue (Figure 3.10 C).  IR ICM significantly increased adhesion to IR injured tissue 
(p<0.001), but not to sham injured tissue.  Adhesion to IR injured ileum following pre-treatment with 
IR ICM was significantly (p<0.001) greater than the adhesion of IR ICM pre-treated HPC7 to sham 
injured tissue (Figure 3.10 C).   
 
Colitis ICM was more effective at enhancing adhesion on ileal tissue (Figure 3.10 D).  Again, adhesion 
to ileum sham and colitis tissue was significantly affected by pre-treatment (p<0.001) and injury of 
the ileal sections (p<0.001), but there was no significant interaction between them.  Colitis ICM 
significantly enhanced adhesion to colitis injured tissue when compared to sham ileal tissue (Figure 
3.10 D) and similarly, within the colitic tissue colitis ICM pre-treatment significantly increased 
adhesion compared to the vehicle control (p<0.05) and SCM (p<0.001).  However, SCM had no 
significant effect on adhesion to colitis tissue (Figure 3.10 D).   
  





Figure 3.9  Pre-treating HPC7 can enhance adhesion to colon endothelial cells in vitro, but does 
not affect cell viability 
(A) Pre-treatment with jejunum IR injury conditioned media (IR ICM) significantly enhanced adhesion to colon endothelium 
compared to sham conditioned media (SCM; p<0.05) and vehicle controls (p<0.01). (B)  Similarly, ileum IR ICM significantly 
enhances adhesion (p<0.05) compared to vehicle control.  (C) Both IR and colitis colon ICM significantly (p<0.05) increase 
adhesion compared to SCM controls.  (D) Pre-treatment of HPC7 with CM had no significant effect on HPC7 adhesion to 
murine cardiac endothelium.  (E) Pre-treatment of HPC7 has no effect on cellular viability as determined by trypan blue 
exclusion.  Results presented as mean ± SEM.  Statistical analysis performed using one-way ANOVA with Dunnet’s post-hoc 




































































































































































































































































3.2.9.3 Colon and colonic conditioned media 
HPC7 adhesion to sham and IR injured colon sections was significantly affected by both the pre-
treatment (p<0.01) and the injury status of the tissue (p<0.001) but there was no significant 
interaction observed between them.  Similarly to the jejunum, HPC7 pre-treated with colon SCM 
significantly increased adhesion to both sham (p<0.05) and IR colon (p<0.05) sections (Figure 3.10 E).  
However, colon IR ICM only increased adhesion to IR injured colon sections (p<0.05) compared to 
vehicle control and to SCM treated HPC7 (Figure 3.10 E).  Again, HPC7 adhesion following colon IR 
ICM pre-treatment was significantly (p<0.001) greater to IR tissue than that seen on sham tissue 
following pre-treatment (Figure 3.10 E). 
 
Colitis conditioned media was more effective at enhancing adhesion to sham as well as injured tissue 
(Figure 3.10 F).  Again, adhesion was significantly affected by pre-treatment (p<0.001) and by injury 
to the colon sections (p<0.001) but there was no significant interaction between them.  Colitis ICM 
significantly enhanced adhesion to both sham (p<0.001) and colitis tissue (p<0.001).  Furthermore, 
the increase in adhesion following pre-treatment was greater following colitis injury when compared 
to sham controls (p<0.001).  Interestingly, SCM resulted in an increase in adhesion both on sham 
tissue (p<0.05) and colitis tissue (p<0.05), but in both cases the increase was lower than that seen 
when treated with colitis ICM. 
 
3.2.10  Pre-treatment of HPC7 with conditioned media does not increase surface 
expression of CD18 or CD49d  
Flow cytometry was performed to identify whether pre-treating HPC7 with conditioned media had 
any effect on the surface expression of the CAMs CD18, CD49d or CD44.  Pre-treatment with jejunal 
SCM, IR ICM or Col ICM had no effect on CD18 or CD49d expression (Figure 3.11 A). Col ICM 




appeared to cause a reduction in CD44 expression, but these decreases did not reach significance 
(Figure 3.11 A).   
 
Similarly, Ileal SCM, IR ICM and Col ICM had no effect on CD18 or CD49d expression (Figure 3.11 B), 
but Col ICM did significantly (p<0.05) reduce the surface expression of CD44 (Figure 3.11 B).   
 
Colon conditioned media also had no effect on the surface expression of CD18 and CD44, but Col ICM 
does appear to show an increase in CD49d expression (Figure 3.11 C) but this increase does not reach 
significance. 
 
3.2.11 Pre-treatment of HPC7 with injury conditioned media increases their adhesion to 
ICAM-1 and VCAM-1 
3.2.11.1 Adhesion to ICAM-1 
There was a significant effect of pre-treating HPC7 (p<0.001) on their adhesion to ICAM-1 and also a 
significant difference (p<0.05) between tissue of origin of the conditioned media and the effect on 
adhesion, however, there was no interaction between the two variables.  Only pre-treatment with 
jejunal IR ICM significantly increased adhesion to ICAM-1 when compared to vehicle (p<0.01) and 
SCM (p<0.01; Figure 3.12 A).  Ileal IR ICM and Col ICM pre-treatment significantly increased adhesion 
to ICAM-1 when compared to vehicle controls (IR ICM p<0.001, Col ICM p<0.05) and SCM (IR ICM 
p<0.001, Col ICM p<0.05; Figure 3.12 A).  Colon SCM, IR ICM and Col ICM pre-treatment significantly 
increased adhesion to ICAM-1 when compared to vehicle controls (SCM p<0.05, IR ICM p<0.05, Col 
ICM p<0.05; Figure 3.12 A).  Colon IR ICM and Col ICM pre-treatment also significantly increased 
adhesion when compared to SCM (IR ICM p<0.01, Col ICM p<0.05; Figure 3.12 A).  





Figure 3.10 Pre-treatment of HPC7 significantly enhances adhesion to intestinal tissue sections 
with the greatest adhesion seen to injured tissues compared to sham tissues 
(A-B) Adhesion to jejunal sham, IR injured tissue and colitis tissue following various pre-treatments is presented.  
Interestingly, even SCM could influence adhesion to healthy jejunal tissue.  (C-D).  Adhesion to ileal sham, IR injured tissue 
and colitis tissue following various pre-treatments is presented.  (E-F) Adhesion to colon sham, IR injured tissue and colitis 
tissue following various pre-treatments is presented.  Interestingly, even SCM could influence adhesion to healthy colon 
tissue.  Results presented as mean ± SEM. Statistical analysis performed with two-way ANOVA, with Student’s t-test 
performed post-hoc. *p<0.05, **p<0.01, ***p<0.001.  Abbreviations SCM- sham conditioned media, IR ICM- IR injury 
































































































































































































































































































































































































































































































Figure 3.11 Pre-treatment of HPC7 with conditioned media has no effect on CD18 or CD49d expression, but small bowel Col ICM reduces expression of CD44 
(A) Pre-treatment with jejunum SCM, IR ICM and Col ICM has no effect on CD18 or CD49d expression, however, Col ICM reduces CD44 expression but the decrease is not significant.  (B) Pre-treatment 
with ileum SCM, IR ICM and Col ICM has no effect on CD18 or CD49d expression, but there is a significant decrease in CD44 expression (p<0.05).  (C) Colon SCM, IR ICM and Col ICM have no effect on 
CD18, CD49d and CD44 expression.  Data presented as fluorescence histographs. Inset: bar graphs with geometric mean fluorescence intensity values for each group.  Statistical analysis performed 
with one-way ANOVA with Dunnet’s post-hoc testing. 
 




3.2.11.2 Adhesion to VCAM-1 
There was a significant effect of pre-treating HPC7 (p<0.001) on their adhesion to VCAM-1 but there 
was no significant differences due to the origins of the conditioned media on adhesion and 
furthermore, there was also no interaction between the two variables.  Pre-treatment of HPC7 with 
jejunal IR ICM and Col ICM significantly increased adhesion to VCAM-1 when compared to vehicle (IR 
ICM p<0.001, Col ICM p<0.05) and SCM (IR ICM p<0.01, Col ICM p<0.05; Figure 3.12 B).   Ileal SCM 
pre-treatment also caused a significant (p<0.05) increase when compared with vehicle (Figure 3.12 
B).  Similarly, ileum IR ICM and Col ICM significantly increased adhesion when compared to vehicle 
(IR ICM p<0.05, Col ICM p<0.01) and SCM (IR ICM p<0.05, Col ICM p<0.05; Figure 3.12 B).  Colon SCM 
significantly (p<0.05) increased adhesion as did colon IR ICM (p<0.05) and Col ICM (p<0.05) when 
compared to vehicle.  Colon IR ICM (p<0.05) and Col ICM (p<0.05) also significantly increased 
adhesion when compared to SCM (Figure 3.12 B).  
 
3.2.12  Luminex analysis of conditioned media did not identify any cytokines or 
chemokines  
To determine what bioactive molecules may be present within the conditioned media, the samples 
were investigated using a Luminex assay (Invitrogen, UK) targeted against a (20mer plex) wide screen 
of cytokines and chemokines including IFNγ, IL1β and KC.  However, no cytokines or chemokines 





In this chapter, we have developed a murine model of colon IR and colitis injury and also successfully 
imaged stem cell trafficking intravitally within the mucosal microcirculation.  We present novel in  







Figure 3.12 Pre-treatment with intestinal conditioned media significantly enhances adhesion to 
ICAM-1 and VCAM-1 
(A) Pre-treatment with jejunal, ileal and colonic IR ICM significantly enhances adhesion to ICAM-1 surface compared to 
vehicle controls (p<0.05, p<0.001, p<0.01 respectively).  However, only ileal and colonic Col ICM significantly enhanced 
adhesion to ICAM-1 compared to vehicle controls (p<0.05, p<0.05 respectively.  (B) Pre-treatment of HPC7 with jejunal, ileal 
and colonic IR ICM significantly enhanced adhesion to VCAM-1 coated surface compared to vehicle controls (p<0.001, 
p<0.05, p< 0.05 respectively.  Similarly, pre-treatment with jejunal, ileal and colonic Col ICM also significantly enhanced 
adhesion to VCAM-1 coated surface (p<0.05, p<0.01, p<0.05 respectively). Results presented as mean ± SEM. Statistical 
analysis performed with two-way ANOVA, with Student’s t-test performed post-hoc. *p<0.05, **p<0.01, ***p<0.001.  




































































































































































vitro and in vivo evidence that HSCs are recruited to IR and DSS injured colon more readily than to 
healthy controls.  It was interesting that the degree of adhesion in both acute and chronic injuries 
was similar, initially suggesting a recruitment maximum for HPC7 cells within injured colon.  
However, pre-treating HPC7s prior to their infusion with soluble factors found within the injury 
milieu enhanced their recruitment.  This suggests that recruitment to the injured colon is actually a 
modulatable event.  A summary of the data can be seen in Table 3.1. Importantly, this data provided 
the first evidence that colonic recruitment achieved as a result of the injury was not maximal.   
 
The Kalia group previously published data that HPC7 adhesion within IR injured ileum was greater 
than non-injured ileum in vivo (Kavanagh et al., 2012).  However, our initial attempts at the S-W 
assay did not confirm these observations, most likely due to tissue destruction upon sectioning.  
Furthermore, transverse sectioning meant that only a small area of mucosa was available for the 
assay.  Since this region is most susceptible to ischaemic and colitis injury (and also the region that is 
viewed intravitally), we developed a new methodology that allowed the mucosa to be monitored 
with minimal tissue destruction when sectioned. Cryosectioning to remove either the microvillous 
tips of the small intestine or the crypt structure of the colon exposed the mucosal vasculature 
providing a greater area of ‘substrate’ for HSC adhesion.  Using this modified method, we 
demonstrated that HPC7 adhesion was indeed significantly increased following intestinal IR and 
colitis injury, in both the small intestine and colon. Although limited studies have monitored 
leukocyte adhesion in the murine colon (Soriano et al., 2000, Panes et al., 2007, Vowinkel et al., 
2007b, Santen et al., 2010), no studies to date have directly monitored stem cell trafficking in the 
mouse colon following either of these different inflammatory insults.  We demonstrated that HPC7 
adhesion was also increased within the injured colon in vivo.  This could potentially be attributed to 
an increased blood supply to the colon (reactive hyperaemia) as has been observed after 
inflammatory injuries (Cobellis et al., 2010)  This would increase the delivery of the HPC7s to the.   











Table 3.1 Summary of experiments investigating the effect of conditioned media pre-treatment on HPC7 adhesion to injured tissue 
The results table summarises significant increases and decreases in the number of HPC7 adherent to either: colon endothelial cells, immobilised ligands, frozen tissue sections or in vivo investigations.  
Data displayed are significant differences against relevant controls.   +++ - p<0.001 increase in HPC7 adhesion, ++ - p<0.01 increase in HPC7 adhesion, + - p<0.05 increase in HPC7 adhesion, ± - No 
significant difference in HPC7 adhesion, - - p<0.05 decrease in HPC7 adhesion 
 
ICAM-1 VCAM-1 Sham IR Injury Colitis Injury Sham IR Injury Colitis Injury Sham IR Injury Colitis Injury CD18 CD48d CD44 Lungs Ileum Colon Lungs Ileum Colon
Naïve Control +++ ++ Control ++ + Control ++ ++ ± +++ ++ ± ± +
SCM ± ± ± +++ + ± ± ± ±
IR ICM ++ ++ +++ +++ +++ ± ± ±
Col ICM ± ± + +++ + ± ± -
± ±
SCM ± ± + ± ± ± ± ± ±
IR ICM + +++ + ± +++ ± ± ±
Col ICM ± + ++ ++ + ± ± -
± ±
SCM ± + + + + + ± ± ±
IR ICM + + + + + ± ± ±
Col ICM + + + + +++ ± ± ±
Compared to relevant controls
IR Injured Colitis Injured
Frozen Tissue SectionsImmobilised 
Ligands























colon and the potential for recruitment.  However, laser Dopple speckle microscopy demonstrated 
that blood flow to injured colon was actually decreased.   
 
The reduction seen in IR injured colon may have been caused by the no-reflow phenomenon.  This is 
when, upon reperfusion, activated leukocytes and platelets obstruct microvessels.  Vasoconstriction 
induced by vasoactive factors such Endothelin-1 and the loss of nitric oxide also contributes to no-
reflow.   Reduced blood flow has also been demonstrated within the colitis injured colon 
microvasculature (Harris et al., 2011).  However, it is also possible that reduced blood flow promotes 
HPC7 adhesion, as lower perfusion rates would lower vessel shear rates.  This is more conducive to 
circulating cell adhesion and also the maintenance of adhesion than at higher shear rates.  
Interestingly, no rolling HSCs were observed within the colon either in sham or injured tissues.  This is 
likely due to the abrogated need for rolling in tissues in which there is low-shear flow in the blood 
vessels (Sanz and Kubes, 2012).   
 
An increase in the number of free flowing HPC7s was also seen immediately upon infusion in IR 
injured colons only.  Again this may be due to the lowered blood flow as it may be possible to 
actually see more free flowing cells – at high flow rates it is difficult to accurately count cells as they 
flow too fast to be captured intravitally.   Alternatively, the establishment of a chemokine gradient 
following IR injury may prevent the cells from being cleared from the microcirculation (McDonald et 
al., 2011).  However, the increase was only observed at 5 minutes post-infusion, and there was only 1 
free-flowing cell more than was seen in sham tissue, and thus is not likely to have much physiological 
impact.    
 
Immediately following systemic administration of HPC7s, numbers of free-flowing cells rapidly 
decreased to plateau at approximately 2 cells/minute in both sham and injured tissue.  This was 
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despite the fact that a single bolus dose of 2x106 cells were injected.  However, a significant 
proportion of HPC7s were observed within the pulmonary vasculature when examined ex vivo.  This 
suggests that most of the injected cells become lodged immediately within vascular beds remote to 
the site of injury.  The number of HPC7s in the lungs did not vary regardless of whether they were 
removed from mice undergoing gut injury or not.  This was somewhat surprising as it has been 
reported that extensive intestinal IR injury can trigger systemic inflammation which leads to remote 
injury in multiple organs including the lungs (Kalia et al., 2002, Kalia et al., 2005).  However, it is 
possible that the acute timeframe of the IR experiments meant pulmonary injury was not evident, 
with the large number of HPC7 within the lungs most likely due to their physical entrapment within 
the small pulmonary capillaries.  Indeed, numerous studies investigating exogenous SC infusion 
report very high pulmonary entrapment (Aguilar et al., 2009, Kavanagh, 2009, Loebinger et al., 2009, 
Sordi, 2009, Kavanagh et al., 2012).  Identifying strategies that reduce this phenomenon may be a 
potential mechanism for improving SC therapy efficacy. 
 
With the little variation seen in the number of free-flowing cells and the reduced blood flow, it 
suggests that the enhanced HPC7 adhesion is most likely due to an active process and not merely a 
result of increased delivery.  This is supported by the in vivo observations that blocking integrins on 
the SCs surface reduced HPC7 numbers within injured colon and also suggests adhesion was not due 
to their physical entrapment within colonic microvessels.   Blocking CD18 reduced adhesion within 
the IR colon, to the extent of lowering that adhesion to baseline, whereas, blocking CD49d did not 
influence adhesion at all. This suggests that there is no redundancy within the adhesion mechanisms 
involved in mediating HPC7s to IR injured colon.  The lack of a role for CD49d is perhaps not all that 
surprising as there would probably be no endothelial VCAM-1 up-regulation at this early stage of IR 
injury.  Others have previously demonstrated VCAM-1 to be upregulated after several hours 
reperfusion (Esposito et al., 2007).   




A critical role for CD18 has also been demonstrated by the Kalia group for mediating HPC7 
recruitment to the similarly injured small intestine (Kavanagh et al., 2013).  However, further studies 
from our group have demonstrated that differing tissues utilise different adhesive mechanisms.  For 
example, in the IR injured hepatic microcirculation, CD49d-VCAM-1 interactions are critical.  
Knowledge of the local adhesive events involved is particularly important when trying to develop 
strategies to enhance recruitment in specific sites.   
 
Interestingly, in the colitis injured colon, blockade of either CD18 or CD49d reduced adhesion to a 
similar level with neither blockade lowering SC numbers equivalent to that seen in sham 
experiments.  This is contrary to HPC7 recruitment seen in other tissues and injuries (Kavanagh et al., 
2010, Kavanagh and Kalia, 2011, Kavanagh et al., 2012, Kavanagh et al., 2013, White et al., 2013), 
where recruitment can be ameliorated following blockade of one specific integrin or its endothelial 
counterligand.  The colitis colon therefore appears to be using multiple mechanisms with a degree of 
redundancy as adhesion is merely reduced and not completely inhibited.  This again may not be 
surprising, as the chronically injured tissue will have had sufficient time to up-regulate other 
endothelial cell adhesion molecules in response to the injury (Soriano et al., 2000, Farkas et al., 2006, 
Vowinkel et al., 2007a, Vowinkel et al., 2007b).  Overall, the function blocking data demonstrates 
that SC adhesion is governed not only by the tissue type but also the nature and extent of the 
inflammatory injury as well.   Of interest was also the observation that blocking either CD18 or CD49d 
did not decrease the HPC7 number in the lungs.  This suggests that pulmonary recruitment is not an 
active process and that entrapment is the most likely explanation for their presence.   
 
The next aim of this chapter was to identify whether HPC7 recruitment to the colon could be 
enhanced by exposing them to a conditioned media derived from injured tissue.   As there were 
Chapter 3: Using ICM to enhance HPC7 Adhesion  
101 
 
inherent differences between the recruitment mechanisms observed between IR and colitis tissue, it 
was decided that the pre-treatment was to be tailored specific to the injury and tissue of interest.  
Overall, these novel studies investigating pre-treatment with ICMs demonstrated for the first time 
that colon adhesion was a modulatable event with most pronounced in vitro adhesion observed 
when HPC7 were pre-treated with an ICM generated from colitis colon.  It is interesting that the 
nature of the injury and the tissue from which ICM was generated differently modulated adhesion.  
The enhanced adhesion was not due to any detrimental or cytotoxic effects on the HPC7 cells as the 
pre-treatment followed by 24 hours of culture did not affect the survival or proliferation of the cells 
in culture.   
 
The work in this chapter, and indeed the work of others, describes how HSC adhesion to injured 
tissue is mediated by integrins (Kavanagh et al., 2010, Kavanagh and Kalia, 2011, White et al., 2013).  
It is known (Hart and Greaves, 2010, Yu et al., 2010) that integrin mediated cellular adhesion can be 
modulated in three ways: (i) changing adhesion molecule number expressed on the cell surface, (ii) 
changing the affinity of the integrin for its endothelial counterligand and (iii) changing the 
distribution of integrins on the cell surface.  In the current study it was demonstrated using flow 
cytometry that the ICM did not enhance HPC7 adhesion by changing the surface expression of either 
CD18 or CD49d. However, the enhanced adhesion mediated by ICM could be due to an increased 
affinity of CD18 and CD49d for their endothelial counterligands ICAM-1 and VCAM-1 respectively, 
although this was not investigated directly.  What was observed was an increased adhesion to an 
immobilised ICAM-1 and VCAM-1 surface, a result that can be explained via a change in integrin 
avidity and/or a change in affinity for integrins and their counterligands. These events may have been 
brought about by clustering integrins on the stem cell surface – however this was not investigated in 
this current chapter (see later results chapters).   
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 Another potent mediator of cell adhesion is the non-integrin glycosaminoglycan CD44 (Turner et al., 
1995, Avigdor et al., 2004, Aldridge et al., 2012).  CD44 is primarily recruited to endothelial 
hylauronan, but also has other ligands (Avigdor et al., 2004, Garton et al., 2006, White et al., 2013).  
Interestingly, pre-treatment of HPC7s with an ICM generated from the colitis ileum decreased CD44 
surface expression.   This could be as a result of CD44 shedding.  This process has been described in 
several inflammatory situations and has been suggested to play a role in signalling as well as cell 
adhesion (Garton et al., 2006).  Indeed, it has been suggested that soluble proteases such as 
ADAM10 are capable of dissociating the extracellular portion of CD44 from leukocytes to allow for 
their detachment and subsequent transmigration (Garton et al., 2006).   
 
To improve the efficacy of stem cell therapies for inflammatory bowel disorders, it has been 
suggested that cellular recruitment levels must be increased.  However, for therapies to be readily 
available within a clinic they must be safe, effective and efficient.  Hence, the use of a conditioned 
media is not a readily viable option therapeutically.  However, it has enabled the observation that 
recruitment mediated by the presence of the injury alone is not maximal.  Furthermore, 
identification of the active soluble component(s) in the ICM could lead to more ‘clean’ pre-treatment 
strategies.  It was hypothesised that the conditioned media would contain a variety of inflammatory 
cytokines and chemokines that could activate stem cells.  Following Luminex analysis, a highly 
sensitive technique capable of detecting pg/ml of protein within a solution it was found that none of 
the samples contained any of the 20 cytokines or chemokines assayed for.  It is not clear why this 
assay was not successful – it may be that during the production of conditioned media, any cytokines 
and chemokines were broken down or degraded.  In the following chapter data are presented on 
how hydrogen peroxide, a free radical produced in inflamed tissue, and most likely contained within 
the ICM and thus the injury milieu, can influence HPC7 recruitment to the injured colon.    
 










Chapter 4  
 
USING H2O2 TO ENHANCE HPC7 ADHESION 





The previous chapter presented novel data demonstrating that HPC7 recruitment to IR and colitis 
injured colon could be enhanced using soluble factors released in an ICM.  This was demonstrated in 
vitro on frozen tissue sections and also on mouse colon ECs.  This was the first demonstration that a 
pre-treatment strategy, that did not involve genetic modification of stem cells, could enhance their 
adhesion in mouse colon.  The use of a conditioned media cannot be considered a clinically viable 
pre-treatment option – it would be difficult to obtain, it is time consuming and difficult to 
reproducibly develop.  Therefore, identifying bioactive molecules within the conditioned media may 
unveil another pre-treatment option which has the potential to be used for therapeutic purposes 
clinically.   
 
A potent modulator of circulating cell behaviour, identified in the inflammatory milieu, is the reactive 
oxygen species (ROS) hydrogen peroxide (H2O2).  This molecule is released from a wide array of cells 
including vascular endothelium and inflammatory leukocytes such as neutrophils (Matoba et al., 
2000, Li and Jackson, 2002).  It is widely known that H2O2 synthesis increases in many inflammatory 
situations including IR injury, colitis and other non-digestive inflammatory disorders such as 
rheumatoid arthritis (Lopes et al., 2011).  It has been previously shown that H2O2 has many roles 
within the inflammatory environment and is capable of establishing a gradient such as to recruit 
leukocytes (Niethammer et al., 2009), enhancing neutrophil rolling and increasing cellular 
recruitment (Fraticelli et al., 1996, Johnston et al., 1996).  As a result of this, it is capable of 
influencing the fate of many cells via modulation of the action of redox sensitive second messengers, 
which in turn can affect signalling pathways such as NF-κB, a key pathway in regulating cell survival 
(Anderson et al., 1994, Baeuerle et al., 1996).   
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The Kalia group previously developed a method of pre-treating murine HPC7s with H2O2 (100M; 
1hr), which significantly increased their adhesion to murine cardiac ECs and frozen sections of murine 
IR injured gut in vitro.  Furthermore, when injected systemically, a three-fold increase in H2O2 pre-
treated HSC adhesion within IR injured intestinal villous microcirculation in vivo was observed 
(Kavanagh et al., 2012).  It is not known whether pre-treatment of HPC7s with H2O2 is a universal 
means of enhancing stem cell recruitment within all injured tissues or whether its effects are site and 
injury specific.  We therefore aimed, in this chapter, to determine whether H2O2 pre-treatment could 
enhance HPC7 adhesion in vitro and in vivo within IR and colitis injured colon microcirculation.  
Furthermore, a mechanism by which enhanced adhesion could occur was identified, focussing 
primarily on effects on stem surface integrins.   
 
4.1 Materials and Methods 
4.1.1 Mice and injury models 
Experiments were conducted on healthy C57BL/6 wild-type mice or those that had undergone either 
IR injury (45 minutes ischaemia, 120 minutes reperfusion) or 5 days of 3% DSS induced colitis injury. 
 
4.1.2 H2O2 concentration measurement and pre-treatment protocol 
Preliminary studies were conducted looking at endothelial adhesion of HPC7s pre-treated with 
different H2O2 concentrations to determine the most effective concentration and it was found that 
100μM was most pro-adhesive and so all subsequent experiments were conducted using this dose.  
HPC7 were pre-treated in media supplemented with H2O2 to establish the required concentration 
and incubated at 37°C, 5% CO2 for 1 hour.  Cells were then washed by centrifugation and 
resuspended in base Stem Pro SFM34 media for in vitro assays, and PBS for in vivo assays.  H2O2 
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concentration was measured using PeroXOquant Quantitative Peroxide Assay Kit (ThermoScientific, 
UK) as per manufacturer’s instructions. 
 
4.1.3 Cell Adhesion Assays 
Murine colon ECs, cultured in 24 well plates, were used to identify whether tissue specific differences 
in stem cell adhesion could be identified in vitro.  Some ECs were treated with TNFα for 4 hours to 
activate them prior to monitoring adhesion of fluorescently labelled HPC7.  Wells were washed and 
fixed prior to imaging. 
 
Immobilised ICAM-1 and VCAM-1 surfaces were also used to investigate cell adhesion.  Flat 
bottomed 96-well plates were incubated with 50μl at 10μg/ml protein solution and subsequently 
blocked using 1% PBSA.  Pre-treated HSC were incubated on the plate surface, wells were 
subsequently washed and fixed prior to imaging. 
 
4.1.4 Immunofluorescence and Scanning Electron Microscopy Imaging 
HPC7 were labelled with Cell Tracker Orange as described in Chapter 2 and then pre-treated with 
H2O2 as described above.  Following pre-treatment, HPC7s were fixed in 5% neutral buffered 
formalin/1% bovine albumin in PBS (PBSA) for 30 minutes at room temperature. Following fixation 
HPC7 were washed by centrifugation 3 times in 2% PBSA.  Following final wash, HPC7 were left in the 
PBSA for 30 minutes to reduce any un-specific binding.  HPC7 were washed and resuspended in cold 
integrin blocking antibody (LEAF rat anti-mouse CD18 (GAME-46), LEAF rat anti-mouse CD49d (R1-2)) 
at a 1:50 dilution in 2% PBSA, incubated on ice for 60 minutes.  HPC7 were washed 3 times then 
resuspended in Alexa Fluor 488 goat anti-rat IgG in 2% PBSA at 1:100 on ice for 30 minutes.  
Following incubation HPC7 were washed 3 times allowed to settle onto poly-L-lysine coated 
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coverslips overnight and then mounted using Hydromount prior to imaging.  Cells were imaged using 
a DM IRE2 confocal microscope (Leica, UK), with a 63x oil immersion lens and images captured using 
Leica Control Software.  Offline analysis conducted using ImageJ (NIH, US).  
 
For SEM samples were kindly prepared for imaging by Paul Stanley and team at University of 
Birmingham Centre for EM.  In brief, pre-treated cells were fixed and washed as described in Chapter 
2.  HPC7 were mounted onto poly-L-lysine coverslips and dehydrated using a graded ethanol series.  
Samples were then critical point dried, mounted onto SEM stubs and coated with evaporated carbon. 
Samples were examined in a Jeol 7000F SEM. 
 
4.2 Results 
4.2.1 There is a greater concentration of H2O2 in injured tissue conditioned media 
It is known that H2O2 is common product of inflammation, and so it was probable that it would be 
found in the injury microenvironment and thus the ICMs used in Chapter 3.  However, this was 
confirmed using a commercial kit.  It was identified that in both IR ICM and Col ICM, the 
concentration of H2O2 was significantly greater than that observed in the respective SCM across all 
tissues (jejunum IR ICM vs. SCM, p<0.05; Col ICM vs. SCM, p<0.01; ileum IR ICM vs. SCM, p<0.001; Col 
ICM vs. SCM, p<0.05; colon IR ICM vs. SCM, p<0.05; Col ICM vs. SCM, p<0.05; Figure 4.1).  
Interestingly, out of all the ICMs, the least H2O2 was found in colitis ICM generated from the colon.  
Furthermore, two-way ANOVA analysis identified that there were significant differences between the 
tissue of origin (p<0.001) and the injury status of the tissue (p<0.001), however, there was no 
interaction between the two groups. 
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4.2.2 Greater intensity of anti-8-oxo-2’-deoxyguanosine staining demonstrates 
increased oxidative damage in IR and colitis injured colon 
We further assayed for H2O2 indirectly, in the injured colon tissue by determining the presence of 8-
oxo-2’-deoxyguanosine (8-oxodG).  8-oxodG is one of the major products of oxidative damage to 
DNA and its concentration within a cell is an indicator of oxidative stress after triggered by exposure 
to ROS such as H2O2.   Interestingly, some 8-oxodG was observed within the sham colon, suggesting a 
basal level of oxidative damage occurring within the colon (Figure 4.2 A).  However, a greater 
intensity and more widespread labelling of 8-oxodG was observed following injury, indicating there 
were signs of oxidative damage in both IR and colitis injured colon (Figure 4.2 B and C), with the 
labelling being focussed predominantly in the mucosal region. 
 
4.2.3 H2O2 pre-treatment significantly enhances HPC7 adhesion to colon endothelial 
cells and is mediated by the integrins CD18 and CD49d 
Pre-treated cells were incubated with colon ECs and adhesion quantitated in vitro.  Only pre-
treatment with 100μM H2O2 significantly (p<0.01) enhanced adhesion compared to pre-treatment 
with the vehicle control (Figure 4.3).   To determine whether the enhanced adhesion following pre-
treatment with 100μM H2O2 was integrin mediated, CD18 and CD49d activity on HPC7s was 
functionally blocked with monoclonal antibodies. Blocking either CD18 (p<0.01) and CD49d (p<0.001) 
significantly reduced endothelial adhesion compared to the IgG control (Figure 4.3). 
 
4.2.4 H2O2 pre-treatment enhances adhesion to all sham and IR intestinal tissues, but 
only enhances adhesion to the colitic ileum and colon 
The effect of 100μM pre-treatment on HPC7 adhesion to tissue sections was also evaluated.  
Interestingly, H2O2 pre-treatment significantly (p<0.05) increased HPC7 adhesion to healthy jejunal 
sham tissue when compared to vehicle pre-treated cells (Figure 4.4 A).  H2O2 pre-treatment also  
  


























Figure 4.1 H2O2 concentration is greater in injury conditioned medias than sham conditioned 
medias 
H2O2 concentration is greater in jejunal, ileal and colonic IR and colitis ICM when compared to the respective SCM. Results 
are presented as mean±SEM.  Statistical analysis performed with 2-way ANOVA and Student’s t-test for post hoc analysis.  
Abbreviations: SCM = sham conditioned media, IR ICM = IR injury conditioned media, Col ICM = colitis injury conditioned 
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significantly (p<0.01) increased adhesion to IR injured jejunum compared to vehicle pre-treated cells.  
Importantly, this was significantly (p<0.01) higher than that observed on healthy sham tissue (Figure 
4.4 A).  However, H2O2 pre-treatment did not induce any increases in HPC-7 adhesion on jejunal 
tissue following colitis injury (Figure 4.4 B). 
 
Similarly, H2O2 pre-treatment significantly (p<0.01) increased HPC7 adhesion to healthy ileal sham 
tissue when compared to vehicle pre-treated cells (Figure 4.4 C).  H2O2 pre-treatment also 
significantly (p<0.05) increased adhesion to IR injured ileum compared to vehicle pre-treated cells.  
Importantly, this was significantly (p<0.05) higher than that observed on healthy sham tissue (Figure 
4.4 C).  However, unlike the jejunum, H2O2 pre-treatment did significantly (p<0.01) enhance adhesion 
to ileal colitic injured tissue when compared to healthy sham tissue (Figure 4.4 D).  However, this 
increase was not significantly greater compared to the pre-treatment control (Figure 4.3 D). 
 
Again, H2O2 pre-treatment significantly (p<0.001) increased HPC7 adhesion to healthy colon sham 
tissue when compared to vehicle pre-treated cells (Figure 4.4 E).  Increased adhesion to IR injured 
colon was also observed when compared to vehicle pre-treated cells (p<0.01) and importantly, this 
was significantly higher than that observed on healthy sham tissue (p<0.01; Figure 4.4 E). However, 
H2O2 pre-treatment did not induce any increases in HPC-7 adhesion on colon tissue following colitis 
injury (Figure 4.4 F).  
 
4.2.5 H2O2 pre-treatment enhances adhesion to the colitis colon, but not to the IR 
injured colon in vivo 
Interestingly, H2O2 did not enhance HPC7 recruitment within the IR colon or have any effect on 
numbers of free flowing HPC7 (Figure 4.5 A and B). Conversely, H2O2 pre-treatment significantly  
  










Figure 4.2 8-oxo-2’-deoxyguanosine staining reveals oxidative damage in colon tissues, with 
more extensive damage observed in IR and colitis tissue 
(A) Sham colon tissue displays a basal level of oxidative damage occurring within the colon. (B) Greater intensity and more 
widespread staining of 8-oxodG is indicative of greater levels of oxidative damage in the IR colon.  (C) Similar to the IR 
injured colon, the colitis injured colon displays more 8-oxodG staining than the sham colon.  Representative images of 3 
colons from each injury group over 2 separate experiments. 











Figure 4.3 Pre-treating HPC-7s with 100μM H2O2 significantly enhances adhesion to colon 
endothelial cells and this is integrin mediated 
Only pre-treatment with 100μM H2O2 enhances adhesion to colon endothelial cells.  This adhesion is ameliorated following 
functional blockade of either CD18 (100μM antiCD18 mAb) or CD49d (100μM antiCD49d mAb) compared to an IgG control.  
Results are presented as mean±SEM.  Statistical analysis performed using 1-way ANOVA, with Bonferroni multiple 
comparisons test. N≥3 across all groups.  **p<0.01, ***p<0.001. 
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enhanced adhesion within the colitis colon (p<0.05).  Again it had no effect on numbers of free 
flowing HPC7 (Figure 4.5 C and D). 
 
4.2.6 H2O2 pre-treatment has no effect on recruitment to the lungs following IR or colitis 
injury, but does enhance adhesion to the IR ileum and the colitis colon 
Ex vivo analysis revealed that H2O2 pre-treatment had no effect on pulmonary recruitment following 
IR or colitis injury (Figure 4.6 A and B respectively).  However, it did enhance adhesion to the IR ileum 
(p<0.05; Figure 4.6 C).  Adhesion within the colitis ileum was increased following H2O2 pre-treatment, 
but this increase failed to reach statistical significance (Figure 4.6 D).  As observed intravitally, H2O2 
recruitment had no effect on adhesion to the IR colon (Figure 4.6 E), but adhesion to the colitic colon 
was significantly increased (p<0.05; Figure 4.6 F). 
 
4.2.7 H2O2 pre-treatment results in ruffling and cellular projections from HPC7 
Scanning electron microscopy identified phenotypic changes in HPC7 membrane organisation 
following H2O2 pre-treatment. Extended cellular projections and ruffling, similar to that seen in 
activated leukocytes, was observed indicative of an activated HPC7 phenotype (Figure 4.7). 
 
4.2.8 H2O2 pre-treatment enhances adhesion to ICAM-1 and VCAM-1 coated surfaces 
To identify whether H2O2 pre-treatment modulated integrin based adhesion, pre-treated cells were 
incubated on an ICAM-1 and VCAM-1 surfaces.  HPC7 adhesion to ICAM-1 was significantly increased 
following pre-treatment (p<0.01; Figure 4.8 A).  Furthermore, following functional blockade of CD18, 
adhesion was ameliorated (p<0.001; Figure 4.8 A).  Similarly, adhesion was significantly increased to 
VCAM-1 surface (p<0.001; Figure 4.8 B) and this adhesion was mediated solely by CD49d, as 
demonstrated by reduced adhesion following functional integrin blockade (p<0.01; Figure 4.8 B). 
  





Figure 4.4 H2O2 pre-treatment of HPC7 significantly increases adhesion IR injured jejunal, ileal 
and colon tissue sections, but only increases adhesion to colitis injured ileum and colon. 
(A) H2O2 pre-treatment significantly enhances adhesion to sham and IR jejunal tissue, with the greatest effect seen on IR 
tissue.  (B) H2O2 pre-treatment does not further enhance adhesion to colitic jejunal tissue.  (C) H2O2 pre-treatment 
significantly enhances adhesion to sham and IR ileal tissue sections, with the greatest effect seen on IR injured tissue.  (D) 
H2O2 pre-treatment significantly enhances adhesion compared to colitis injury control, but not to the vehicle control.  (E) 
H2O2 pre-treatment significantly enhances adhesion to sham and IR colon tissue, with the greatest effect seen on IR injured 
colon.  (E) Similar to the sham and IR tissue, H2O2 pre-treatment significantly enhances adhesion to colon tissue, with the 
greatest effect seen with colitis injured tissue.  Results presented as mean+SEM.  Analysis performed using 2-way ANOVA 

























































































































































































































































































































Figure 4.5 H2O2 pre-treatment significantly enhances adhesion within the colitis colon, but not 
the IR colon. 
H2O2 pre-treatment has no effect on HPC7 adhesion (A) or the number of free flowing (B) HPC7 within the IR colon.  
However, pre-treatment significantly increases adhesion within the colitis colon (C) without affecting the number of free 
flowing (D) HPC7.  Results presented as mean+SEM.  Statistical analysis performed on area under the curve data using 









































































































Figure 4.6 H2O2 pre-treatment has no effect on lung recruitment following injury but increases 
adhesion within the IR injured ileum and colitis injured colon 
Recruitment to the lungs following IR (A) and colitis (B) injury is unaffected by H2O2 pre-treatment.  Recruitment to the IR 
(C), but not the colitis (D), ileum was increased following H2O2 pre-treatment.  Recruitment within the colon was increased 
in the colitis colon (F), but not the IR colon (E).  Results presented as mean+SEM.  Statistical analysis performed using 
Student’s t-test. N≥4 for all groups.  *p<0.05.  




























































































































































Figure 4.7 H2O2 pre-treatment induces ruffling and cellular protrusions in the HPC7 membrane 
Scanning electron micrographs of vehicle (A) and H2O2 (B) pre-treated HPC7.  H2O2 induces cellular protrusions (open 
arrows, seen on edge of cell) from the cell surface and ruffling of the membrane (closed arrows, seen in the centre of the 
cell) indicative of cellular activation.  Representative images of N=5 cells per group.  
A
B
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4.2.9 H2O2 pre-treatment increases the number of CD18 clusters, without affecting size, 
and increases CD49d cluster size, without affecting cluster number 
The increased adhesion following pre-treatment observed on ICAM-1 and VCAM-1 suggests direct 
modulation of integrin adhesion mechanisms.  It was identified by Kavanagh et al. (2012) that pre-
treatment of HPC7 had no effect on cell adhesion molecule expression.  Hence, an alternative 
mechanism was investigated.  It was found that following pre-treatment with H2O2, CD18 clustered 
on the cell surface, compared to the less clustered, more diffuse distribution observed on vehicle 
treated cells (p<0.05; Figure 4.9 A).  However, it was found that pre-treatment had no effect on the 
area of the clusters found on the cell surface (Figure 4.9 A).  Interestingly, H2O2 had an opposite 
effect on the clustering of CD49d; pre-treatment had no effect on CD49d cluster number (Figure 4.9 
B) but significantly increased the area of the integrin clusters (p<0.05; Figure 4.9 B). 
 
4.3 Discussion 
Although Chapter 3 demonstrated that an ICM could enhance HSC adhesion, it is not an attractive 
option as an adjuvant pre-treatment for clinical purposes.  However, the data obtained revealed that 
adhesion was a modulatable event, and that factors found within the injury microenvironment could 
enhance HSC delivery to sites of injury.   H2O2 was hypothesised to be a potential factor within the 
conditioned media and this was confirmed in the current chapter.  The concentration of H2O2 in ICM 
was approximately 70μM which, importantly, is similar to the concentration found physiologically 
(Johnston et al., 1996).  H2O2 is also generated during inflammation by endothelial cells, smooth 
muscle and activated macrophages and neutrophils. Indeed, resident neutrophils can generate local 
concentrations of 200-500µM H2O2 upon stimulation (Johnston et al., 1996).  Hence it is likely that 
trafficking HSCs will be exposed to similar concentrations of H2O2 in IR injured colon.  Novel data 
generated in this chapter demonstrated that pre-treating HPC7 with H2O2 significantly enhanced  









Figure 4.8 H2O2 pre-treatment significantly enhances adhesion to ICAM-1 and VCAM-1 coated 
surfaces 
(A) Pre-treatment of HPC7 with H2O2 significantly enhances adhesion to and ICAM-1 coated surface and is dependent on 
CD18.  (B) Similarly, H2O2 pre-treatment results in enhanced adhesion to VCAM-1 coated surface and is dependent on 
CD49d.  IgG= IgG Isotype control incubation group, antiCD18= function blocking antibody against CD18 incubation group, 
antiCD49d= function blocking antibody against CD49d incubation group.  Results presented as mean±SEM.  Statistical 


































































































Figure 4.9 H2O2 pre-treatment induces greater cluster number of CD18, without affecting 
cluster size, but does not alter CD49d cluster number, but increases cluster size. 
H2O2 pre-treatment increases the number of CD18 clusters, without affecting cluster size (A).  However, H2O2 increases 
CD49d cluster size without significantly affecting cluster number (B).  Fluorescence micrographs representative of N≥5 cells 
over 3 independent experiments, scale bars = 5μm.  Red= cytoplasmic cell tracker orange labelled HPC7, Green= Alexa 488 
labelled integrin clusters.  Results presented as mean+SEM.  Statistical analysis performed using Student’s t-test. N≥5 cells 
over 3 independent experiments. *p<0.05.  
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their adhesion both in vitro and in vivo.  The most effective dose was 100μM, with lower and higher 
concentrations having no effect on cellular adhesion.  It is interesting that this effective 
concentration is very similar to that seen in vivo in the injured environment and to that observed 
within the ICM.  This suggests that the changes induced by pre-treatment may be similar to the 
actions of the injury microenvironment on trafficking HPC7s in vivo. 
 
As expected, IR and colitis ICM contained greater concentrations of H2O2 than observed in sham 
tissue.  Interestingly, H2O2 concentrations were greater in the SI (jejunum and ileum) than in the 
colon.  This may be due to greater damage occurring in the SI or that it undergoes greater oxidative 
stress than the colon, either during rest or injury, or that the colon is more capable of managing 
oxidative stress than the SI.  Certainly, the SI is one of the most susceptible organs to ischaemic 
injury.  The presence of H2O2 even within SCM media was interesting, suggesting a baseline level of 
H2O2 even in an un-inflamed, relatively healthy environment.  This could suggest a role for H2O2 in 
intestinal homeostasis, or may simply reflect the nature of intestinal tissue whereby constant 
challenges to the immune system result in an active state (Maloy and Powrie, 2011).  This is further 
supported by the 8-oxodG staining results, where sham colon showed a residual level of oxidative 
damage.  However, the IR colon, and to a lesser degree, the colitis colon showed a greater level of 
oxidative damage.  Interestingly, Lee and colleagues reported that a basal level of mutations 
occurred even within healthy mouse intestinal epithelium, which they postulated could be linked to 
oxidative stress induced DNA damage (Lee et al., 2006).   
 
The adhesion studies conducted on frozen tissue demonstrated that H2O2 pre-treatment could 
enhance HPC7 adhesion to sham jejunum/ileum/colon, IR injured jejunum/ileum/colon and colitis 
injured ileum/colon.  No increase was observed on colitis injured jejunum but this may be due to the 
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fact that the DSS colitis injury model predominantly affects the terminal ileum and colon rather than 
the more proximal jejunum, thus not altering the phenotype of the jejunal vascular endothelium.   
 
The enhanced adhesion to sham tissues suggests H2O2 pre-treatment increases HPC7 adhesion by 
modulating stem cell surface adhesion molecules i.e. H2O2 leads to increased adhesion to 
counterligands that are already present, such as ICAM-1 which is constitutively expressed on even 
healthy endothelium. This may be brought about by increased integrin/adhesion molecule 
expression, affinity for endothelial counterligands or enhanced avidity/clustering.  The further 
enhanced adhesion to injured tissues suggests increased HPC7 recruitment is mediated by injury 
increasing the expression of endothelial cell counterligands as well as the direct effects of H2O2 on 
stem cell surface adhesion molecules.   Indeed, collective results from this chapter and from Chapter 
3, suggest that HPC7 are recruited more readily to injured (activated) endothelium rather than to 
sham (un-activated) endothelium.   However, when these two processes are combined i.e. when pre-
treated stem cells traffick through an injured environment, a greater propensity for adhesion occurs.   
 
Interestingly, colonic intravital studies demonstrated that enhanced HPC7 adhesion following H2O2 
pre-treatment was only observed within the colitis colon and not the IR injured colon.  Inducing IR 
injury within the colon involves occlusion of the superior mesenteric artery.  However, since this 
artery also feeds the SI as well as the colon, both small and large bowel injury occurs upon 
reperfusion.  Therefore, when naïve HPC7s are injected, they become adherent within the SI as well 
as the colon.  Thus, pre-treated HPC7s also adhere with greater efficiency with the SI, which most 
likely reduces the number of HPC7 available to bind within IR injured colon.  This phenomenon is not 
observed following colitis injury, as the ileum is not injured to a greater extent than the colon; in 
which the damage is most severe.  Interestingly, the adhesion of H2O2 pre-treated cells within colitis 
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colon appears to be sustained throughout the duration of the experiment.  This adhesion pattern is 
different to the adhesion of naïve HPC7 which is initially high and then falls to a lower plateau.   
 
4.3.1 Mechanisms by which H2O2 mediates increased adhesion  
We further sought to determine the mechanisms by which H2O2 could enhance stem cell adhesion.  
After electron microscopic examination of the cell surface, it was revealed that H2O2 induced ruffling 
of the cell membrane and the extension of cellular protrusions, reminiscent of pseudopodia and 
filopodia.  However, we did not determine exactly what these protrusions were, how they were 
formed and the mechanism behind their formation.  Regardless of the make-up of these phenotypic 
changes, they are often features of cellular activation.  Indeed, macrophages have been shown to 
‘ruffle’ following activation with lipopolysaccharide, but prior to antigen binding, suggesting that this 
is a direct cellular effect during activation (Patel and Harrison, 2008). Unlike other ROS mediators 
such as hydroxyl radicals and superoxide anions, H2O2 readily diffuses across plasma membranes and 
can thus act as a potent intracellular signalling messenger (Enesa et al., 2008).  This may explain why 
H2O2 was able to induce morphological changes.  Since cell migration requires the coordinated 
formation of filopodia at the cell front, the development of such structures prior to administration 
may enable HPC7 to increase their migratory responses to local chemokines and thus improve their 
subsequent adhesion.   Ruffling could also be a means by which cells potentially regulate the 
clustering and positioning of cell surface receptors so as to enhance ligand binding (Lim and Hotchin, 
2012).  This may also contribute to the enhanced adhesion of HPC7 following H2O2 pre-treatment.  
However, further work needs to be undertaken to investigate how integrin and other cell adhesion 
molecules localise within the ruffles, and indeed how the H2O2 triggers the formation of ruffles and 
filopodia. 
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To identify specifically which surface integrins could be modulated by H2O2 pre-treatment, HPC-7 
adhesion to immobilised ICAM-1 and VCAM-1 surfaces was determined in vitro.   Pre-treatment 
significantly enhanced adhesion to both these surfaces and was dependent on CD18 and CD49d 
respectively.  Similarly, when function blocking antibodies were used to investigate the roles of 
integrins in adhesion to colon endothelium in vitro and intravitally in vivo, blockade of either CD18 or 
CD49d ameliorated adhesion (See Chapter 3).  These data demonstrate that H2O2 enhanced adhesion 
is likely modulated by changes in α4 or 2 integrin affinity/avidity changes for endothelial 
counterligands.  This dependence on integrin activity, and the complete amelioration of adhesion 
following blockade, could infer that H2O2 directly acts upon the integrins CD18 and CD49d 
themselves.  This is perhaps not all that surprising as there is substantial evidence that integrin 
conformational changes and integrin-ligand interactions are mediated by the redox status of the 
environment and the redox modulation of peptide domains of the integrins and cytoskeletal 
structure (de Rezende et al., 2012, Fiaschi et al., 2012). 
 
Furthermore, evidence has been presented here suggesting H2O2, through its effects on integrin 
clustering, was also able to modulate integrin avidity, the increased adhesiveness of a cell 
independent of integrin conformational changes. Further evidence that demonstrates that dynamic 
reorganisation of integrins into microclusters, through F-actin polymerisation, is a major mechanism 
regulating integrin binding strength and is a prerequisite for their activation and ligand binding (van 
Kooyk et al., 1999, van Kooyk and Figdor, 2000). Changes in levels of cytoskeletal elements and 
integrin clustering may play a major role in H2O2 mediated HPC7 adhesion.  With regards to CD18, 
H2O2 caused an increase in the number of clusters upon the cell surface, whereas CD49d cluster 
number did not increase, but the clusters themselves became greater in size.  We have previously 
demonstrated using flow cytometry that pre-treatment of HPC7 with H2O2 has no effect on surface 
adhesion molecule expression (Kavanagh et al., 2012).  The observed changes in integrin cluster size 
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or number were not detected by flow cytometry.  This may be due to how dense the distribution of 
integrins on the cell surface are – under a resting state the diffuse integrins are unable to be seen 
using confocal microscopy, but are still labelled with a fluorescent antibody and so can be detected 
with a flow cytometer.  However, once clustered, hence at a more dense distribution, the collective 
integrins can be identified using confocal microscopy, but without increasing copy number, as they 
have merely moved laterally across the cell membrane.  Thus this phenomenon is a result of receptor 
re-distribution and not copy number change.  Importantly, changes in integrin cluster number and 
cluster size can both represent an increase in avidity – either through enhanced interaction with their 
endothelial counter-ligands or through increased probability of interaction with their counter-
ligands.  Therefore, the increased avidity can explain the enhanced adhesion observed in our in vitro 
and in vivo studies.   
 
It is also likely that H2O2 pre-treatment directly affects the affinity state, or the physical 
conformation, of integrins.  However, this is difficult to determine directly in murine samples.  In 
human samples, monoclonal antibodies have been developed to specifically detect conformational 
changes in integrins, but we are unaware of any such antibodies for murine samples.  However, Yu et 
al. (2010) described a method to specifically identify integrin affinity changes indirectly in mice that 
would exclude avidity alterations.  They demonstrated that the Mn2+ ion, when bound to the metal 
ion dependent adhesion site (MIDAS) on integrins, specifically triggered a conformational change in 
their structure and hence changed their affinity state (Yu et al., 2010).  To determine whether H2O2 
directly affected integrin affinity, we could have conducted an additional experiment pre-treating 
HPC7 with Mn2+.  If the enhanced adhesion observed following H2O2 pre-treatment was even further 
increased in the presence of Mn2+, we would have been able to state that H2O2 increased adhesion 
by predominantly changing integrin avidity/clustering with a limited affinity change.  Unfortunately, 
we did not perform these eloquent and informative experiments. 
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Similar to results described in Chapter 3, naïve and H2O2 pre-treated HPC7 recruitment within the 
lungs was unaltered following either colitis or IR injury.  This again suggests pulmonary recruitment is 
either at a maximum capacity, not influenced by intestinal injury or is not integrin mediated.  Pre-
treatment did not enhance HPC7 recruitment to the lungs which from a clinical perspective is highly 
desirable.  Respiratory distress following systemic stem cell transfusion has been proposed as a 
stumbling block for therapy – by not exacerbating this problem, whilst increasing recruitment to 
injured organs, highlights that H2O2 pre-treatment may be a viable therapeutic option. 
 
To conclude, we have demonstrated that H2O2 pre-treatment increases HPC7 adhesion with no 
concomitant negative effect on cell viability.  This enhanced adhesion is achieved through changes in 
integrin avidity, and potentially affinity, without altering integrin copy number.  Hence, pre-treating 
HSCs with H2O2, at physiologically relevant concentrations, could therapeutically enhance retention 
within acutely and chronically injured colon, effectively ‘priming’ them for maximal adhesion prior to 
their systemic delivery.  Interestingly, MSCs are protected from apoptosis following oxidative 
preconditioning, suggesting that H2O2 pre-treatment may also aid in enhancing stem cell survival in 
ischaemic tissues (Li et al., 2009b).  
 










Chapter 5  
 
USING PMP TO ENHANCE HPC7 ADHESION 
  




Microparticles are defined as vesicles that bud off cells, that are lacking a nucleus, contain a 
membrane skeleton and are defined by size (<1μm diameter) (Johnstone, 2006, Perez-Pujol et al., 
2007). They are further defined by the originating cell and the subsequent surface antigens 
presented (Burnier et al., 2009, Thom et al., 2011).  They have been identified to originate from a 
large variety of cell types including red blood cells, leukocytes (in both myeloid and lymphoid 
lineages), endothelial cells and platelets (Leroyer et al., 2007, Gelderman and Simak, 2008, 
Flaumenhaft et al., 2009).   
 
Not only have microparticles been identified from a plethora of cell types, the rate at which they are 
produced, and indeed the phenotype that they possess, is highly dependant on the disease state of 
the body.  For example, it has been identified that hypertension (Preston et al., 2003), 
atherosclerosis (Boulanger et al., 2006, Leroyer et al., 2007), Crohn’s disease (Chamouard et al., 
2005) and many other disease conditions exhibit increased microparticle release.  However, it 
appears that the biggest source of circulating microparticles as a result of disease is from platelets 
(See Table 2 from Burnier et al., 2009 for detailed list), released as a result of platelet activation 
(Flaumenhaft, 2006).  However, it has been shown that even at rest, platelet microparticles (PMP) 
form the largest constituent of the microvesicles found in the blood (Lacroix et al., 2010).   
 
The roles of PMPs are widely varied and have ranged from highly reactive procoagulation bodies 
(Wolf, 1967, Merten et al., 1999), to playing a role in the transfer of cytokines and chemokines (Barry 
et al., 1997, Mause et al., 2005), transcellular delivery of mRNA (Risitano et al., 2012), as a method of 
transferring surface receptors such as CXCR4 and the platelet integrin αIIb (Janowska-Wieczorek et 
al., 2001) and also as a bridging molecule for enhancing leukocyte adhesion to vessel walls (Forlow et 
al., 2000). 




It is these cellular modulation properties that have been recently investigated to see if PMPs can be 
utilised as a delivery vehicle (Faille et al., 2012) and also as a donor cell modulator (Mause et al., 
2005). PMPs have been reported to enhance HSC engraftment in bone marrow (Janowska-Wieczorek 
et al., 2001), and enhance progenitor cell repair efficiency (Mause et al., 2010), highlighting their 
potential in modulating HSC recruitment.  However, previous studies have not investigated whether 
short term pre-treatment (≤1 hour) of HSCs with PMPs improves their recruitment to extramedullary 
sites of injury such as the microcirculation of injured intestinal tissues in vivo.  Furthermore, the 
potential mechanisms by which PMPs may increase HSC recruitment have not been identified.  The 
previous chapter has demonstrated that HSC adhesion within the injured gut could indeed be 
significantly improved using H2O2.  Since this pre-treatment strategy utilises a ROS chemical approach 
to modify HSC trafficking, it may raise concerns for translational applicability.   The use of PMPs to 
improve adhesion offers a more biological approach to modify HSC trafficking and this will be 
investigated in this chapter. 
 
Initial studies aimed to confirm whether thrombin stimulation of mouse platelets could generate 
PMPs in vitro and also to determine whether the generated PMPs could be purified.   Two forms of 
platelet generated microparticles were to be investigated.  The total platelet releasate – supernatant 
from activated platelets that would be enriched in PMPs, thrombin, and other factors released by 
thrombin stimulated platelets termed PMP enriched supernatant (PES).  The other pre-treatment to 
be investigated were purified PMPs (PMP).  The purified PMP were to be isolated from PES by high 
speed centrifugation and resuspended into empty media.  From both PES and PMP pre-treatment it 
was hypothesised that HPC7 cells could be coated with PMPs following a short-term co-incubation 
with them and that this pre-treatment would enhance their subsequent adhesion.  This was explored 
via a range of in vitro and in vivo adhesion assays.  Furthermore, some of the potential mechanisms 
Chapter 5: Using PMP to enhance HPC7 Adhesion  
130 
 
involved in the predicted increase in adhesion, such as integrin clustering and surface expression 
changes of CAMs, were also investigated. 
 
5.1  Materials and Methods 
5.1.1 Mice and injury models 
Experiments were conducted on healthy C57BL/6 wild-type mice or those that had undergone either 
IR injury (45 minutes ischaemia, 120 minutes reperfusion) or colitis injury (5 days of 3% DSS in the 
drinking water). 
 
5.1.2 Isolation of murine platelets and PMP generation 
Blood was taken from the descending aorta of C57BL/6 wild type mice, platelets isolated, washed by 
centrifugation and resuspended in Stem Pro SFM34 at 3x107/ml.  Platelets were then stimulated with 
thrombin (30 minutes, 37oC). Platelet microparticle enriched supernatant (PES) was derived by 
removing intact platelets by centrifugation from the stimulated platelet releasate.  Purified PMPs 
were isolated by high speed centrifugation of PES, discarding the supernatant and resuspending the 
PMP pellet with the same volume of Stem Pro as was initially centrifuged.  HPC7 were resuspended 
in either PES or PMP solution at 4x106 cells/ml for 60 minutes for use experimentally immediately 
following pre-treatment. 
 
5.1.3 Fluorescent Labelling of Cells 
Work within this chapter utilises a range of fluorescent dyes to facilitate microscopy studies.  In order 
to visualise PMPs, a platelet rich plasma (PRP; obtained during the process of washing and isolating 
platelets) was incubated with DiOC6 at a final concentration of 4μg/ml and mixed gently by inversion 
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(in the dark, room temperature, 30 minutes) and then washed.  DiOC6 (3,3′-dihexyloxacarbocyanine 
iodide) is a cell permeant, green fluorescent, lipophilic dye used for staining membranes. 
 
For this chapter, HPC7 were labelled with two dyes, CFDA-SE or CellTracker Orange (CTO; Invitrogen, 
UK).  CFDA-SE labelling was performed as described in other chapters.  HPC7 were labelled with CTO 
as per the manufacturer’s instructions.  In brief, HPC7 were incubated at 4x106 cells/ml in 5μM dye in 
base Stem Pro media (30 minutes, 37oC), washed by centrifugation and kept in base media (within 2 
hours) until ready for use. 
 
5.1.4 Endothelial Static Adhesion Assay 
Murine colon ECs, cultured in 12 well plates, were used to identify whether differences in stem cell 
adhesion following pre-treatment with PES or PMP could be identified in vitro.  Some ECs were 
treated with TNFα for 4 hours to activate them prior to monitoring adhesion of fluorescently labelled 
HPC7.  Wells were washed and fixed prior to imaging. 
 
5.1.5 Intravital microscopy  
Fluorescent IVM was performed to determine HPC7 recruitment in the murine colon microcirculation 
in vivo.  Mice were anaesthetised and prepared for surgery as described in Chapter 2.  The colon was 
exteriorised following a mid-line laparotomy and the mucosal surface of the ascending colon was 
exposed following an incision along the anti-mesenteric border. In mice undergoing IR injury, HPC7s 
were injected at 60 minutes post-reperfusion.  A randomly selected field of view was imaged every 5 
minute for 60 minutes.  Adherent and free flowing cells were quantitated.  
 




5.2.1 Pre-treatment of platelets with 2U/ml thrombin generates platelet microparticles 
In order to determine whether PMPs could be generated in vitro using thrombin, freshly isolated (<2 
hours) murine platelets were isolated, washed, labelled with DiOC6 and finally resuspended in Stem 
Pro and then stimulated with thrombin.  The whole solution containing the stimulated platelets, 
releasate and any microparticles released were mounted onto glass slides and imaged. Figure 5.1 
depicts a fluorescently labelled platelet surrounded by small circular fluorescently labelled particles 
approximately 0.2-1μm in diameter.  These labelled smaller structures are highly likely to be 
microparticles generated from thrombin stimulated murine platelets.  
 
5.2.2  Incubation of platelet microparticle enriched supernatant and purified platelet 
microparticle coats HPC7 with microparticles 
HPC7 were pre-treated with either PMPs or PES and flow cytometry was used to identify whether the 
platelet markers glycoprotein (GP) IIb and GPIb could be found on the HSC surface.  Interestingly, but 
not unexpectedly, GPIIb was found to already be expressed on the HPC7 surface (Figure 5.2 A).  
Although GPIIb is most often described as a platelet marker, it is also found on early haematopoietic 
progenitor cells such as HSCs (Janowska-Wieczorek et al., 2001).  However, following pre-treatment 
with both PES and PMP, surface expression of both GPIIb and GPIb were increased on HPC7s (Figure 
5.2 A), providing evidence that these microparticles can indeed bind or coat HPC7 cells. 
 
To further confirm interactions between PES and PMP pre-treatments with HPC7s, labelled 
microparticles were incubated with HPC7 and imaged using confocal microscopy.  The upper panels 
of Figure 5.2 B are representative Z projections of unlabelled HPC7 incubated with PMPs labelled 
with the green membrane dye DiOC6 (Figure 5.2 B).  This membrane dye is considered to be a leaky 

















Figure 5.1 Platelet stimulation with thrombin induces PMP expression 
Fluorescence micrograph of DiOC6 labelled platelet that has been stimulated with 2U/ml thrombin.  Both the stimulated 
platelet (labelled with an arrow) and released microparticles surrounding (circled) are clearly labelled.  As described in the 
literature, the PMP seen here are small, sub-micrometer particles. 
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dye and can leach out and diffuse into neighbouring membranes. This ‘artefact’ highlighted very 
effectively the binding of PMPs from both pre-treatments, as the intensity of the HSC themselves 
(the dimmer larger objects within the frame) was greater in the groups pre-treated with PES and 
PMP compared to the thrombin controls.  Interestingly, there are no clear particle shapes found to 
be bound to the HPC7 in the PMP group.  This could potentially be due to membrane fusion of the 
microparticles as has been previously described (Mause et al., 2010). 
 
The lower panels of Figure 5.2 B presents images again confirming PMP interactions with HPC7s but 
using a different labelling protocol.  GPIb from the microparticles are labelled green, via an Alexa 488 
antibody against anti-GPIb (Figure 5.2 B) and the HPC7 are labelled red with CTO.  The increased 
expression of GPIb on the PES and PMP pre-treated HPC7 cells was clearly evident.  It is interesting  
that the GPIb remains highly clustered in the PMP pre-treated cells, although their membranes 
diffuse and merge with the HSC membrane.  This may occur as a result of the hierarchal architecture 
of the membrane  (Kusumi et al., 2011), whereby transmembrane proteins, such as GPIb are known 
to diffuse slower (Yu et al., 2010), and thus would remain clustered, potentially due to interaction 
with the cell cytoskeleton or trapping within the picket fence regions (Kusumi et al., 2011).    
 
As the number of GPIb and GPIIb on the PMP surface could not be quantified, and as a result of the 
DiOC6 leaking, the number of PMP coating each HPC7 could not be identified, however, the confocal 
imaging of the cells highlights that a large proportion of HPC7 exhibit coating following pre-
treatment.  However, the flow cytometry data highlights that the number coating is potentially very 
low in a large population and also highly heterogeneous in nature. 
  







Figure 5.2 Pre-treatment of HPC7 with PES and PMP results in transfer of the platelet markers 
GPIb and GPIIb, which can be visualised by flow cytometry and microscopically on the surface of 
HPC7  
(A) Pre-treatment of HPC7 with PES (blue line) and PMP (green line) increases their surface expression of glycoproteins GPIb 
and GPIIb compared to thrombin controls (black line).  Plots representative of 3 experiments; Isotype IgG control 
represented by filled black peak. (B) Confocal microscopy reveals that pre-treating HPC7 with PES and PMP results in 
microparticle binding to HPC7.  Upper panels are Z projections of HPC7 pre-treated with microparticles labelled with DiOC6. 
In the lower panels Cell Tracker Orange labelled HPC7 (red) are pre-treated with PES and PMP, with the microparticles 
labelled with an anti-GPIb monoclonal antibody and counterstained with Alexa Fluor-488 antibody (green).  Scale bar = 
5μm, images representative of 3 experiments.   
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5.2.3 PES and PMP pre-treatment of HPC7 significantly enhances HPC7 adhesion to 
colon endothelial cells 
To investigate the effects on HP7 adhesion following pre-treatment with PES and PMP, pre-treated 
fluorescently labelled HPC7 were incubated on a TNFα stimulated colon endothelial cell (CEC) 
monolayer, washed and adhesion quantitated using fluorescence microscopy.  ANOVA statistical 
analysis revealed that there was a significant difference between the groups (p<0.001) with Dunnet’s 
post testing utilised to identify differences between the groups.  Pre-treatment with PES significantly 
(p<0.05) increased the number of HPC7 adherent to stimulated CEC compared to the thrombin 
control whereas PMP pre-treatment had no significant effect on HPC7 adhesion compared to the 
thrombin control (Figure 5.3 A and B). 
 
5.2.4  PES and PMP pre-treatment of HPC7 had no effect on the number of freeflowing 
cells in either IR or colitis injured colon in vivo 
Neither pre-treatment strategy had any effect on the numbers of freeflowing HPC7 within the IR 
injured colon in vivo (Figure 5.4 A).  Similarly, within the colitis colon there was no effect on the 
number of freeflowing cells (Figure 5.4 A). 
 
5.2.5  PES and PMP pre-treatment of HPC7 significantly enhances HPC7 adhesion to 
colitis injured but not to IR injured colon microvasculature in vivo 
In the IR injured colon, neither pre-treatment significantly raised HPC7 adhesion (Figure 5.4A). 
However, within the colitic colon there was a significant (p<0.05) effect on adhesion following pre-
treatment. Dunnet’s post testing identified that only PES pre-treatment significantly (p<0.05) 
increased adhesion compared to thrombin controls, whilst, PMP pre-treatment again failed to elicit a 
significant increase in adhesion (Figure 5.4 B).  As described in earlier chapters, all adherent cells 
were observed intravascularly with no indication of extravasation.  




Figure 5.3 Pre-treatment of HPC7 with PES, but not PMP, enhances adhesion to TNFα 
stimulated colon endothelial cells 
(A) Pre-treatment of HPC7 with PES significantly (p<0.001) enhances HPC7 adhesion to colon endothelial cells.  However, 
PMP pre-treatment has no effect on HPC7 adhesion compared to thrombin controls.  (B) Representative micrographs 
display a brightfield CEC monolayer with fluorescently labelled HPC7 adherent to the surface.  Inset images are 2x electronic 
magnification of boxed region.   Data are presented as mean+SEM.  Statistical analysis performed with one way ANOVA 
with Dunnet’s post testing - results from the Dunnet’s test are displayed.   Abbreviations: PES – platelet microparticle 
enriched supernatant, PMP – purified platelet microparticles, ***p<0.001. 
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Ex vivo analysis of the colon tissue from both IR and colitis colons revealed a similar pattern to that 
observed in the pre-selected region of interest in vivo.  There were no significant differences within 
the IR colon (Figure 5.5 A). Similarly, the colitis ex vivo data again demonstrated that PES significantly 
(p<0.05) enhanced HPC7 adhesion compared to thrombin pre-treatment, whereas PMP did not 
(Figure 5.5 A). 
 
5.2.6  PES pre-treatment of HPC7 significantly enhances their adhesion within the lungs 
and ileum of mice undergoing colonic IR injury 
Following intravital experiments the lungs and ileum were excised from mice undergoing intestinal IR 
injury and also microscopically imaged ex vivo for adherent labelled HPC7 cells.  Within the lungs, 
only PES pre-treatment significantly (p<0.01) enhanced adhesion when compared to the thrombin 
controls (Figure 5.5 B).  Similarly, within the ileum of IR injured mice, it was found that only PES pre-
treatment significantly (p<0.05) enhanced adhesion (Figure 5.5 C).  Overall, the greatest number of 
HPC7s was observed within the pulmonary tissue, with around 100 cells identified per field of view 
quantitated.  This is more than 10x the number of cells observed in the ileum and more than 20x the 
number of cells observed per field of view in the colon.   
 
5.2.7 PES pre-treatment significantly lowers HPC7 adhesion within the lungs of a colitis 
mouse, but has no significant effect on the colitis injured ileum in vivo 
Following intravital experiments the lungs and small intestinal ileum were also excised from mice 
undergoing colitis injury and imaged ex vivo for adherent labelled HPC7 cells.  Interestingly, within 
the lungs, PES pre-treatment significantly (p<0.05) reduced HPC7 adhesion when compared to 
thrombin controls (Figure 5.5 B).  However, PMP pre-treatment had no effect compared to thrombin 
controls (Figure 5.5 B).   Within the ileum derived from mice undergoing colitic injury, neither PES or   













Figure 5.4 Neither PES nor PMP pre-treatment affects the number of freeflowing HPC7 within 
injured colon, but PES enhances adhesion to colitis colon in vivo. 
(A) Neither PES nor PMP pre-treated changed the number of freeflowing HPC7 within the IR or colitis injured colon (B) 
Similarly, neither PES nor PMP pre-treatment enhanced HPC7 adhesion to IR colon, although there was a trend for the PES 
pre-treated cells to exhibit greater adhesion.  However within the colitis colon, HPC7 adhesion was significantly increased 
following PES pre-treatment (p<0.05) with a trend towards increased adhesion also seen with PMP pre-treatment.    Data 
are presented as Mean HPC7/field+SEM.  Statistical analysis performed using One-way ANOVA with Dunnet’s post-test and 
calculated using AUC data. Abbreviations: PES – platelet microparticle enriched supernatant, PMP – purified platelet 
microparticles.  
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PMP pre-treatment significantly affected adhesion when compared to the thrombin controls, 
although there was a trend for adhesion to increase with PES pre-treatment (Figure 5.5 C).  
 
5.2.8 The increased adhesion of HPC7 following pre-treatment is not as a result of 
increased integrin copy number 
Increased cellular adhesion can occur as a result of many different components.  One such factor is 
the copy number of the integrins and other CAMs on the cell surface following stimulation of the 
cells.  Therefore, to investigate whether HPC7 pre-treatment had any effect on CAM expression on 
the cell surface flow cytometry was applied to determine if the expression levels were altered. 
 
Figure 5.6 A displays a representative flow cytometry histogram of CD18 expression following pre-
treatment with either thrombin, PES or PMP.  As can be clearly seen, there was no difference 
between each pre-treatment (Figure 5.6 A).  Similarly, there was no significant difference in CD49d 
expression following pre-treatment with PES and PMP compared to thrombin controls (Figure 5.6 B).  
Finally, the cell adhesion molecule CD44 was also investigated, but again there was no significant 
difference of the surface expression levels (Figure 5.6 C).  
 
5.2.9  Pre-treatment of HPC7 with PES and PMP significantly increases adhesion to VCAM-1, 
whereas adhesion to ICAM-1 is only increased following pre-treatment with PES 
To begin to determine the mechanism by which PES and PMP pre-treatments enhance adhesion of 
HPC7, their adhesion to an ICAM-1 or VCAM-1 surface was quantitated by light microscopy.  One way 
ANOVA analysis reveals that pre-treatment of HPC7 has a significant effect on HPC7 adhesion to 
ICAM-1 (p<0.01; Figure 5.7 A).  Further analysis revealed that adhesion to ICAM-1 following pre- 
treatment with PES significantly (p<0.05) enhanced adhesion, however, PMP pre-treatment had no 
significant effect on adhesion compared to thrombin controls (Figure 5.7 A).  







Figure 5.5 Ex vivo analysis of lung, ileal and colon tissue demonstrated that PES pre-treatment 
enhances HPC7 adhesion to injured tissue 
(A) Ex vivo analysis of the excised colon from the IR and colitis injured mice confirmed what was seen in vivo.  Within the IR 
colon (left panel), PES and PMP pre-treatment did not significantly enhance recruitment, but within the colitis colon (right 
panel) only PES pre-treatment significantly (p<0.05) enhanced adhesion. (B) PES pre-treatment significantly (p<0.01) 
increased HPC7 adhesion within lungs derived from intestinal IR injured mice (left panel), whereas, it significantly (p<0.05) 
reduced adhesion within lungs from colitis injured mice (right panel).  In both IR and colitic lung tissue, PMP did not 
enhance adhesion. (C) Analysis of ileum derived from IR injured mice (left panel) demonstrated that only PES pre-treatment 
significantly (p<0.05) enhanced HPC7 adhesion. Within the colitic ileum (right panel) neither PES nor PMP pre-treatment 
significantly enhanced HPC7 adhesion.  Data presented as mean+SEM, with statistical analysis performed using one way 
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5.2.10 Pre-treatment of HPC7 with PES and PMP trigger clustering of the integrins CD18 
and CD49d and membrane ruffling 
As mentioned above PES and PMP pre-treatment did not alter integrin expression.  However, 
enhanced adhesion to the counterligands ICAM-1 and VCAM-1 was observed.  Thus it was 
investigated whether pre-treatment of HPC7s affected integrin distribution upon the cell surface. 
Confocal microscopy was used to quantify the extent of clustering of the integrin sub-units CD18 and 
CD49d.   
 
The analysis identified that both PES and PMP pre-treatment resulted in a significantly (p<0.05) 
increased number of CD18 clusters compared to the thrombin control (p<0.05; Figure 5.8 A).  
However, there was no significant difference in the size of the CD18 clusters regardless of pre-
treatment (Figure 5.8 A).  Similarly, PES significantly (p<0.05) increased integrin subunit CD49d 
cluster number, although PMP pre-treatment did not when compared to thrombin controls (Figure 
5.8 B).  Again, neither PES nor PMP pre-treatment had any significant effect on the size of the CD49d 
clusters (Figure 5.8 B).  Interestingly, unlike the clustering observed following H2O2 pre-treatment, 
PES and PMP pre-treatments resulted in some internalisation of integrin clusters (Figure 5.8; yellow 
colour on fluorescence micrographs). 
 
Further to investigating integrin clustering effects, the morphology of the cell was also studied.  
Scanning electron microscopy was employed to identify any overt morphological changes of the 
HPC7 following pre-treatment with PES or PMP.  It revealed that following exposure to PES and PMP 
the membrane of the HPC7 ruffles (Figure 5.9 B and C) – a phenomenon often seen in activated 
macrophages (Patel and Harrison, 2008) but this is not seen in the thrombin treated HPC7 (Figure 5.9 
A).  Furthermore, cells pre-treated with PES (Figure 5.9 B) also appear to have extended 
pseudopodia, far more than that seen with the thrombin treated (Figure 5.9 A) control or the PMP  
  





Figure 5.6 Enhanced HPC7 adhesion following pre-treatment is not due to increased cell 
adhesion molecules on the cell surface 
Pre-treatment of HPC7 with PES or PMP had no effect on the surface expression of CD18 (A), CD49d (B) or CD44 (C).  Inset 
graphs mean±SEM of geometric mean normalised against the IgG controls.  Black line = Stem Pro control, yellow line = 
thrombin controls, light blue line = PES group, dark blue line = PMP group.  Abbreviations: SP – Stem Pro, Thr – thrombin, 
PES – platelet microparticle enriched supernatant, PMP – purified platelet microparticles.   



















































































































































































Figure 5.7 PES pre-treatment enhanced HPC7 adhesion to ICAM-1 and VCAM-1, but PMP pre-
treatment only increased adhesion to ICAM-1 
(A) Pre-treatment of HPC7 with PES resulted in a significant (p<0.01) increase in adhesion to an ICAM-1 coated surface, 
whereas, PMP pre-treatment had no effect on HPC7 adhesion to ICAM-1.  (B) Pre-treatment of HPC7 with PES and PMP 
significantly (p<0.001, p<0.01 respectively) enhanced adhesion to an immobilised VCAM-1 surface.  Data presented as mean 
(normalised to BSA protein control)+SEM.  Statistical analysis performed using one way ANOVA with Dunnet’s post test, 
with the Dunnet’s test results displayed.  Abbreviations: PES – platelet microparticle enriched supernatant, PMP – purified 
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treated (Figure 5.9 C) HPC7, but it is interesting to note that both of the latter two groups do seem to 
have extended some pseudopodia unlike the PBS treated cells in Figure 4.7.   
 
5.3  Discussion 
The data presented in this chapter provides novel evidence that thrombin generated PMPs can coat 
HSCs and that this process results in an enhanced intestinal recruitment potential as demonstrated 
both in vitro and in vivo.  This phenomenon appeared to be dependent upon the tissue type and the 
injury status of the tissue.  Furthermore, we demonstrated that co-incubation of HPC7s with PMPs in 
a supernatant also containing the activated platelet releasate was even more effective at enhancing 
adhesion.   Similar to the enhanced adhesion observed with H2O2, the mechanisms primarily involved 
increasing the affinity of stem cell surface integrins for endothelial counterligands.  Although this 
approach offers a more biological strategy for improving stem trafficking to the colon, to be fully 
realised clinically there are several areas that require further in-depth investigation and refinement. 
 
The data demonstrating that a high dose of thrombin can trigger the production of PMPs, 
corroborates previous work published (Jy et al., 1995, Perez-Pujol et al., 2007).  We further 
demonstrated that platelet surface markers, such as GPIIb (CD41; αIIbβ3) and GPIb (CD42), could be 
transferred to the stem cell via the PMPs.  Interestingly, it was identified that this transfer was not 
seen to occur to all of the incubated HPC7.  This raises a few questions, many of which warrant 
further investigation.  For example, it is not clear whether the variability in coating is due to 
heterogeneity within the PMP population or within the HSC population.  It could be that there are 
subsets within either the target cell or the microparticle population that have the correct phenotype 
to facilitate binding.  It could be a more technical problem in that the duration of the incubation 
process needs to be increased or the generation of PMPs needs to be better optimised.   




Figure 5.8 PES and PMP pre-treatment result in enhanced clustering of the integrin subunit 
CD18, but only PES pre-treatment results in enhanced clustering of CD49d 
(A) Both PES and PMP significantly (p<0.05) enhances CD18 cluster number.  However, neither pre-treatment had a 
significant effect on the size of integrin clusters.  The lower three panels are representative Z-projections of HPC7 (red) with 
CD18 clusters (green) following pre-treatment. (B) CD49d clustering only significantly (P<0.05) increased following PES pre-
treatment. Again no change in cluster size was observed.  Below are representative Z-projections of HPC7 (red), the integrin 
clusters (green) and internalised clusters (yellow) following pre-treatments and the thrombin control.  Data are presented 
as mean±SEM and statistically analysed using one way ANOVA and Dunnet’s post test, with the Dunnet’s results displayed.  
Scale bars = 5μm.  Abbreviations: Thr – Thrombin, PES – platelet microparticle enriched supernatant, PMP – purified 
platelet microparticles.  












Figure 5.9 PES and PMP pre-treatment result in membrane ruffling and more pseudopodia 
extension 
(A) Scanning electron micrograph of thrombin treated HPC7 displaying little membrane ruffling (insert box: 2x zoom of 
highlighted area) with some extended pseudopodia, whereas, following PES pre-treatment (B) HPC7 exhibit increased 
membrane ruffling (insert box: 2x zoom of highlighted area) with much greater numbers of pseudopodia extended.  (C) 
PMP pre-treatment displays extensive membrane ruffling (insert box: 2x zoom of highlighted area), with pseudopodia 
extension comparable to that seen with the thrombin controls. Abbreviations: PES – platelet microparticle enriched 
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Indeed, a variety of agonists have been used to generate mouse PMPs other than thrombin including 
collagen, calcium ionophores and combinations of these stimuli (Janowska-Wieczorek et al., 2001, 
Mause et al., 2005, Perez-Pujol et al., 2007).  However, to date there is yet to be a comprehensive 
study comparing the effects of the different stimuli.  The generation of a higher concentration or 
yield of PMPs may lead to more effective coating of stem cells and potentially lead to even better 
recruitment both experimentally and therapeutically. 
 
There is a paucity in the current literature regarding PMP binding to any cell type.  Probably the most 
characterised interaction is between PMPs and neutrophils.  PMPs expose platelet-specific antigens 
on their surface and can adhere to leukocytes in a P-selectin/PSGL-1 dependent manner (Barry and 
FitzGerald, 1999).  Also, more recent studies have demonstrated that platelet GPIb may also play a 
role in PMP binding to neutrophil CD11/CD18 and that the glycoproteins IIb/IIIa are not involved (Lo 
et al., 2006)  Furthermore, both P-selectin/PSGL-1 and GPIb-CD11/CD18 interactions can also 
subsequently activate the neutrophil and modify its adhesion.   To the author’s knowledge, such 
detailed investigations have not been carried out with regards to stem cells, and furthermore, it has 
not clear what proportion of platelet derived microparticles are GPIb positive, or indeed, if GPIb is 
involved in PMP coating of HPC7. 
 
The observed increase of DiOC6 labelling and GPIb and GPIIb surface expression on HPC7 can be 
explained by a number of options including the possibility that (i) the microparticles are bound as 
separate entities on the stem cell surface, (ii) they become endocytosed (or possibly phagocytosed), 
with a subsequent transfer of cell surface markers to the stem cell or (iii), the two membranes 
become fused in a novel mechanism.  Interestingly, we did not note any obvious microparticles 
bound to the HPC7 surface when observed using electron microscopy.  However, this may be due to 
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our inability to differentiate between the microparticles and the highly activated HPC7 membrane 
surface.   
 
There have also been several reports of microparticles delivering their intermembranous contents 
into the target cell, which also partially negates the possibility of them remaining as separate entities 
(Mause et al., 2005, Faille et al., 2012).  Indeed, Faille and colleagues demonstrated that one of the 
ways PMPs are cleared from the circulation is by becoming internalised by ECs.  They further 
demonstrated that PMP internalisation by ECs did not involve the fusion of PMP lipids with the 
endothelial plasma membrane but, rather, an uptake of PMP material with subsequent localization in 
intracellular vesicles (Faille et al., 2012).  Further investigations into the mechanisms by which 
microparticles may deposit themselves or their contents is essential as this could be a keystone for 
the use of microparticles for cellular transformation (Faille et al., 2012), clinical applications (such as 
the one investigated here) or as novel targeted drug delivery vehicles (van Dommelen et al., 2012). 
 
Regardless of the mechanisms involved in PMP coating, it is likely that the method employed to coat 
cells is capable of further optimisation.  This is demonstrated by the observation that PES pre-
treatment was more capable of enhancing HPC7 adhesion than purified PMPs both in vitro and in 
vivo (Table 5.1).  In fact, PMPs only raised adhesion to the colitis colon in vivo, but not significantly.    
Co-incubation with PES also appeared to have the highest level of HPC7 coating, as determined by 
confocal microscopy and flow cytometry.  This may be due to the loss of PMPs during the high speed 
centrifugation step involved in PMP generation.  However, it is also possible that other constituents 
within the PES may play an additive role in facilitating PMP binding.  Indeed, Coppinger and 
colleagues, who also stimulated platelets with thrombin for 3 minutes to achieve maximum release 
of all granule contents (, dense, and lysosomal), identified using a proteomics approach more than 
300 proteins in the releasate (Coppinger et al., 2004).   Many of these are well known to have pro-
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adhesive effects on inflammatory cells (IL-8, SDF-1, RANTES, etc.) and in combination with the PMPs 
themselves may have a greater stimulatory effect on stem cells.   Table 5.1 summarises how PES was 
a far more effective pre-treatment than PMPs at increasing HPC7 adhesion in the various in vitro and 
in vivo assays used in this chapter.   
 
The enhanced adhesion to the injured colon of HPC7 following PES pre-treatment was to a certain 
extent dependent on the type of colonic injury.  PES pre-treatment only significantly enhanced HPC7 
adhesion to the colitis colon, with only a trend for increased adhesion observed in the IR injured 
colon.  As previously mentioned in Chapter 4, inducing IR injury within the colon involves occlusion of 
the superior mesenteric artery.  This artery also feeds the small intestine (SI), as well as the colon, 
and so both small and large bowel injury occurs upon reperfusion.  Indeed, it is well known that 
following intestinal IR injury, significantly more damage takes place in the ileum than the ascending 
colon.  Therefore, when naïve HPC7s are injected, they become adherent within the SI as well as the 
colon.  Therefore, PES pre-treated HPC7s also adhere with greater efficiency with the SI, which most 
likely reduces the pool of circulating HPC7s available to bind within IR injured colon.  PES most likely 
would have significantly increased HPC7 adhesion in the IR injured colon had it not been for the fact 
that most of the injected cells probably adhered in the simultaneously injured SI  - this is particularly 
true since PES significantly increased adhesion in all the assays used (Table 5.1).   
 
Interestingly, PMP pre-treatment failed to significantly enhance adhesion to the colon in vivo 
regardless of the severity of the injury.  The reasons for a lack of enhanced adhesion in the IR injured 
colon may be similar to the reason given earlier for PES.  The absence of adhesion in lungs derived 
from colitis mice may be due to the fact that there is little evidence demonstrating any injuries to the 
pulmonary system following DSS induced colitis injury.   However, within the colitis colon there was a 
trend for the PMP pre-treated cells to enhance adhesion, but this did not reach significance.  This 
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again calls into question whether this is due to insufficient coating of HPC7s with PMPs during co-
incubation, or whether the mode of action of PES and PMPs vary considerably.   However, it is worth 
noting that the adhesion of PMP-coated HPC7s was greatly enhanced on the immobilised endothelial 
counterligand ICAM-1.  Interactions between the 2 integrin (CD11/CD18; LFA-1) and ICAM-1 are 
critical in mediating stable leukocyte adhesion to the colonic endothelium during IR injury (Riaz et al., 
2002a).  It is therefore possible that PMP coating may show some benefit in improving stem cell 
adhesion in other injured organs where expression of ICAM-1 is significantly increased. 
 
The mechanisms of enhanced adhesion were also investigated in this chapter.  One mechanism that 
can be excluded to explain increased adhesion is that of increased surface expression of CAMs.  
Neither pre-treatment with PES or PMP increased surface expression of CD18, CD44 or CD49d.  This 
is not surprising as various attempts within the Kalia lab, using a whole host of pre-treatment 
strategies including H2O2 described in Chapter 4, have failed to induce any increase in expression of 
CAMs.  Platelets also have no CD18, CD49d or CD44 which could be transferred to the HPC7s.  
However, the potential transfer of known platelet surface markers to stem cells may be one of the 
main mediators of increased adhesion. During haemostasis, platelet-platelet interactions or their 
aggregation primarily involves bridging of GPIIb-IIIa receptors by the adhesive protein fibrinogen 
(Kasirer-Friede et al., 2007). Therefore, the increased presence of GPIIb on the HPC7 surface may 
allow similar interactions of the stem cell to take place with platelet aggregates or monolayers 
already adherent in the injured microcirculation.  Indeed, both intestinal and DSS-induced colitis 
injuries are associated with the presence of platelet microthrombi (Anthoni et al., 2007).  Platelet 
GPIb is a component of the GPIb-V-IX complex which binds von Willebrand factor immobilised on the 
endothelium, permitting platelet capture at high shear (Kasirer-Friede et al., 2007).  Therefore, the 
transfer of GPIb to the stem cell surface may also provide a means of increasing stem cell-endothelial 
interactions.     







































Table 5.1 Summary of the pro-adhesive effects of PES and PMP pre-treatment when 
investigated in vitro and in vivo.   
PES most likely would have significantly increased HPC7 adhesion in the IR injured colon had it not 
been for the fact that most of the injected cells probably adhered in the simultaneously injured small 
intestine. Up arrows = Increase, down arrows = decrease, line = no change. *p<0.05; **p <0.01; 
***p<0.001; NS = not significant.  
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Only PES pre-treatment enhanced HPC7 adhesion to an ICAM-1 coated surface in vitro.  This was 
surprising, as despite the absence of an increase in CAMs, both PES and PMP pre-treatments 
clustered CD18 on the stem cell surface. However, the observed CD18 clustering may not be 
‘effective’.  It has previously been demonstrated that the neutrophil integrins can interact with 
platelet GPIIb via a fibrinogen cross-bridge (Patko et al., 2012).  Hence, the leukocyte integrin 
CD11/CD18 can serve as a receptor for fibrinogen (Loike et al., 1991).   It is well established that the 
binding of a ligand to the cell surface can induce triggering of surface integrins (Takagi and Springer, 
2002, Yu et al., 2010).  Therefore the observed CD18 clustering in our HPC7s may be the result of 
residual soluble fibrinogen on an adherent microparticle surface that was not fully removed during 
washing and isolation of the platelets.  The use of a fibrinogen bridge to link the PMP to the HPC7 
may not always be necessary.  The assumption is based on the observations made by others that 
PMP can actively deliver their contents to target cells – a process that would require membrane 
fusion.   
 
Unlike with ICAM-1, pre-treatment with both PES and PMP increased adhesion to VCAM-1 surface.  
This was a surprising result when the clustering data was considered as only PES pre-treatment 
significantly enhanced CD49d clustering.  Therefore, PES enhanced adhesion is most likely due to the 
increased clustering of CD49d, with the clustering being induced by some component of the platelet 
releasate rather than the PMPs themselves.  This may be SDF-1α, a potent chemokine released in 
large quantities by stimulated platelets and thus likely to be a large component of the PES.  We have 
recently demonstrated that SDF-1α also results in a significant increase in HPC7 adhesion to a VCAM-
1 surface, which again may be a result of alteration in integrin distribution.  Interestingly, however, 
SDF1α pre-treatment had no effect on CD49d cluster number/cell, but instead resulted in an 
increased cluster size (Kavanagh et al., 2013).  These seemingly juxtaposed results (in terms of the 
effects on integrin distribution) are likely due to other contributing factors altering integrin behaviour 
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in a highly complex and intricate pathway.  Interestingly, PMPs were also able to enhance adhesion 
to VCAM-1 surface.  In the absence of PMPs increasing CD49d expression or its clustering, it is likely 
to be either another platelet receptor that is capable of binding to VCAM-1, such as αVβ1 (Barry et 
al., 2000), being transferred to the HPC7 surface, or it may be that a component of the microparticles 
(surface bound or internal content) is capable of altering integrin structure and hence its affinity 
state. 
 
Another phenotypic change exhibited by HPC7 following pre-treatment with PES and PMP was the 
membrane ruffling and pseudopodia extension.  Both of these occurrences have been demonstrated 
to be markers of cellular activation (Bretscher, 2008, Patel and Harrison, 2008, Hoon et al., 2012).  
What is noticeable, however, is that the extension of the pseudopodia occurred even following 
thrombin stimulation, although not to the same extent as that observed with PES pre-treatment.  
This suggests HPC7 are capable of responding to thrombin, but no subsequent effect on adhesion 
molecule expression, clustering or stem cell adhesion was observed.  Interestingly, the membrane 
ruffling only appeared to be exhibited on the PES and PMP pre-treated cells.  It is unknown why this 
would occur, although as described in Chapter 4, ruffling has been linked with re-distribution of 
integrins and other cellular processes. 
 
Overall, it has been demonstrated that HSC recruitment to injured tissue can be enhanced by pre-
treatment with PES – the platelet releasate.  The recruitment appears to be predominantly enhanced 
at sites of greatest damage.  This is the key aim of enhancing recruitment of infused stem cells in 
regenerative medicine in an effort to improve clinical efficacy.  However, it is yet to be determined 
whether enhanced cellular recruitment, by pre-treatment with PES, will also improve the therapeutic 
repair efficacy of stem cells.  Furthermore, it will be interesting to determine whether pre-treatment 
will have other effects on repair efficiency, other than that of enhancing recruitment. 

















6.0 Summary of the Main Findings  
HSC transplantation has been used routinely over the past 50 years for the treatment of various 
diseases such as cancers, numerous anaemias and various inborn errors of metabolism (Copelan, 
2006). The safety and efficacy of this procedure is well documented in both autologous and allogenic 
transplantation (Gatti et al., 1968, Copelan, 2006).  When the first studies suggested BM-derived cells 
could reconstitute injured intestinal and non-intestinal tissue, the relatively routine nature of the 
technique fuelled much hope in the field of regenerative medicine.  However, their limited homing 
means that in order for HSCs to be beneficial in the clinic for disorders of the colon, a better 
understanding of the molecular adhesive factors regulating their engraftment is essential in order to 
develop strategies to enhance recruitment.  Therefore, this thesis elucidated the adhesion 
mechanisms involved in the recruitment of HSCs to injured colonic microvasculature.  A summary of 
the major findings from the thesis have been presented in Table 6.1. 
 
The body of work contained in this thesis firstly presented novel data that inflammatory injuries of 
the colon do indeed result in increased adhesion of exogenously administered HPC7 cells, a cell line 
considered a very good model of haematopoietic stem cells.  The increased adhesion of stem cells 
following injury is similarly seen in other organs investigated by our group, including the liver 
(Kavanagh et al., 2010), kidney (White et al., 2013), ileum (Kavanagh et al., 2012) and the cremaster 
muscle (Kavanagh et al., 2013).  It is likely, given the diversity of tissues examined, that this 
phenomenon is common to all tissues following injury.  However, there are several key differences 
between homing to different tissue types that may allow for targeted cellular treatment, and 
furthermore, there are also differences within the same tissue that is dependent upon the type of 
injury.  Novel data within this thesis demonstrate that colonic recruitment following an acute IR 
injury was dependent on the integrin subunit CD18, whereas, within the chronically inflamed colitis










Table 6.1 Summary results table displaying HPC7 adhesion changes following pre-treatment strategies  
The results table summarises significant increases and decreases in the number of HPC7 adherent to either: colon endothelial cells, immobilised ligands, frozen tissue sections or in vivo investigations.  
Data displayed are significant differences against relevant controls and obtained from results chapters. 0 – Not investigated, +++ - p<0.001 increase in HPC7 adhesion, ++ - p<0.01 increase in HPC7 
adhesion, + - p<0.05 increase in HPC7 adhesion, ± - No significant difference in HPC7 adhesion, - - p<0.05 decrease in HPC7 adhesion. 
ICAM-1 VCAM-1 Sham IR Injury Colitis Injury Sham IR Injury Colitis Injury Sham IR Injury Colitis Injury Lungs Ileum Colon Lungs Ileum Colon
Naïve 0 0 0 0 +++ ++ 0 ++ + 0 ++ ++ ± +++ ++ ± ± +
SCM ± ± ± +++ + ± 0 0 0 0 0 0 0 0 0 0 0 0
IR ICM ++ ++ +++ +++ +++ 0 0 0 0 0 0 0 0 0 0 0 0 0
Col ICM ± ± + +++ 0 + 0 0 0 0 0 0 0 0 0 0 0 0
SCM ± ± + 0 0 0 ± ± ± 0 0 0 0 0 0 0 0 0
IR ICM + +++ + 0 0 0 ± +++ 0 0 0 0 0 0 0 0 0 0
Col ICM ± + ++ 0 0 0 ++ 0 + 0 0 0 0 0 0 0 0 0
SCM ± + + 0 0 0 0 0 0 + + + 0 0 0 0 0 0
IR ICM + + + 0 0 0 0 0 0 + + 0 0 0 0 0 0 0
Col ICM + + + 0 0 0 0 0 0 + 0 +++ 0 0 0 0 0 0
H2O2 ++ ++ +++ + ++ ± ++ + ++ +++ ++ + ± + ± ± ± +
PES +++ ++ +++ 0 0 0 0 0 0 0 0 0 ± + ± - ± +
















IR Injured Colitis Injured
Frozen Tissue SectionsImmobilised 
Ligands
In vivo  experiments
Colon
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colon, both CD18 and CD49d were required for HPC7 adhesion. Interestingly, within IR injured small 
intestine, adhesion was also solely dependent on CD18, whereas in IR injured kidney additional and 
multiple adhesion molecules, including CD49d and CD44, are involved (White et al., 2013).  Overall, 
these studies demonstrate that the kinetics of HSC recruitment follows a similar adhesion cascade to 
that well described for inflammatory neutrophils.   This has very important implications from a 
clinical perspective because one of the major areas of debate clinically for cellular therapy is on the 
best and most effective route for delivery.  This current study (and others from our group) 
demonstrates that these cells can be delivered systemically, they are capable of circulating in the 
bloodstream and they can home to and be captured by inflamed colonic vasculature.   
 
Interestingly, increased adhesion within injured colon was not due to a reactive hyperaemia, an 
increased blood perfusion, often associated with tissue injury.  In fact, perfusion rates within the 
injured colon mucosal microcirculation were actually reduced compared to healthy sham controls.  It 
is not clear whether adhesion would have been better if perfusion was not altered.  In similar 
experimental models of DSS-induced colitis in mice, a modest decrease in blood flow within the 
resistance arterioles of the colon submucosa has been demonstrated at days 4 and 6 post-DSS (Mori 
et al., 2005b).  However, the current study is the first to demonstrate that the mucosal lining of 
injured colon also undergoes a significant reduction in blood flow.  Preservation of the lining of the 
gut is essential.  Therefore, it is reassuring to observe that circulating stem cells can still be recruited 
to the mucosa despite the poor perfusion in this region.  This has important clinical implications as 
many inflamed organs suffer from poor blood flow.  Indeed, in human subjects with ulcerative colitis, 
a reduction in flow is often detected in the chronically inflamed and remodelled colon (Hulten et al., 
1977).  It is possible that this reduced blood flow in injured sites is more conducive to adhesive 
interactions of stem and endothelial cells taking place, whereas it may limit the local bioavailability of 
systemically administered drugs.  To achieve successful colonic delivery, oral drugs need to be 
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designed that are protected from absorption in the upper GIT and are released into the proximal 
colon.  Therefore, systemically delivered stem cells may have advantages over pharmacological drugs 
for treatment of diseases of the colon such as Crohn’s disease and ulcerative colitis.   
 
Regardless of the molecular mechanisms utilised for stem cell adhesion within injured tissue, it is 
commonly reported that the clinical efficacy and success of cellular therapies is either minor or 
transitory.  This may be due to the limited number of stem cells recruited, when delivered by the 
preferred systemic route, as a result of poor homing and a subsequent low efficiency of tissue 
engraftment, processes essential for stem cells to mediate repair. Developing methodologies that 
improve trafficking and recruitment into injured tissues is a high priority for cellular therapies and 
could potentially confer more efficient, rapid and longer lasting tissue recovery.  Indeed, transfecting 
plasmid DNA encoding for SDF-1 into ischaemic muscle enhances endothelial progenitor cell 
recruitment (Hiasa et al., 2004).  However, delivery of vectors to allow for targeted chemokine 
expression has been challenging, particularly in the clinical setting. Thus, non-invasive (and relatively 
easier and cheaper) techniques that do not require introduction of genetic material are appealing.  
The gained understanding of the mechanisms governing SC homing to injured colonic microvessels 
may have significant clinical consequences as it may allow us to optimise their effective colonic 
delivery and improve their therapeutic efficacy.   
 
Hence, the next stage of the research was to identify strategies that enhanced stem cell colonic 
recruitment in vivo.  With the observation that trafficking through injured tissue resulted in stem cell 
adhesion, it was hypothesised that exposing stem cells to soluble factors, commonly identified within 
the inflammatory microenvironment, would prime the cells and increase their ability to interact with 
inflamed endothelium.  Initially, we demonstrated that pre-treating cells with media that had been 
conditioned by incubation with injured tissue resulted in increased adhesion in vitro.  Increased 
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adhesion was observed on endothelial cells, injured tissue sections and immobilised endothelial 
counter-ligand coated surfaces. These proof of concept experiments clearly demonstrated HSC 
adhesion to injured colon could indeed be modified.  However, this strategy does not have the 
potential to be applied clinically, and so more translational approaches were identified.   
 
One factor identified within ICM was the reactive oxygen species H2O2.  Within injured gut, 
particularly the small intestine, a significantly higher concentration of H2O2 was present compared to 
healthy tissue.  With earlier studies demonstrating that H2O2 increased leukocyte rolling and 
chemotaxis (Fraticelli et al., 1996), it was investigated whether pre-treatment of HPC7 with H2O2 also 
influenced their adhesion.  Pre-treatment of cells with 100μM H2O2, a concentration reported to be 
similar to that seen in vivo (Johnston et al., 1996), resulted in a significant increase in HPC7 adhesion 
in vitro. Furthermore, through the use of antibody blockade of CD18 and CD49d, it appeared that the 
increased adhesion was an active process and integrin mediated, when investigated in vitro.  Integrin 
clustering may provide a mechanism by which stem cell adhesion could be improved.   
 
H2O2 also increased adhesion in vivo but only under certain circumstances, with the increased 
adhesion in vivo occurring only within colitic colon, not IR colon.  This surprising result can be 
explained due to greatly increased adhesion within the IR ileum, likely resulting in a reduced pool of 
circulating cells available to be recruited within the IR colon. 
 
These studies present the first evidence that colonic stem cell homing can be modified using a 
relatively cheap, effective and easy protocol.  These studies also highlight how chemically 
manipulating stem cell surface integrins can modify their adhesion.  One very important therapeutic 
implication of improving or targeting delivery to a particular site is that non-specific retention in 
healthy tissues is avoided.  Indeed, we have previously demonstrated that improving HSC 
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recruitment in the small intestine reduces non-specific entrapment in the pulmonary tissue 
(Kavanagh et al., 2012).   
 
Overt morphological changes were also observed following H2O2 pre-treatment, namely an increase 
in membrane ruffling and cellular protrusions that resembled filopodia.   Although we can only 
speculate that these morphological changes are not detrimental to the cells ability to function 
therapeutically, this clearly would need further investigation.  However, similar morphological 
occurrences have been described when LPS activated macrophages were examined (Patel and 
Harrison, 2008) and it was suggested that the ruffling allowed for directed cellular motility (Stupack 
et al., 2000, Bretscher, 2008), phagocytosis (Patel and Harrison, 2008), adhesion (Arjonen et al., 
2011) and receptor re-distribution (Hoon et al., 2012) and so could be considered a marker of cellular 
activation.  Furthermore, it should be noted that there are several classes of membrane ruffling that 
are described to play many diverging roles.  Hence, further investigation into the nature and 
biochemical make-up of these ruffles and extensions may reveal deeper insight into the cellular 
effects following H2O2 pre-treatment.   
 
The advantages of pre-treating stem cells with H2O2 may not just be limited to their ability to 
improve adhesion.  Li and colleagues demonstrated that the ability of MSCs to survive in an 
ischaemic environment could be improved by pre-exposure to H2O2.   They demonstrated that 
preconditioning MSCs with 20μM H2O2 significantly protected them against apoptosis induced by 
higher concentrations of H2O2 (Li et al., 2009b).  More recently, Pendergrass et al., demonstrated that 
left ventricular cardiac function, when assessed 28 days after IR injury, was greatly improved when 
cardiac progenitor cells pre-treated for 2 days with 100µM H2O2 were used as opposed to naïve ones 
(Pendergrass et al., 2013).  Furthermore, cardiac fibrosis was significantly decreased and endothelial 
cell density significantly increased when using pre-conditioned cells.  Although our study focussed on 
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improving stem cell retention, we may not have fully discovered any additional therapeutic effects 
this pre-treatment strategy may have.  Recovery studies assessing tissue and vasculoprotective 
effects of naïve versus H2O2 pre-treated HSCs are therefore essential future experiments. 
 
Another component of the injury milieu are PMPs, released as a result of platelet activation and 
microthrombus formation.  It has been prior demonstrated that PMP can interact with cells and alter 
behaviour to enhance activity and homing (Barry et al., 1998, Forlow et al., 2000, Janowska-
Wieczorek et al., 2001, Mause et al., 2005).  Thus, their ability to improve stem cell retention was 
investigated as this was considered an alternative and more biological approach, when compared to 
the H2O2 chemical approach, which may have resulted in further benefits due to the complexity of 
the PMP contents and their make up.  Both purified PMPs and PMPs contained within the activated 
platelet releasate (PES) allowed for reproducible coating of HPC7s, as demonstrated by transfer of 
platelet glycoproteins to the HPC7 surface.   
 
It is not clear whether the transfer of platelet adhesion molecules such as GPIb, an integrin that 
allows platelets to tether to immobilised von Willebrand factor, aids in stem cell recruitment.  This 
would need to be determined using an anti-GPIb antibody.  If transfer of GPIb is useful, improving the 
protocol to generate a greater number of PMPs or improving the coating of stem cells with PMPs 
may be a worthwhile pursuit.   
 
At present the likely mechanism of enhanced adhesion is via the redistribution of existing integrins 
on the stem surface as changes in integrin cluster size or number were observed confocally.  This 
parallels what was demonstrated with H2O2.  Similarly, the increased membrane ruffling and cellular 
protrusions were observed following pre-treatment, as was observed following H2O2 pre-treatment. 
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Interestingly, only the PES pre-treatment significantly increased adhesion in vivo, and that the 
increased adhesion was only observed in the colitis injured, not IR injured, colon.  The lack of an 
effect following PMP pre-treatment was a somewhat unexpected result as both PES and PMP pre-
treatment did result in increased adhesion to some surfaces investigated with in vitro assays.  This 
suggests activated platelets release important factors that significantly modulate the adhesion of 
stem cells, but in a potentially site-specific manner.   
 
It has previously been demonstrated that platelets, often found adherent in abundance in ischaemic 
and inflammatory environments, may guide the homing of stem cells to sites of injury (de Boer et al., 
2006).  Further characterization of the chemical and cellular factors in platelet related homing, 
platelet releasate effects on target cells and the processes of PMP generation and their interactions 
may contribute to the development of innovative strategies to augment stem cell mediated tissue 
repair for colon pathophysiological conditions. 
 
6.1  The two-component enhanced recruitment model 
This project has shown that injury promotes HPC7 adhesion and that pre-treatment with known 
inflammatory mediators enhances adhesion.  Interestingly, it was also found that pre-treated HPC7 
displayed enhanced adhesion to sham or healthy tissue. It is from these observations that a potential 
model with regards to stem cell adhesion can be postulated. This model suggests stem cell 
recruitment, and the enhancement of this event, requires at least two components.   
 
The first component is tissue injury, with the concomitant increase in expression of endothelial CAMs 
and generation of the inflammatory releasate (Figure 6.1 B). The second component is cellular 
activation, achieved pathophysiologically by exposure to environment (such as the inflammatory 
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releasome; Figure 6.1 B), but this can also be achieved by pre-treatment in the absence (Figure 6.1 C) 
or presence of tissue injury (Figure 6.1 D).  It appears that each component can act independently of 
each other, but when the actions are combined, the greatest level of adhesion is observed (Figure 
6.1 D).  Hence, maximal adhesion requires activation of the stem cells, but also activation of the 
tissue.  Evidence supporting all of these stages has been presented in this thesis.  For example, the in 
vitro SW assay performed with H2O2 pre-treatment demonstrates this very well (See Figure 4.4 and 
Table 6.1).  When pre-treated cells were incubated on the sham tissue there was a significant 
increase in adhesion, but when pre-treated cells were incubated on IR injured tissue there was a 
greater increase. 
 
Further investigation and understanding of this mechanism may allow for improved pre-treatment 
strategies to be developed that may be used for future therapeutic purposes.  Our observations that 
certain pre-treatments are effective only in certain organs or in diseases are novel as it highlights 
how a single universal approach may be difficult to identify.  Careful consideration will need to be 
given to identifying which pre-treatment generates the correct cellular response for tissue type or 
injury.   
 
6.2 Future directions 
Although these data have demonstrated that phenotypic alterations of the cell modify their 
adhesion, it is yet to be fully investigated whether enhancing the local presence of stem cells 
improves tissue repair and regeneration above and beyond that observed when they are recruited by 
injury alone.  Furthermore, it needs to be determined whether the identified pre-treatment 
strategies have therapeutic benefits independent to their effects on adhesion.  Recent work 
undertaken by the Kalia group has demonstrated that although HPC7s home to IR injured small 
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intestine, they were only able to significantly reduce the presence of inflammatory neutrophils 
(within 4 hours post-injury)  if their local presence was enhanced using SDF-1 (Kavanagh et al., 
2013).It is yet to be determined whether the dampened neutrophil recruitment was a result of 
increased stem cell presence, or whether the pre-treatment exerted some, as yet unidentified, effect 
on the HPC7s to improve/introduce immunomodulatory effects.   The fact that SDF-1 can modify 
stem cell adhesion is interesting in light of our PES/PMP data as this chemokine can be released by 
platelets.   
 
Identification of additional chemical and biological factors within the ICM pre-treatment would be 
interesting as they may be more potent modulators of stem cell behaviour than H2O2/PMPs.  
Luminex analysis failed to identify any likely factors in the form of cytokines and chemokines, and 
furthermore, MALDI-TOF spectroscopic analysis of CM performed (data not presented within this 
thesis) reinforced this absence of chemo/cytokines but did detect complement and leukotrienes 
within these ICMs.  Although, these many other potent cellular activators, such as leukotrienes and 
complement, may have an effect on the HPC7, they were not investigated.   Indeed, such factors may 
be unique to tissue or injury type and may offer the potential to further refine the targeting process.  
Although this concept is seemingly far-fetched, the data from the H2O2 experiments reveal that the 
tissues that contained the greatest concentration of H2O2, namely the IR injured ileum and jejunum, 
also had more HPC7 adhering within them following H2O2 pre-treatment.   
 
It has been demonstrated by several groups that altering the redox balance within the cytosol can 
have many different effects from protein kinase activation (Staal et al., 1994), phosphatase inhibition 
(Heffetz et al., 1990, Reyes et al., 2005), transcription factor localisation (Los et al., 1995), enhanced 
affinity of integrins (Liu et al., 2008, de Rezende et al., 2012) and integrin re-distribution, as 
demonstrated here.  But, with regards to stem cell behaviour and regenerative potential, the multit-  














Figure 6.1 The two-component enhanced recruitment model 
(A) HPC7 flowing through uninjured microvasculature will only adhere in very low numbers, the few that do adhere are 
likely to become detached over time.  This is probably due to ‘un-opened’ integrins (those in an inactivated state) and low 
copy number of cell adhesion molecules (CAMs). However, when HPC7 are flowing through injured microvasculature (B) 
they are exposed to the inflammatory factors released by endothelium (black arrows).  This in turn activates the HPC7 
causing integrins to cluster and probably achieve an ‘open’ or activated conformation.  This will result in greater HPC7 
numbers adhering to the activated endothelium (now exhibiting increased CAM on the surface) with fewer detaching. (C) 
When HPC7 are pre-treated then exposed to uninjured tissues, their integrins are clustered and activated and so can 
interact more readily with the limited numbers of CAMs on the vascular surface.  This results in a marginal increase in HPC7 
adhesion, with a reduced rate of detachment. However, pre-treated HPC7 flowing through an injured environment (D) are 
primed (that is their integrins are clustered and open) to bind to the increased number of CAMs on the injured surface 






































Chapter 6: General Discussion 
167 
 
- udes of effects of H2O2 pre-treatment are yet to be investigated, but hold considerable promise.  
 
Another intriguing question is how the PMPs physically interact with the stem cell surface.  Although 
several studies have investigated this for other cell types, there remains no overwhelming consensus 
on the surface receptors used (although it is highly likely that differing cell types, and indeed MP 
types, will utilise differing markers) or the mechanisms involved in PMP loading.  Suggestions that 
have been made include that they are endocytosed or phagocytosed with their receptors recycled 
(Faille et al., 2012), whilst others have proposed membrane assimilation for PMP loading and 
incorporation, however, the mechanisms for this remain unclear and somewhat unsubstantiated 
(Mause et al., 2010).  Increased studies would be highly informative considering the increasing role of 
many types of microparticles, including those from platelets, in the aetiology of many diseases 
(Boulanger et al., 2006, Burnier et al., 2009), as well as them potentially being powerful therapeutic 
agents in their own right (van Dommelen et al., 2012).   
 
A further consideration to be made regarding PMPs is the nature of the generated population.  It has 
been demonstrated that depending on the source of stimulation platelet microparticles display 
differing phenotypes (Perez-Pujol et al., 2007), but this needs to be fully explored to determine the 
extent of variation between stimuli. Furthermore, it needs to be determined whether the PMP 
populations are heterogeneous in receptor repertoire as well as size, even when derived from a 
single source.  More importantly, with regards to the application made here, does one sub-
population alter SC behaviour in a more beneficial manner than another – that is, does a certain 
phenotype of microparticle further improve engraftment, does another improve the regenerative 
capacity of microparticles?  These are fairly sizeable holes in MP research that need to be 
investigated to allow their use as research tools as well as therapeutically.   
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6.3 Implications and closing remarks 
Overall, this thesis has described several methods of enhancing SC recruitment within both IR and 
colitic injured intestinal tissue.  This may allow for improved stem cell therapeutics by increasing SC 
presence in the most damaged and affected areas, thus improving the reported poor efficacy of 
current SC treatments.  This requirement for improved efficacy is emphasised further when the poor 
prognosis for patients with intestinal IR injury and the loss of effective treatments for those with IBDs 
over time is taken into consideration. 
 
Increasing our knowledge of stem cell homing may have benefits beyond those associated with their 
regenerative potential.  The fact that stem cells home specifically to certain sites may provide an 
important clinical application – namely targeted drug delivery.  There is current excitement that 
MSCs, may be an attractive cellular vehicle for anti-cancer drugs (Loebinger et al., 2009, Ciavarella et 
al., 2011), but HSC have also been considered potential tools for targeted drug and gene delivery 
(Coleman and Steptoe, 2012, Kiem et al., 2012, Freistadt et al., 2013).   Furthermore, it is possible 
that these pre-treatment strategies may also be employed within the bone marrow transplantation 
field.  It has already been demonstrated that crude PMP pre-treatment strategies can enhance HPC 
recruitment to bone marrow (Janowska-Wieczorek et al., 2001), thus refining the process is more 
likely to allow PMP pre-treatment to enter therapeutic protocols and increase effectiveness and 
efficacy of treatment. 
 
It is hoped that these promising pre-treatments can be explored further with regards to both how 
they are working and, most importantly, whether they are increasing SC therapeutic efficacy.  With 
the solution to these questions it can be hoped that they lead to further development of the field of 
regenerative medicine. 
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